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UL12 and ICP0 Regulate DNA Repair Pathway Choice During HSV-1 Infection

Samantha Smith, PhD
University of Connecticut, 2015

In order to promote lytic infection, HSV-1 manipulates components of the cellular
DNA damage response (DDR). We hypothesized that correct pathway choice during
HSV-1 infection is essential for productive infection. The central objective of this thesis
was to determine whether UL12 acts a mediator of DDR pathway choice in order to
produce DNA that is infectious and that can be packaged for productive infection.
Previous studies have identified the classic non-homologous end joining (C-NHEJ) as
antiviral, and we first sought to determine whether an incoming viral genome alone was
sufficient to activate C-NHEJ. We transfected cells with purified virion DNA and
monitored phosphorylation of RPA by DNA-PKcs. By adding 5’ flaps to virion DNA, we
were able to increase stimulation of DNA-PKcs activity, resulting in loss of infectivity.
We showed that infectivity of the modified virion DNA could be restored by
overexpression of ICP0 and in the cells deficient for DNA-PKcs. Thus, ICP0 may play an
important role in promoting productive infection by inhibiting C-NHEJ. Since the UL12null (AN-1) produces near wild type levels of DNA, but exhibits a severe growth defect,
we next asked whether AN-1 DNA was infectious. By transfecting wild type and UL12complementing Vero cells with purified AN-1 DNA, we determined that the DNA
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produced in the absence of UL12 was aberrant and non-infectious. We hypothesized that
in the absence of UL12, aberrant viral DNA is produced due to incorrect DDR pathway
choice. To test this, we measured viral yields of UL12 mutant viruses on cells deficient
for core C-NHEJ proteins and analyzed the DNA produced by pulsed field gel
electrophoresis. We found that AN-1 grows better and produces less aberrant DNA on CNHEJ-deficient cells. To determine whether UL12 and ICP0 are sufficient to effect
pathway choice, we used a plasmid-based repair reporter that measures the ratio of CNHEJ activity to MMEJ activity. We showed that both ICP0 and UL12 inhibit aspects of
the C-NHEJ pathway in order to promote productive infection. This work demonstrates
that C-NHEJ is antiviral, and that correct DDR pathway choice is essential for productive
HSV-1 infection.
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“Why are things as they are and not otherwise?”
- Johannes Kepler

“The capacity to blunder slightly is the real marvel of DNA. Without this special attribute,
we would still be anaerobic bacteria and there would be no music.”
- Lewis Thomas, Lives of the Cell

“Never ignore coincidence, unless of course, you’re busy. In which case, always ignore
coincidence.”
-Doctor Who
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CHAPTER 1

Introduction

Samantha Smith and Sandra K. Weller

Portions of the text and Figures 1.5, 1.6, and 1.8 from this chapter were submitted as a
review manuscript for publication in Future Virology.

1.1. Herpes simplex virus I (HSV-1) Overview.
1.1.a. Characteristics of Herpesviridae family members.
Herpesvirales is a large and ancient order of viruses that is thought to have
evolved approximately 500 million years ago. The Herpesviridae family is composed of
more than 100 species, which infect a variety of reptilian, avian, and mammalian hosts.
They are able to persist indefinitely within their hosts in a latent form, reactivating
periodically to produce lytic infection. Members of Herpesviridae, commonly called
herpesviruses, are grouped into three subfamilies (α, β, and γ herpesviruses) based on
length of replicative cycle and the range of hosts they infect. Alphaherpesviruses have a
short replication cycle and a broad host range; whereas, beta- and gammaherpesviruses
have longer replication cycles and the range of host cells they infect are more restricted
(Pellet and Roizman, 2007). Herpes simplex virus 1 & 2 (HSV-1, HSV-2) are
alphaherpesviruses that cause lesions in the oral and genital mucosa, respectively.
Varicella zoster virus (VZV or HHV-3), another alphaherpesvirus, causes chicken pox
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(varicella) during primary infection, and shingles (zoster) during reactivation from
latency. Epstein-Barr virus (EBV or HHV-4) is a gammaherpesvirus that causes
mononucleosis and is associated with several types of cancer, including Burkitt’s
lymphoma. Human cytomegalovirus (HCMV or HHV-5), a betaherpesvirus, typically
does not cause symptoms in healthy individuals, but can be deadly for
immunocompromised individuals and newborn infants. HHV-6 and HHV-7 have not
been as well researched as the other human herpesviruses. Both are betaherpesviruses and
belong to the genus roseolovirus and are associated with febrile illness (Suga, Suzuki et
al. 1998). HHV-6 causes sixth disease in young children, which can have serious
complications. Kaposi’s sarcoma-associated herpesvirus (KSHV or HHV-8) is a
gammaherpesvirus, and is one of six known human oncoviruses* (Mesri, Feitelson et al.
2014).
Herpesviruses are extremely diverse with respect to tissue tropism and pathology;
however, they all possess a similar virion structure (Figure 1.1). Herpesvirus virions
contains a linear double strand DNA (dsDNA) genome that is relatively large (~124kb241kb (Gray, Starnes et al. 2001, Davison, Dolan et al. 2003)) and contains terminal
repeats and complementary single strand DNA (ssDNA) regions at each end (McGeoch,
Rixon et al. 2006). The genome is housed within an icosahedral-shaped protein capsid,
which is surrounded by a layer of viral proteins and mRNAs called the tegument. All of
this is encased in a lipid bilayer envelope that is decorated with glycoproteins, which
facilitate entry into the host cell. The herpesvirus lifecycle is biphasic, consisting of a
primary lytic infection followed by latency (Figure 1.1).
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1.1.b. Overview of the HSV-1 lifecycle.
Herpes simplex virus 1 (HSV-1) is a ubiquitous human pathogen responsible for
significant disease during acute infection, HSV-1 lytic infection manifests in epithelial
cells, most commonly of the oral and ocular mucosal, and results in cell death. Lytic
infection is initiated when envelope glycoproteins on the virion bind to the attachment
fact, heparin sulfate, and cell surface receptors, such as herpesvirus entry mediator
(HVEM) and nectin-1 (Herold, WuDunn et al. 1991, Spear 2004). The envelope fuses
with the cellular plasma membrane (Figure 1.2, top left). The capsid is then trafficked
along microtubules by the dynein-dynactin motor complex, ultimately arriving at the
nucleus (Sodeik, Ebersold et al. 1997, Dohner, Wolfstein et al. 2002, Mabit, Nakano et al.
2002). There it docks at the nuclear pore complex and releases its genome into the
nucleoplasm (Batterson, Furlong et al. 1983, Lycke, Hamark et al. 1988). The incoming
viral genome is a naked, linear dsDNA molecule that contains nicks and gaps (Kieff,
Bachenheimer et al. 1971, Frenkel and Roizman 1972, Wilkie 1973, Biswal, Murray et al.
1974, Hirsch and Vonka 1974, Wadsworth, Hayward et al. 1976, Jacob and Roizman
1977, Roizman, Jacob et al. 1979). Within the nucleus, viral gene expression occurs in
three kinetically distinct classes (described below). Viral gene expression, DNA
replication, and packaging occur in large globular structures called replication
compartments (RCs) (Quinlan, Chen et al. 1984, Lamberti and Weller 1996, Phelan,
Dunlop et al. 1997). HSV-1 DNA replication produces highly branched, multimeric
structures that must be resolved into linear, longer-than-unit length concatemers for
packaging (Jacob and Roizman 1977, Jacob, Morse et al. 1979, Jongeneel and
Bachenheimer 1981, Bataille and Epstein 1994, Severini, Morgan et al. 1994, Zhang,
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Efstathiou et al. 1994, Severini, Scraba et al. 1996). DNA is packaged into preformed
capsids. During egress from the nucleus, there is budding from the inner membrane, and
fusion with the outer nuclear membrane, followed by a series of envelopment and deenvelopment steps (Enquist, Husak et al. 1998, Mettenleiter 2002). The tegument layer
consists of 23 viral proteins and also viral (Loret, Guay et al. 2008). Although the
nucleocapsid is thought to acquire components of the tegument layer in the cytoplasm,
there is some evidence that some tegument proteins associate with nucleocapsids in the
nucleus (Kelly, Fraefel et al. 2009). Finally, budding occurs at the cellular membrane,
where the virion acquires its bi-lipid envelope and glycoproteins and is released into the
extracellular space (Campadelli-Fiume, Amasio et al. 2007).
Following primary lytic infection, HSV-1 establishes a latent infection that can
last for the life of the host with the potential for reactivation and recurrent disease. HSV-1
establishes latency in non-dividing sensory neurons within the trigeminal ganglion of its
host. Sensory neurons can harbor anywhere between 10 to 100 copies of the HSV
genome per cell (Sawtell, Poon et al. 1998, Wang, Lau et al. 2005). During latency, HSV1 carries out minimal gene expression. The limited genes that are expressed during
latency are called the latency associated transcripts, or LATs, which facilitate
maintenance of the viral genome within the cell and allows for occasional reactivation
from latency. It is thought that the ability to reactivate from latency and shed new virus is
kept in check by cellular repressors and immune surveillance (Cantin, Hinton et al. 1995,
Khanna, Bonneau et al. 2003).
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1.1.c. The HSV-1 genome and gene expression.
The HSV-1 genome is approximately 152 kilobase pairs in length. It is composed
of two unique regions (UL and Us), each of which is flanked by inverted repeat regions
(Figure 1.3) (Hayward, Jacob et al. 1975, Sheldrick and Berthelot 1975, McGeoch,
Dalrymple et al. 1988). Genomic inversions occur between the inverted repeats (Brown,
Ritchie et al. 1973, Hayward 1974, Delius and Clements 1976, Zhang, Efstathiou et al.
1994). Thus, there are four possible isomers of the genome, which have been reported to
be present in equimolar proportions during wild type infection (Bataille and Epstein
1997).
The genome encodes at least 74 proteins, which are temporally regulated and fall
into three general kinetic classes: immediate early (IE, or α), early (E, or β), and late (L,
or γ) (Honess and Roizman 1974). The five IE proteins (ICP0, ICP4, ICP22, ICP27, and
ICP47) serve to promote a positive environment for productive viral replication and
regulate viral gene expression. As the name implies, IE proteins are transcribed
immediately and do not require protein synthesis for expression. IE transcription requires
the viral tegument protein, VP16 (also called TIF, or α-trans-inducing factor) and the
cellular transcription factors, Oct1 and HCF (Kristie and Roizman 1987, Kristie and
Roizman 1988, Kristie and Sharp 1990). The E genes include DNA replication proteins
and some envelope glycoproteins. Unlike IE genes, the E gene promoters do not require
VP16, but they do contain elements that bind the cellular transcription factor, SP1
(Wagner, Guzowski et al. 1995, Kim and DeLuca 2002). In addition, E genes require IE
gene expression. For example, ICP4 plays a very important role in stimulating E gene
expression by binding directly to E promoters and helping to recruit TFIID and other
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transcription factors (reviewed in DeLuca, 2011). L genes require DNA replication for
their expression and they encode capsid proteins.

1.1.d. The earliest stages of HSV-1 infection.
HSV-1 DNA synthesis takes place in the infected cell nucleus in large globular
domains called replication compartments. Replication compartments serve to concentrate
and partition viral and cellular proteins that are required for productive infection. At the
earliest stages of infection, cellular proteins are recruited to the vicinity of viral genomes
in an attempt to thwart the infection. For instance, PML (promyelocytic leukemia protein)
and other ND10 proteins form virus-induced PML-nuclear bodies (viPML-NB) that are
associated with repression of vial gene expression (reviewed in (Everett 2001)). ViPMLNBs are subsequently disrupted by the E3 ubiquitin ligase activity of ICP0 (Everett,
Meredith et al. 1999). As described below, other cellular proteins, many of which also
exert antiviral effects, are also recruited to viral genomes including cellular histones as
well as components of the DNA damage response pathways. HSV-1 has evolved to
counteract antiviral mechanisms primarily through the action of ICP0. Some components
of the DDR may also be beneficial to viral infection, and in this section we will discuss
how HSV-1 navigates this complex cellular environment to create conditions that are
conducive to productive viral infection.
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1.1.e. HSV-1 DNA replication is closely associated with recombination.
The virus encodes seven essential replication proteins: the origin binding protein
(UL9), the single strand DNA binding protein (SSB, ICP8), the heterotrimeric
helicase/primase (UL5/8/52), the polymerase (UL30), and the polymerase processivity
factor (UL42). Replication occurs in a biphasic manner, beginning with an UL9dependent phase and later switching to a mechanism that does not require UL9 (Blümel
and Matz 1995, Schildgen, Graper et al. 2005). The HSV genome contains three origins
of replication: two copies of oriS and one oriL (Figure 1.3.A) (reviewed in (Weller and
Coen 2012)). Current models suggest that together ICP8 and UL9 trigger the melting of
one of these origins followed by recruitment of the helicase/primase complex and the
HSV polymerase to carry out unwinding and elongation, respectively (Weller and Coen
2012).
HSV-1 DNA replication produces concatemers, which are required for the
generation of progeny (Figure 1.3); however, the mechanism by which they are formed is
unclear. It has long been recognized that HSV-1 genomes undergo a high degree of
recombination (Wildy 1955, Brown, Ritchie et al. 1973, Hayward, Jacob et al. 1975,
Sheldrick and Berthelot 1975, Delius and Clements 1976, Zhang, Efstathiou et al. 1994,
Dutch, Bianchi et al. 1995, Fu, Wang et al. 2002). Although it has been proposed that the
viral genome circularizes and rolling circle replication leads to the formation of
concatemers (Poffenberger and Roizman 1985, Garber, Beverley et al. 1993, Deshmane,
Raengsakulrach et al. 1995, Strang and Stow 2005), several lines of evidence suggest that
HSV DNA replication is more complex. Controversy still remains over whether the
incoming viral genome circularizes prior to replication, and recent evidence suggests that
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circularization may actually be associated with latency (discussed in Chapter 2) (Jackson
and DeLuca 2003, Strang and Stow 2005). HSV-1 replication proteins are able to
catalyze rolling-circle replication in vitro (Skaliter and Lehman 1994, Skaliter, Makhov
et al. 1996, Graves-Woodward, Gottlieb et al. 1997, Falkenberg, Lehman et al. 2000), but
it has not been shown conclusively that rolling circle replication occurs during infection.
Simple rolling circle replication does not explain the observation that genomic inversions
occur as soon as viral DNA synthesis can be detected (Zhang, Efstathiou et al. 1994,
Lamberti and Weller 1996, Severini, Scraba et al. 1996). In addition, replication of the
HSV-1 genome produces X and Y branched structures that can be visualized by electron
microscopy and 2D gel electrophoresis (Jacob and Roizman 1977, Severini, Scraba et al.
1996). These structures are reminiscent of recombination intermediates and suggest a
more complex mode of replication. We have suggested that the HSV replication
machinery promotes a unique form of DNA replication that utilizes a recombinationdependent mechanism to produce concatemers, which are required for packaging
infectious virus (Wilkinson and Weller 2003, Weller and Sawitzke 2014).
The notion that HSV replication machinery promotes recombination-dependent
replication is supported by experiments using HSV-1 as a helper virus to facilitate
replication of other viruses and amplicons. For instance, replication of SV40 DNA by the
six core HSV-encoded replication factors and SV40 large T-antigen produces
concatemers composed of X-shaped DNA structures that may represent recombination
intermediates (Blumel, Graper et al. 2000). Since SV40 replication normally produces
two circular daughter molecules, it is noteworthy that the presence of HSV replication
proteins can alter the mode of replication to generate complex concatemeric DNA (Matz
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1987). In addition, adeno-associated virus (AAV) propagated using HSV as a helper virus
produces high molecular weight forms of DNA that are not observed when adenovirus is
used as a helper (Nicolas, Alazard-Dany et al. 2010). Thus, in the context of an HSV-1
infection, recombination may play a role in the generation of high molecular weight AAV
concatemers that have a complex structure. Taken together, these data are consistent with
the notion that the HSV replication machinery is inherently recombinogenic, giving rise
to complex concatemeric DNA.
In addition to the core HSV replication machinery, we have identified a virusencoded two-subunit recombinase that is reminiscent of the well-studied RedExo/β
system of phage lambda (Stahl, Thomason et al. 1997, Reuven, Willcox et al. 2004). The
lambda RedExo/β recombinase has been shown to perform strand annealing reactions in
vitro (Stahl, Thomason et al. 1997, Reuven, Willcox et al. 2004). In addition, RedExo/β
and related recombinases from other bacteriophages have been shown promote in vivo
recombination-mediated genetic engineering using short homologies - “recombineering”
in bacteria (reviewed in (Weller and Sawitzke 2014)). The HSV recombinase consists of
UL12, a 5’ to 3’ exonuclease, and ICP8, which in addition to its role as a single strand
DNA binding protein (SSB) can also function as a single strand DNA annealing protein
(SSAP). UL12 and RedExo share conserved sequence elements, and both proteins
interact with their partner SSAPs, ICP8 and Redβ, respectively (reviewed in (Weller and
Sawitzke 2014)). The precise role of the UL12/ICP8 complex during infection remains
unclear. We initially proposed that UL12 might be responsible for processing replication
intermediates into a form suitable for encapsidation (Goldstein and Weller 1998);
however, recent work has suggested that the viral recombinase may be involved at an
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earlier step of infection during DNA synthesis to influence the mode of replication itself
(Schumacher, Mohni et al. 2012). Thus, UL12 may stimulate a pathway of
recombination-dependent replication required to produce concatemers that can be
packaged into infectious virus.
A role for cellular DDR proteins in viral DNA replication has been suggested
based on the observation that several cellular factors involved in HR including MRE11,
RAD50, NBS1, and RAD51 are recruited to viral prereplicative sites and replication
compartments (Wilkinson and Weller 2003, Taylor and Knipe 2004, Wilkinson and
Weller 2004, Lilley, Carson et al. 2005, Shirata, Kudoh et al. 2005). In addition, both
ICP8 and UL12 have been shown to interact with many DDR proteins (Taylor and Knipe
2004, Balasubramanian, Bai et al. 2010, Mohni, Mastrocola et al. 2011, Karttunen, Savas
et al. 2014); however, attempts to identify the precise roles played by these proteins in
HSV DNA replication have not been straightforward. For instance, although HSV may
take advantage of cellular components to promote viral DNA replication, many DDR
pathways promote antiviral mechanisms such as silencing and the induction of innate
immune signaling. Because many components of cellular DDR pathways have complex
and overlapping roles, it has been difficult to tease apart the precise functions of cellular
DDR pathways during infection. Furthermore, DNA-PKcs, ATM, and the MRN complex
also participate in other cellular processes and may play roles in HSV replication that are
distinct from their roles in DDR pathways.
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Figure 1.1. Herpesviruses share similar virion structures and have biphasic
lifecycles. This figure illustrates the structural elements of the herpesvirus virion. The
linear ds DNA genome is housed inside of a proteinaceous capsid. The capsid is
surrounded by a layer tegument proteins and mRNAs. The tegument is enclosed within a
lipid envelope layer that is decorated with glycoproteins. Viral and cellular factors
influence whether viral infection manifests as lytic or latent.
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Figure 1.2. Diagram of the HSV-1 lytic life cycle. The HSV-1 virion binds to receptors
on the surface of the host cell and fuses its envelope with the cellular plasma membrane
(top left). The capsid is then transported on microtubules and docks at the nuclear pore
complex where it injects its linear, dsDNA genome into the host cell nucleus. Within the
nucleus, viral gene expression is initiated and occurs as three kinetically distinct classes.
Viral genome replication results in complex, multimeric structures that must be resolved
into linear, loner-than-unit length concatemers for packaging. The packaged capsid then
undergoes a series of envelopment and de-envelopment steps during egress from the
nucleus. In the cytoplasm, the tegument layer coats the capsid. Finally, budding occurs at
the cellular membrane, where the virion acquires its bi-lipid envelope and glycoproteins.
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Figure 1.3. Diagram of the HSV-1 genome showing the region containing the UL12
gene. The top of the diagram depicts the HSV-1 genome, below it are the physical map
units. The region of the genome approximately spanning from map units 0.15 to 0.20 are
enlarge to show the open reading frames encoding the UL11, UL12, and UL13 genes. The
pink bar indicates the portion of the genome that was used to create the UL12complementing cell line, 6-5. The blue bar indicates the portion of UL12 that was deleted
and replaced with the ICP6::lacZ cassette to produce the UL12-null virus, AN-1. The
green bars indicate portions of the genome that were used to produce rescuants of the
AN-1 virus.
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Figure 1.4. Diagram of the HSV-1 genome and concatemers. A. Schematic of the
HSV-1 genome structure and key elements. UL and US refer to the unique long and
unique short regions, respectively. The inverted repeat sequences are labeled as a, b, and
c. ✶ represents oriL, and ♣ represents oriS. The grey bars labeled S, SQ, and Q are
restriction fragments produced by enzymatic digestion with BamHI. Below the genome,
the four possible genome isomers are represented as blue arrows. NB: Genomic elements
are not proportionately to scale. B. Diagram of the DNA packaging mechanism. A
longer-than-unit length HSV-1 concatemer is required for packaging to occur. DNA
molecules are expected to contain a higher proportion of junctions than terminal ends. On
the other hand, genomes that have been cleaved for packaging are expected to contain
equimolar ratios of junctions and termini.
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Table 1.1. List of Abbreviations
Abbreviation

Name

Description

A-NHEJ

alternative nonhomologous
end joining

DNA repair mechanism; also
called MMEJ

AN-1

alkaline nuclease-1

Virus; mutant HSV-1 virus
(KOS strain) that lacks the UL12
gene

AT

Ataxia telaniectasia

Genetic disorder caused by
mutations in the ATM gene

ATM

Ataxia telaniectasia mutated

Enzyme, kinase

BER

base excision repair

DNA repair mechanism

C-NHEJ

classic nonhomologous end
joining

DNA repair mechanism

CMV

cytomegalovirus

Betaherpesvirus

DDR

DNA damage response

DNA-PKcs

DNA-dependent protein
kinase catalytic subunit

Enzyme, kinase; involved in the
C-NHEJ repair pathway and the
IRF-3 inducible innate immune
response

DSBR

double strand break repair

DNA repair mechanism

dsDNA

double strand DNA

Molecule

EBV

Epstein-Barr virus

Gammaherpesvirus; infects
humans

HCMV

human cytomegalovirus

Betaherpesvirus; infects humans

HR

homologous recombination

DNA repair mechanism

HSV

herpes simplex virus

Alphaherpesvirus

ICP0

infected cell protein 0

Viral (HSV-1) protein, E3
ubiquitin ligase
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Abbreviation

Name

Description

IFI16

interferon inducible 16

Protein; DNA sensing protein;
component of the IRF-3
inducible innate immune
response

KSHV

Kaposi's sarcoma-associated
herpesvirus

Gammaherpesvirus; infects
humans

LIG I

DNA ligase I

Enzyme, ligase; associated with
NER and MMEJ

LIG III

DNA ligase III

Enzyme, ligase; associated with
BER and MMEJ

LIGIV

DNA ligase IV

Enzyme, ligase

MEF

mouse embryonic fibroblast

Cell line

MMEJ

microhomology mediated
end joining

DNA repair mechanism; also
called A-NHEJ

MMR

mismatch repair

DNA repair mechanism

MRE11

meiotic recombination 11
homolog A

MRN

MRE11/RAD50/NBS1

Protein complex; involved in HR

NBS1

Nijmegen breakage
syndrome 1

Protein; involved in HR;
component of the MRN complex

NER

nucleotide excision repair

DNA repair mechanism

PAMP

pathogen-associated
molecular pattern

Molecule; associated with
groups of pathogens that are
recognized by cells of the innate
immune

PAR

poly (ADP-ribose)

Molecule, covalently attached to
proteins and DNA as polymeric
chains in response to DNA
damage
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Abbreviation

Name

Description

PARG

poly (ADP-ribose)
glycosylase

Enzyme; involved in DNA
repair; responsible for removal
of PAR chains from proteins and
DNA

PARP-1

poly (ADP-ribose)
polymerase 1

Enzyme; involved in DNA repair
and cellular stress response;
catalyzes the covalent attachment
of PAR chains to proteins and
DNA

PFGE

pulsed-field gel
electrophoresis

Assay for analyzing large DNA
molecules

RAD50

radiation protein 50

Protein; involved in HR;
component of the MRN
complex

RNAP II

RNA polymerase II

Transcription protein

RPA

replication protein A

DNA binding protein involved in
DNA repair and replication

SDSA

synthesis-dependent strand
annealing

DNA repair mechanism;
associated with repair of stalled
replication forks

SSA

single strand annealing

DNA repair mechanism

ssDNA

single strand DNA

Molecule

UL

unique long

Unique region of the HSV-1
genome that encodes UL genes

VZV

varicella zoster virus

Alphaherpesvirus

XLF

Cernunnos/XRCC4-like
factor

Protein; involved in the C-NHEJ
repair pathway

XRCC4

X-ray-crosscomplementation gene 4

Protein; involved in the C-NHEJ
repair pathway
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Table 1.2. Properties of ICP0
ICP0 gene7

Also known as IE gene 1
Located in the RL regions of the HSV-1 genome
Immediate early (IE) expression kinetics

ICP0 protein

626 amino acids in length
Approximately 110 kDa
Also known as Vmw110

Enzymatic
activity

RING finger E3 ubiquitin ligase

Other functions

Transactivator of viral gene expression

Some targets of
ICP0 ubiquitin
ligase activity1,7

PML, hDAXX, sp100, p53, NF-κB, CENP-A, CENP-B, CENP-C,
DNA-PKcs2,3, RNF8, RNF168, IFI16, PARG

Interacting
partners

USP7, also called HAUSP; a ubiquitin-specific protease4,5,6
Class II histone deacetylases8

1

Reviewed in Lilley, Chaurushiya, et al. 2011; Lees-Miller, Long, et al. 1996; 3Parkinson, Lees-Miller, et al.
1999; 4 Meredith, Orr, et al. 1994; 5Meredith, Orr, et al. 1995; 6Everett, Meredith, et al. 1997; 7Reviewed in
Smith, Boutell, et al. 2011; 8Lomonte, Thomas, et al. 2004
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Table 1.3. Properties of UL12
UL12 gene

Maps between approximately 0.168 and 0.175 map units on the HSV1 genome, which is within the UL region 1,2
Contained within a 2.3 kb mRNA that encodes a family of unspliced,
3’ co-terminal mRNAs 2,3,4
Early (E) gene expression kinetics

UL12 protein

626 amino acids in length
Approximately 85kDa
Phosphoprotein
Binds Mg2+

Nuclease activity

Alkaline nuclease; in vitro, the nuclease activity is optimal in
conditions between pH 8-9 5
Possesses both exo- and endonuclease activity in vitro 6
5’ to 3’ exonuclease activity7
Degrades ssDNA, dsDNA, and branched DNA structures8

Additional
activities

Forms a putative two-subunit recombinase with ICP810
 UL12/ICP8 catalyze strand exchange in vitro
Stimulates SSA during HSV-1 infection14

Intracellular
localization

Nuclear-diffuse9

Interacting
partners

ICP8, viral ssb

Detergent-resistant population in replication compartments,
observable by immunofluorescence microcopy9

MRN complex9
MSH2/6 heterodimer11
Ku7012
FANCD213

1

Banks, Haliburton, et al. 1985; 2Costa, Draper, et al. 1983; 3Draper, Devi-Rao, et al. 1986; 4McGeoch,
Dolan et al. 1986; 5Keir and Gold 1963; 6Hoffman and Cheng 1978; 7Knopf and Weisshart 1990; 8Golstein
and Weller 1998b; 9Balasubramanian, Bai, et al. 2010; 10Reuven, Staire, et al. 2003; 11Mohni, Mastracola,
et al., 2011; 12Balasubramanian 2011; 13Karttunen, Savas, et al. 2014; 14Schumacher, Mohni, et al. 2012
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1.2. HSV-1 and the cellular DNA damage response pathways.	
  
1.2.a. Overview
In order to maintain its genetic integrity, the cell encodes a variety of mechanisms
collectively termed the DNA damage response (DDR). The pathway by which cellular
DNA is repaired depends on multiple factors, including cell type and cell cycle, as well
as the nature and severity of the DNA lesion. Certain pathways are only activated during
S phase at replication forks. Some types of repair require a template strand, while others
do not, and some types of damage can be repaired by several mechanisms. The cell can
utilize either direct chemical reversal of damage or excision repair to replace damaged or
mismatched bases in DNA. Excision repair requires a template strand and the removal of
stretches of nucleotides or bases. This mechanism encompasses base excision repair
(BER), nucleotide excision repair (NER), and mismatch repair (MMR). For double strand
breaks, the cell employs recombination-mediated repair. When DNA damage cannot be
repaired by any of these strategies, the cell may utilize damage tolerance mechanisms,
like translesion synthesis (TLS), post replication gap-filling, or replication fork regression.
These mechanisms do not repair the damaged DNA, per se, but allow replication to
proceed, often resulting in mutations. If damage is too great, the biological response tips
from repair/tolerance toward cell cycle arrest and apoptosis.

1.2.b. Direct reversal and excision repair pathways.
Direct reversal of simple DNA adducts do not require a DNA template for repair.
Instead, specific enzymes chemically reverse the lesion. For example, pyrimidine dimers
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caused by exposure to UV can be repaired by photolyase†, and O6 methylguanine adducts
are repaired by O6 methylguanine methyltransferases (MGMT). Unlike the other types of
repair, direct reversal does not require a template, neither does it involve breaking of the
DNA backbone. Direct repair is, however, less versatile than other types of repair, due to
the specificity required by each direct repair enzyme for a specific lesion.
Excision repair, which includes base excision repair (BER), nucleotide excision
repair (NER), and mismatch repair (MMR), requires a template strand and involves the
removal of stretches of nucleotides or bases. Pyrimidine dimers can be repaired via the
nucleotide excision repair (NER) pathway, in addition to direct reversal. Of the three
classes of excision repair, BER and NER are thought to occur throughout the cell cycle,
whereas MMR is thought to occur primarily during replication (S-phase) (reviewed in
(Branzei and Foiani 2008)).
Excision repair during HSV-1 infection. It is currently not known whether HSV1 utilizes direct reversal or excision repair mechanisms to repair viral DNA. In a PCRbased assay, Millhouse, et al., demonstrated that repair of HSV-1 DNA damaged by UV
irradiation can be repaired in Vero cells, but not in quiescently infected neuronal cells.
Repair of viral DNA in Vero cells occurred in the absence of HSV pol, but appeared to be
enhanced by HSV pol, even when viral replication was inhibited (Millhouse, Wang et al.
2012). In the absence of DNA replication, UV damage most commonly causes
pyrimidine dimers. Thus, NER is likely responsible for the repair described in this paper,
and it is possible that NER is active during HSV-1 infection.
	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  
†	
  Although	
  photolyase	
  is	
  expressed	
  in	
  a	
  wide	
  variety	
  of	
  organisms,	
  humans	
  lack	
  this	
  gene	
  

(Kato,	
  Todo,	
  et	
  al.	
  1994).	
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1.2.c. Mismatch repair (MMR) proteins are required for efficient HSV-1 replication.
MMR overview. The MMR pathway is a highly conserved mechanism that is
responsible for detecting and repairing mismatched bases, as well as insertion-deletions
loops (IDLs) that arise during DNA replication. Single base mismatches and 1-2 base
IDLs are recognized and bound by the MSH2/MSH6 heterodimer, while larger IDLs are
bound by the MSH2/MSH3 heterodimer. The MLH1/PMS2 heterodimer is then recruited
to help organize other MMR proteins, such as EXOI and replication protein A (RPA),
onto mismatched DNA to facilitate resection and repair.
MMR and HSV. Both MSH2 and MLH1 are required for efficient replication of
HSV-1 in normal human cells and are localized to viral replication compartments (Mohni,
Mastrocola et al. 2011). In addition, interactions have been reported between ICP8 and
UL12 and MMR proteins MSH2, MSH3, and MSH6 (Taylor and Knipe 2004, Mohni,
Mastrocola et al. 2011). Interestingly, however, these proteins may have functions in
HSV infection that are distinct from their canonical roles in recognizing mismatched
DNA. MLH1 is recruited to viral genomes at the earliest stages of viral infection, and
depletion of MLH1 in the context of viral infection inhibits immediate early gene
expression (Mohni, Mastrocola et al. 2011). On the other hand, MSH2, which is generally
thought to function before MLH1, is apparently recruited after MLH1 and may play a
later role in HSV infection (Mohni, Mastrocola et al. 2011). These results suggest that
although both MLH1 and MSH2 are required for efficient HSV infection, MLH1 may
play a role in viral infection that is independent of MSH2 and may be distinct from the
MMR pathway. MLH1 was also shown to be a component of PML-NBs, although unlike
other components of these nuclear bodies, it is not degraded by ICP0 (Mohni, Mastrocola
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et al. 2011). It will be of considerable interest to further explore the precise roles of both
MLH1 and MSH2 during HSV infection.

1.2.d. HSV-1 influences pathway choice for double strand break repair (DSBR).
DBSR overview. Probably the most well studied type of DNA repair is double
strand break repair (DSBR), which encompasses a variety of recombination-mediated
pathways with distinct but overlapping functions. These mechanisms include:
homologous recombination (HR), single strand annealing (SSA), classic nonhomologous
end joining (C-NHEJ), and microhomology-mediated end joining (MMEJ) (Figure 1).
The three pathways shown on the right side of Figure 1 (HR, SSA, and MMEJ) require
some degree of homology; whereas, C-NHEJ does not. The homology driven pathways
involve resection of DNA followed by annealing to a complementary strand. HR is
generally more accurate than the other DSBR pathways, since HR employs strand
invasion into a homologous chromosome or sister chromatid. SSA and MMEJ, on the
other hand, are more error prone, often resulting in deletions or genomic translocations.
Another type of homology driven repair, synthesis dependent strand annealing (SDSA)
occurs during DNA replication in response to stalled replication forks. C-NHEJ does not
require homology and can directly fuse unrelated DNA molecules (reviewed in (Dueva
and Iliakis 2013)). Despite the potential for generating errors, C-NHEJ is the preferred
mechanism of repair in higher eukaryotes and can occur during G1, S and G2 phases of
the cell cycle.
DSBR and HSV. As shown in Figure 1.5, several cellular DDR mechanisms are
available for recombination/repair during HSV-1 infection. In order to determine whether
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HSV utilizes one or more of these pathways during infection, chromosomally integrated
GFP correction assays were used to measure the frequency of DSBR by C-NHEJ, MMEJ,
HR and SSA in infected cells (Schumacher, Mohni et al. 2012). Using these assays, we
have shown that HSV infection stimulates SSA; however, HR, C-NHEJ and MMEJ were
inhibited (Schumacher, Mohni et al. 2012). These results suggest that HSV has evolved
to utilize SSA, and in the following sections we will explore possible reasons and
mechanisms for the apparent inhibition of the other three pathways in infected cells.

1.2.e. HSV-1 inhibits classic non-homologous end joining (C-NHEJ).
C-NHEJ overview. As stated above, classic non-homologous end joining (CNHEJ) involves the direct fusion of non-homologous dsDNA ends. This process involves
at least three steps: recognition of DSB, end trimming/processing of non-ligatable termini,
and ligation. C-NHEJ is promoted by the Ku70/86 heterodimer, which recognizes DSBs
and binds to dsDNA ends. Ku70/86 recruits the DNA-dependent protein kinase catalytic
subunit (DNA-PKcs), which aligns DNA ends. End processing occurs if the DNA ends
are not easily ligatable, containing either non-homologous regions or unusual structures
such as DNA hairpins. Cellular enzymes thought to play a role in the end-processing step
include DNA-PKcs, Artemis, polynucleotide kinase phosphatase (PNKP), terminal
deoxynucelotidyl transferase (Tdt), and polymerases (pols) λ and µ (reviewed in (Neal
and Meek 2011)). The ligation step of C-NHEJ requires XRCC4, which interacts with
both DNA Ligase IV (LIG IV) and DNA and is thought to be necessary for LIG IV
recruitment to the DSB. XRCC4 also interacts with XLF; however, the precise role of
XLF in NHEJ is not yet known.
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C-NHEJ and HSV. The HSV genome contains nicks and gaps that are randomly
located and present on both strands. Because the HSV-1 genome has dsDNA ends in
addition to nicks and gaps, it is tempting to speculate that one or more of the DDR
pathways might be activated by the genome as soon as it enters the nucleus. In fact, cells
transfected with viral DNA exhibit RPA32 S4/S8 phosphorylation, a mark specific for
DNA-PK activation (Smith, Reuven et al. 2014); however, DNA-PK is not activated in
HSV-infected cells. It has been recognized since 1996 that DNA-PKcs activity is
attenuated in HSV-infected cells in an ICP0-dependent manner (Figure 2) (Lees-Miller,
Long et al. 1996, Parkinson, Lees-Miller et al. 1999, Smith, Reuven et al. 2014), leading
to the suggestion that components of the C-NHEJ pathway are antiviral. In fact, HSV-1
replication is more efficient in cells lacking the catalytic subunit of DNA-dependent
protein kinase (DNA-PKcs) (Parkinson, Lees-Miller et al. 1999), and in Ku-deficient
murine embryonic fibroblasts, viral yields are increased by almost 50-fold (Taylor and
Knipe 2004). In addition, we have recently demonstrated that ICP0 is required to relieve
suppression of HSV-1 DNA infectivity caused by DNA-PKcs (Smith, Reuven et al.
2014). Possible reasons for the antiviral properties of C-NHEJ will be discussed below.

1.2.f. Homologous recombination (HR) components play positive and negative roles in
HSV-1 infection.
HR overview. HR is mediated by the PI3 kinase-like kinase, ATM, which is
activated when the MRN complex (MRE11, RAD50, and NBS1) senses a double strand
break. ATM has numerous substrates, including the histone variant, H2AX, the
phosphorylated form of which is called γH2AX (Rogakou, Pilch et al. 1998). The γH2AX
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signal can spread as far as 1-2 megabases from the initial site of damage in an ATM and
MDC1-dependent manner (Harper and Elledge 2007). This extensive phosphorylation is
responsible for the appearance of damage foci observed by immunofluorescence
microscopy (Fernandez-Capetillo, Celeste et al. 2003). Additional downstream effectors
are then recruited to damage foci in a sequential fashion following ubiquitination of
H2A-type histones by RNF8 and RNF168 (reviewed in (Jackson and Durocher 2013)).
RNF8/RNF168-dependent ubiquitin conjugation is required to recruit and stabilize
downstream repair proteins, such as BRCA1, 53BP1, and RAD51 ((Huen, Grant et al.
2007, Mailand, Bekker-Jensen et al. 2007, Stewart, Panier et al. 2009) and reviewed in
(Jackson and Durocher 2013)). MRE11 and CtIP facilitate the initial end resection step,
after which EXO1 and BLM carry out extensive resection (Williams, Williams et al.
2007, Bolderson, Tomimatsu et al. 2010). Following end resection, ssDNA is coated by
RPA, which is important for activation of the ATR pathway (described below). RAD51
filaments assemble on RPA-coated DNA and facilitate strand invasion, resulting in a Dloop structure. During HR, this process results in Holliday junctions, which must be
resolved to produce repaired, linear dsDNA. Strand invasion can also proceed via another
mechanism, synthesis-dependent strand annealing (SDSA), which does not produce
Holliday junctions (described below). Once the DSB has been repaired, DDR proteins
dissociate from the DNA resulting in the resolution of damage foci.
Manipulation of the HR pathway during HSV-1 infection. Although
chromosomal integration assays suggested that HR is suppressed during HSV-1 infection
(Schumacher, Mohni et al. 2012), several components of the cellular HR machinery are
required for efficient virus production. Virus production is deficient in cells lacking ATM,
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MRN (MRE11, NBS1, RAD50), and WRN (Taylor and Knipe 2004, Lilley, Carson et al.
2005, Balasubramanian, Bai et al. 2010). In addition, we and others have demonstrated
that HSV-1 induces ATM activation, as evidenced by the recruitment and
phosphorylation of ATM, MDC1, NBS1, and CHK2 (Wilkinson and Weller 2004, Lilley,
Carson et al. 2005, Shirata, Kudoh et al. 2005). Lilley et al., demonstrated that damage
foci containing γH2AX and MDC1 are still able to form in IR-treated HSV-infected cells
(Lilley, Carson et al. 2005); however, BRCA1 and 53BP1 are not recruited to damage
foci because RNF8 and RNF168 are degraded by ICP0 (Figure 2) (Lilley, Chaurushiya et
al. 2010). Thus, although ATM is activated in HSV infected cells, HR itself is inhibited,
consistent with the observation that HR is inhibited in HSV-infected cells using the
chromosomal reporter assay (Schumacher, Mohni et al. 2012). Interestingly, since HR
proteins upstream of RNF8 and RNF168 are recruited to replication compartments and
are required for efficient replication, it is possible that some of these components play
positive roles during infection that are distinct from HR (Taylor and Knipe 2004, Lilley,
Carson et al. 2005, Balasubramanian, Bai et al. 2010).

1.2.g. ATR-CHK1 signaling is disrupted in HSV-1 infected cells.
ATR-CHK1 pathway overview. In uninfected cells, the checkpoint kinase, ATR,
is activated in response to stretches of ssDNA adjacent to dsDNA, like those found at
stalled replication forks. ATR is also activated by substrates produced during ATMmediated end-resection. Thus, ATM activation generally results in activation of the ATR
pathway (Jazayeri, Falck et al. 2006, Sartori, Lukas et al. 2007). RPA is recruited to
stretches of ssDNA and recruits ATR, and the ATR-interacting protein (ATRIP).	
   ATR
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signaling also requires the recruitment of the 9-1-1 (RAD9-RAD1-HUS1) checkpoint
clamp, which in turn recruits the ATR-activator, TopBP1, which results in
phosphorylation of CHK1 on S317 and S345 and RPA32 on S33.
ATR-CHK1 inhibition during HSV-1 infection. In uninfected cells, activation of
ATM would be expected to result in the activation of ATR. Interestingly,	
   ATR-‐CHK1	
  
signaling	
   is	
   disrupted	
   during	
   HSV-‐1	
   infection	
   even	
   though	
   HSV-‐1	
   DNA	
   replication	
  
activates	
  ATM	
  signaling	
  (Figure	
  2)	
  (Wilkinson	
  and	
  Weller	
  2004,	
  Lilley,	
  Carson	
  et	
  al.	
  
2005,	
   Shirata,	
   Kudoh	
   et	
   al.	
   2005,	
   Mohni,	
   Livingston	
   et	
   al.	
   2010).	
   ATR is not activated
in HSV-infected cells, even if these cells are treated with hydroxyurea (HU), which
causes replication fork stalling (Gordin, Olshevsky et al. 1973, Mohni, Livingston et al.
2010). We have recently identified the mechanism by which HSV-1 inhibits ATR
signaling: four replication proteins (ICP8 and the three components of the
helicase/primase complex) can bind to substrates that contain ssDNA adjacent to dsDNA,
which are similar to substrates recognized by RPA and ATR. Thus, these four viral
proteins prevent the loading of the 9-1-1 complex and the subsequent recruitment of
TopBP1, effectively disabling ATR signaling. It is still not clear why HSV has evolved to
prevent ATR signaling. It is known that in uninfected cells ATR signaling can stabilize
stalled forks and prevent fork collapse in order to prevent the formation of DSB
(Peasland, Wang et al. 2011). Although DSB formation would be deleterious for cells, it
may be beneficial during HSV replication, perhaps by stimulating recombination. This is
supported by the observation that artificial activation of ATR results in reduced
recombination between co-infecting viruses (Mohni, Dee et al. 2013). Although HR is
inhibited in infected cells, other mechanisms of recombination such as SSA may be
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stimulated under these conditions (discussed below). Despite the observation that ATR
signaling is prevented in HSV-1 infected cells, ATR and several proteins in this pathway
are recruited to viral replication compartments and are essential for efficient virus
production (Mohni, Livingston et al. 2010, Mohni, Dee et al. 2013). These results suggest
that ATR pathway proteins play positive roles in HSV-1 infection that are distinct from
ATR signaling. Alternatively, it may be beneficial for HSV-1 to recruit these proteins to
viral genomes as a way to inhibit cellular DNA replication.

1.2.h. The Fanconi anemia (FA) pathway plays a positive role in HSV-1 infection.
FA pathway overview. In uninfected cells, the Fanconi anemia (FA) pathway is
activated by ATR during S-phase in response to replication stress caused by stalled forks
and interstrand cross-links (ICLs) (Shigechi, Tomida et al. 2012, Tomida, Itaya et al.
2013). The FA pathway has been shown to promote replication restart by coordinating
homology-mediated repair (HR and SSA) and translesion synthesis (TLS) (Nakanishi,
Yang et al. 2005, Sale, Lehmann et al. 2012, Shigechi, Tomida et al. 2012), modulating
MMR (Zhi, Wilson et al. 2009, Peng, Xie et al.) and suppressing C-NHEJ (Adamo, Collis
et al. 2010). The FA pathway is composed of at least 15 proteins, which are divided into
three functional groups: the core complex, the ID complex, and downstream effectors.
Activation of the FA pathway requires monoubiquitination of the ID complex (FANCI
and FANCD2) by the FA core complex (FANCA, B, C, E, F, G, L, and M), which
together with FAAP24 and FAAP100 form a multi-subunit E3 ubiquitin ligase, and the
E2-conjugating enzyme, UBE2T. FA activation is also dependent on phosphorylation of
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FANCI and FANCD2 by ATR (Andreassen, D'Andrea et al. 2004, Ho, Margossian et al.
2006).
The FA pathway and HSV-1 infection. Recently, the Mohr lab demonstrated that
FA proteins are necessary for efficient HSV-1 replication and transcription and suggested
that these proteins act as regulators of DNA repair pathway choice during infection
(Figure 1.8) (Karttunen, Savas et al. 2014). HSV-1 potently activates the FA pathway, by
mono-ubiquitination of FANCI-D2, which seems to require HSV pol and DNA
replication (Figure 2) (Karttunen, Savas et al. 2014). In addition, they demonstrated that
FANCI interacts with ICP8, pol, UL42, UL12, and dUTPase and that FANCD2 interacts
with the helicase subunit, UL5 (Karttunen, Savas et al. 2014). Furthermore, they showed
that HSV-1 replication was restricted in FA-deficient cells, and that this restriction was
partially eliminated by treatment with the DNA-PKcs inhibitor, NU7441(Karttunen,
Savas et al. 2014). These results suggest that the FA pathway may play a role in
restricting DNA-PKcs activity during HSV-1 infection. Previous reports demonstrate that
FA pathway proteins stimulate SSA. This is consistent with the notion that these proteins
direct repair toward the SSA pathway while inhibiting C-NHEJ in HSV-infected cells.

1.2.i. Single strand annealing (SSA) is stimulated in HSV-1 infected cells.
SSA overview. SSA is a form of homology-mediated repair, although it is more
error-prone than HR, and can cause deletions and chromosomal translocations. SSA is
initiated when a double strand break occurs between two repeated sequences oriented in
the same direction. Homologous regions of single stranded DNA are exposed through
extensive end resection by a 5’ to 3’ exonuclease. Annealing is facilitated by RAD52,
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which is an SSAP (Singleton, Wentzell et al. 2002, Stark, Pierce et al. 2004). Following
annealing, it is believed that non-homologous 3’overhangs are cleaved by ERCC1/XPF
(reviewed in (Iyama and Wilson 2013)). GFP reporter assays have been used to identify
the cellular components required for SSA, and interestingly, most appear to overlap with
other DDR pathways (Singleton, Wentzell et al. 2002, Stark, Pierce et al. 2004, Bennardo,
Cheng et al. 2008). For instance, the single strand annealing protein Rad52 is also
involved in assembly of Rad51 filaments during HR, and ERCC1/XPF are also
implicated in NER and MMEJ (reviewed in (Iyama and Wilson 2013).
HSV-1 stimulates SSA. GFP correction assays have demonstrated that HSV
stimulates SSA, raising the question of whether SSA is carried out by viral or cellular
proteins (or both). As mentioned above, HSV encodes a two-subunit recombinase (UL12
and ICP8). The alkaline nuclease (UL12) component of the HSV-1 recombinase is
necessary and sufficient to stimulate SSA (Schumacher, Mohni et al. 2012). Stimulation
of SSA was abrogated in the nuclease-dead mutant, UL12 D340E, suggesting that UL12
nuclease activity may be required for end-resection prior to SSA (Schumacher, Mohni et
al. 2012). Direct involvement of ICP8 in this process has been difficult to demonstrate
because ICP8 is also essential for DNA synthesis. Additional experimentation will be
required to assess the possible involvement of cellular SSA proteins such as RAD52 and
the ERCC1/XPF complex.
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1.2.j. HSV-1 may also utilize MMEJ/SDSA to repair DSBs during replication.
MMEJ and SDSA overview. Perhaps the least understood DSBR mechanism is
microhomology-mediated end joining (MMEJ). Like SSA, this process requires resection
to expose regions of homology and annealing of homologous regions. Unlike SSA,
however, MMEJ is thought to require a small amount of homology (5-25nt) for end
joining to occur. Although MMEJ is not well defined, several proteins are thought to
participate in this process, including: poly (ADP-ribose) polymerase 1 (PARP-1),
XRCC1, ERCC1/XPF, LIG III, and possibly the MRN complex (Audebert, Salles et al.
2004, Wang, Wu et al. 2006, Rass, Grabarz et al. 2009, Xie, Kwok et al. 2009, Zhuang,
Jiang et al. 2009, Cheng, Barboule et al. 2011). Interestingly, MMEJ has been shown to
have an important role in the repair of DSBs at collapsed replication forks (Truong, Li et
al. 2013) and may play a role in synthesis-dependent strand annealing (SDSA) [reviewed
in (Ottaviani, LeCain et al. 2014)].
A model for A-NHEJ/SDSA during HSV-1 infection. As stated above, it is clear
that recombination is tightly linked to DNA replication during HSV-1 infection. Thus, in
addition to classic SSA, it is possible that the HSV-1 may use a synthesis dependent
strand annealing (SDSA) mechanism (reviewed in (Weller and Sawitzke 2014)). SDSA
utilizes strand exchange, in which the 5’ end of dsDNA break is resected, and the 3’ end
is annealed to a homologous region at a single strand region of a growing replication fork
(reviewed in (Ottaviani, LeCain et al. 2014)). Interestingly, the recombineering
machinery employed by the lambda RedExo/β and other bacteriophage-encoded
recombination systems such as RecE/T are also dependent on DNA synthesis (reviewed
in (Weller and Sawitzke 2014)). Recombineering can be performed with either single or
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double stranded oligonucleotides and is used to efficiently incorporate mutations into
bacterial genomes. Single strand oligonucleotides are coated by an SSAP such as lambda
Redß or RecT and inserted at the DNA replication fork. When double stranded
oligonucleotides are used, the exonuclease degrades one entire strand. In the model
shown in Figure 3A, the remaining strand is coated with the SSAP and incorporated on
the lagging strand template (reviewed in (Weller and Sawitzke 2014)). A more elaborate
situation has been proposed to occur during replication of viral genomes (Maresca, Erler
et al.)(Figure 3B). According to this scenario, a DSB on one viral genome is concurrently
resected and annealed at the lagging strand template. This model was originally proposed
by A. Kuzminov [(Kuzminov 1999) and reviewed (Weller and Sawitzke 2014)].
Additional experiments will be required to determine whether HSV utilizes this type of
synthesis dependent annealing reaction during replication; however, it is known that the
HSV-1 recombinase, UL12/ICP8, is capable of performing strand exchange in vitro and
that recombination is linked to DNA synthesis (Reuven, Willcox et al. 2004).

1.2.k. PARP/PARG may play positive and negative roles during HSV-1 infection.
PARP overview. PARP proteins utilize NAD+ to catalyze the covalent attachment
of poly-ADP ribose (PAR) chains to proteins. Although there are 17 members of the
PARP family, PARP-1 is responsible for nearly all PARylation that takes place in the cell,
and only PARP-2 has been shown to complement a PARP-1 mutant (Huber, Bai et al.
2004). Interestingly, PARP-1 plays both pro- and anti-recombinogenic roles and regulates
many DDR pathways. In addition to its role in MMEJ, PARP-1 also plays a crucial role
in recovery from replication fork stalling through stimulation of HR. PARP-1 senses and
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is recruited to nicks, ssDNA breaks, and dsDNA breaks and PARylates itself and other
proteins. The PAR posttranslational modification is thought to control the activity and
function of several DDR proteins such as MRE11, NBS1, and DNA-PKcs. Thus, PARP-1
plays an important role in chromatin remodeling and the recruitment and regulation of
cellular DDR proteins. On the other hand, excess DNA damage can result in
overactivation of PARP and lead to cell death. The enzyme, poly (ADPribose)
glycohydrase (PARG), catalyzes the removal of PAR chains and is required to prevent
cell death and promote replication restart via HR (Min, Cortes et al. 2010, Illuzzi,
Fouquerel et al. 2014). In the absence of PARG, PAR chains are thought to accumulate
on DNA, preventing RPA binding, and as a result, RPA32 phosphorylation by DNAPKcs is inhibited (Illuzzi, Fouquerel et al. 2014). Thus, the PARP/PARG balance plays
an important role in modulating the DNA damage response.
PARP/PARG and HSV-1. A study to examine metabolic changes in HSVinfected cells revealed that PARP is activated during infection. Vastag et al. reported that
NAD+ levels are decreased during HSV-1 infection (Vastag, Koyuncu et al. 2011), and
PARylation carried out by activated PARP1/2 during HSV-1 infection was found to be
responsible for the observed NAD+ depletion (Grady, Hwang et al. 2012). Since
PARP1/2 sense nicks and ssDNA breaks, it is possible that nicks and gaps in the viral
genome are responsible for PARP activation. Whether nicks and gaps in viral genomes
are repaired during the early stages of infection by DDR machinery is not known;
however, PARP binding and the subsequent recruitment of repair proteins may represent
an attempt to fill in gaps. Interestingly, PARG is degraded by ICP0 during HSV-1
infection (Grady, Hwang et al. 2012). Thus, it is possible that although PARP is activated
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by infection, the downstream DNA repair processes facilitated by PARG are prevented
by ICP0. This may be a mechanism by which HSV counteracts the antiviral activity of
some DDR pathways such as C-NHEJ. Although ICP0 degrades DNA-PKcs in some
cells, the activity DNA-PKcs is inhibited even in Vero cells in which DNA-PKcs is not
degraded (Wilkinson and Weller 2004, Mohni, Smith et al. 2013, Smith, Reuven et al.
2014). As mentioned above, in the absence of PARG, DNA-PKcs activity is inhibited.
The degradation of PARG by ICP0 may thus contribute to the inhibition of DNA-PKcs,
implying that HSV has evolved more than one mechanism to inhibit DNA-PKcs and CNHEJ. We are intrigued by the possibility that gap filling facilitated by PARP/PARG and
circularization by C-NHEJ are antiviral and contribute to genome silencing. The ability
of ICP0 to degrade both DNA-PKcs and PARG may be a means by which HSV prevents
circularization, consistent with the demonstration by Jackson and Deluca that in the
presence of ICP0, circularization of the viral genome is prevented (Jackson and DeLuca
2003). Further experimentation will be required to test this model and address the
controversy over whether circularization occurs during lytic infection.

1.2.l. Some DDR proteins function as DNA sensors in intrinsic and innate immune
responses.
DDR and Antiviral Defense. When HSV-1 infects a cell, the viral genome is
released from the capsid into the host cell nucleus, which may be an intrinsically hostile
environment for invading pathogens. Cellular defense strategies include three interrelated arms: intrinsic antiviral mechanisms, innate immune signaling and the adaptive
immune responses. We are intrigued by the observation that DNA damage sensing
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proteins are able to sense “foreign” DNA and trigger various types of antiviral responses.
It is tempting to speculate that these responses are part of a larger network of antiviral
defense mechanisms and that some DDR pathways may have evolved initially to
counteract environmental pathogens such as viruses.
Intrinsic Antiviral Mechanisms. Intrinsic antiviral proteins are cellular factors
that are constitutively expressed and poised to inhibit infection immediately following
viral entry (Bieniasz 2004). The first recognized intrinsic factors target retroviruses, and
the number of retroviral defense factors has now grown to include Fv-1, TRIM5α,
APOBEC3G and SAMHD1. More recently, it has been recognized that nuclear factors
such as PML (TRIM19) exert antiviral effects that target herpesviruses, especially HSV
and HCMV (Tavalai, Papior et al. 2006, Boutell and Everett 2013). As described above,
incoming viral genomes recruit PML into viPML-NBs that have been associated with
repression of viral gene expression (Boutell and Everett 2013). Other proteins that are
recruited to viral genomes at the earliest stages of infection may also be part of the
intrinsic antiviral network. For example, DNA-PKcs may modulate transcription of viral
genes through several mechanisms. It has been reported to modulate RNAP II activity
and inhibit the ability of RNAP II to bypass DSBs (Maldonado, Shiekhattar et al. 1996,
Pankotai, Bonhomme et al. 2012). Alternatively, if DNA-PKcs and Ku proteins are
recruited to viral DNA ends, they might be expected to activate C-NHEJ resulting in the
circularization of viral genomes and the subsequent promotion of chromatinization and
epigenetic silencing (Lees-Miller, Long et al. 1996, Knipe and Cliffe 2008). Activation of
RNF8 and RNF168 and the ubiquitination of H2A has also been suggested to cause
genome silencing (Lilley, Chaurushiya et al. 2010). In addition, interferon-inducible
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protein 16 (IFI16) is a DNA sensor involved in innate IRF-3-mediated signaling as well
as intrinsic antiviral responses. IFI16 has also been shown to sense microbial DNA and
promote epigenetic silencing of DNA lacking or loosely associated with chromatin, such
as HSV-1 genomes (Orzalli, Conwell et al. 2013). Thus, the ability of various cellular
components, including DDR proteins, to silence viral gene expression appears to be a
common mechanism by which cells have evolved to counteract viral infections. The
ability of ICP0 to degrade PML, DNA-PKcs, RNF8/168 and IFI16 demonstrates that
HSV has evolved to evade intrinsically antiviral silencing mechanisms.
DDR proteins may act as DNA sensors that trigger innate immune responses. In
addition to intrinsic defenses such as repression of viral gene expression, cells have
elaborate signaling mechanisms to trigger innate and adaptive immune responses to viral
infection. Viral nucleic acids are the predominant pathogen associated molecular patterns
(PAMP) produced during viral infection and are recognized by pattern recognition
receptors (PRRs). It has been suggested that the cell distinguishes between viral and
endogenous nucleic acids based in part on their cellular compartmentalization and
chemical differences in the DNA itself. For example, DNA that is present in a
compartment other than the nucleus, such as in endosomes or in the cytoplasm, may be
identified as foreign. Cytosolic sensors of viral/microbial DNA include: DNA-dependent
activator of interferon (DAI), RNA polymerase III, PHYIN family proteins (such as:
IFI16 and AIM2), DExD/H-box helicases (like RIG-I), DNA-PKcs, cGAS, and STING
(reviewed in (Orzalli and Knipe 2014)). On the other hand, in the nucleus the cell relies
on chemical differences in DNA to distinguish between foreign and endogenous DNA.
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For example, unmethylated CpG DNA is chemically distinct from cellular DNA and will
flag viral DNA as a PAMP (Unterholzner 2013).
In addition to the possible roles in intrinsic antiviral mechanisms described above,
it appears that DNA-PKcs may also stimulate innate immune signaling. DNA-PKcs has
been reported to sense and respond to DNA and to induce transcription of Cxcl10, IL-6,
and IFN- β as part of the IRF-3 innate immune response (Ferguson, Mansur et al. 2012).
In that report, Ferguson, et al. also demonstrated that HSV-1 infection stimulates IL-6
transcription in MEFs and that this stimulation is partially relieved in DNA-PKcs
knockout cells (Prkdc-/- MEFs). It is thus possible that DNA-PK exerts its antiviral
effects by several different mechanisms including initiating an innate signaling cascade.
Recent studies have demonstrated that IFI16 also may play roles in both the intrinsic and
innate antiviral responses (Unterholzner, Keating et al. 2010, Li, Yamauchi et al. 2012,
Orzalli, DeLuca et al. 2012). HSV-1 triggers IRF-3 induction and activation of the
inflammasome in human fibroblasts in an IFI16-dependent manner (Orzalli, DeLuca et al.
2012, Johnson, Chikoti et al. 2013). ICP0 degrades IFI16 as part of the immune-evasion
strategy of HSV-1 (Orzalli, DeLuca et al. 2012).
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Figure 1.5. Diagram of the types of DNA damage and the cellular DNA repair
strategies. Single strand breaks are produced by direct oxidative attack to the sugar
phosphate backbone; alternatively, oxidative damage can indirectly cause ssDNA breaks
by inducing base excision of damaged bases. In both instances, BER is required for repair
(reviewed in (Ciccia and Elledge 2010)). Nicks can also arise from topoisomerase I
activity. These nicks have intact 5’-P and 3’-OH ends, and are easily ligated back
together. Some types of DNA damage, such as pyrimidine dimers and O6 methylguanine
can also be repaired by direct reversal; however, placental mammals do not express the
photolyase enzyme (Kato,	
  Todo,	
  et	
  al.	
  1994).
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Figure 1.6. Diagram of the DNA double strand break repair (DSBR) pathways. In
response to double strand breaks, DNA can be repaired by one of four major pathways:
classic nonhomologous end joining (C-NHEJ), microhomology-mediated end joining
(MMEJ), single strand annealing (SSA), and homologous recombination (HR). HR, SSA,
and MMEJ are homology-directed forms of repair; whereas, C-NHEJ does not require
homology. Double strand breaks arising at replication forks can also be repaired by
synthesis-dependent strand annealing (SDSA) and break-induced repair (BIR)
mechanisms via ATR-CHK1 signaling (not shown in figure).
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Figure 1.7. DNA damage is sensed by three PI3K-like kinases and has several
possible consequences. DSBR is mediated by the PI3K-like kinases: DNA-PKcs, ATM,
and ATR. These kinases activate signal mediators. Depending on the type and degree of
damage, this signaling can result in DNA repair, apoptosis, cell cycle arrest, and/or gene
silencing. When triggered by viral DNA, all of these consequences may contribute to an
antiviral response.
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Figure 1.8. Schematic of how HSV-1 manipulates components of the cellular DNA
damage response. During infection, HSV-1 inhibits phosphorylation of RPA32 S4/S8 by
degrading or inhibiting DNA-PKcs in an ICP0-dependent fashion (Lees-Miller, Long et
al. 1996, Wilkinson and Weller 2004, Smith, Reuven et al. 2014). Although ATM, NBS1,
and CHK2 are phosphorylated during infection, the HR pathway is inhibited due to ICP0dependent degradation of RNF8 and RNF168 (Wilkinson and Weller 2004, Lilley,
Carson et al. 2005, Shirata, Kudoh et al. 2005, Lilley, Chaurushiya et al. 2010).
ATR/ATRIP phosphorylation of CHK1 S345 and RPA32 S33 is inhibited; however,
FANCD2 is activated by ubiquitination during HSV-1 infection (Mohni, Livingston et al.
2010, Mohni, Smith et al. 2013, Karttunen, Savas et al. 2014). Asterisk (*) indicates
proteins that are degraded by ICP0.
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Figure 1.9. Diagram of FA pathway protein functions in uninfected and HSV-1
infected cells.
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Figure 1.10. Possible SDSA strategies for recombination-dependent replication of
HSV-1 DNA. A. Step-wise model for strand annealing. One entire strand of a dsDNA
molecule is resected by exonuclease and the remaining strand is coated with SSAP prior
to incorporation at the lagging strand of a replication fork. B. Concerted model for
strand annealing. Resection of one strand of a long dsDNA molecule occurs
concomitantly with strand annealing, resulting in incorporation of the entire strand into
the lagging strand at a replication fork. This model was originally suggested by
Kuzminov (1999), and adapted from Weller and Sawitzke (2014).
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1.3. Thesis Objectives
The interaction between HSV-1 and the cell reflects an evolutionary tug of war in
which cells have evolved antiviral mechanisms that are, in turn, counteracted by viral
strategies that promote lytic infection. Because viruses rely on host cellular machinery
during infection, they have evolved to usurp cellular processes. On the other hand, cells
have intracellular antiviral defenses designed to fight viral infections. An important
feature of the antiviral response is the cellular ability to sense viral DNA as “foreign”,
and components of the cellular DNA damage response (DDR) have been shown to
function in this capacity. Thus, although HSV-1 may utilize some components of the
DNA damage response machinery to replicate its genome, other components are antiviral,
and HSV-1 has developed mechanisms to silence some DDR factors in order to avoid
antiviral restriction.
In order to promote lytic infection, HSV-1 expresses IE proteins, which set the
stage for viral replication by attenuating host antiviral factors and by facilitating gene
expression. For example, the IE protein, ICP0, is an E3 ubiquitin ligase that promotes
productive infection by targeting antiviral factors for proteasomal degradation. It is now
becoming clear that, in addition to ICP0, there are other factors that influence the fate of
the incoming genome by mediating DNA repair pathway choice. The viral alkaline
nuclease, UL12, has been shown stimulate single strand annealing (SSA) (Schumacher,
Mohni et al. 2012) and interact with cellular mediators of DDR pathway choice including
the MRN complex and FANCD2 (Balasubramanian, Bai et al. 2010, Karttunen, Savas et
al. 2014). The central hypothesis of this thesis is that DDR pathway choice is essential
for productive HSV-1 infection, and that UL12 acts a mediator of DDR pathway
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choice to produce DNA that is infectious and that can be packaged for productive
infection.

SPECIFIC AIMS‡:

1) Hypothesis: The molecular architecture of HSV-1 DNA affects its infectivity and
its ability to induce a cellular DNA damage response.
a) Enzymatically manipulate HSV-1 DNA to determine structural requirements for
infectivity.
b) Determine whether 5’ flapped DNA is not infectious because it triggers antiviral
DNA damage response.
c) Determine whether overexpression of ICP0 can rescue loss of infectivity of 5’
flapped DNA.
d) Determine whether infectivity of 5’ flapped DNA is restored on C-NHEJdeficient cells.

2) Hypothesis: The growth defect observed in UL12-null (AN-1) infection is due to
the production of aberrant DNA.
a) Determine whether AN-1 DNA is infectious by transfection of:
i) Vero cells
ii) UL12-complementing (6-5) cells.
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  to	
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  the	
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  that	
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  done,	
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  aims	
  presented	
  here	
  have	
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  from	
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  presented	
  in	
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b) Determine whether AN-1 infection produces aberrant DNA on complementing
cell lines.
i) By pulsed field gel electrophoresis (PFGE)
ii) By electron microscopy (EM)
c) Using sucrose gradient ultracentrifugation, determine whether AN-1 exhibits
aberrant capsid packaging during infection of complementing cells.

3) Hypothesis: UL12 is required to inhibit DNA-PKcs-independent C-NHEJ.
a) Determine whether AN-1 virus yield is restored on cell lines deficient for CNHEJ
b) Determine whether C-NHEJ is inhibited in AN-1 infected cells, compared to wild
type infected cells.
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CHAPTER 2

The structure of the HSV-1 genome: manipulation of nicks and gaps can abrogate
infectivity and alter the cellular DNA damage response.
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Weller
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2.1. ABSTRACT
The HSV-1 virion DNA contains nicks and gaps, and in this study a novel assay
for estimating the size and number of gaps in virion DNA was developed. Consistent
with previous reports, we estimate that there are approximately 15 gaps per genome, and
we calculate the average gap length to be approximately 30 bases. Virion DNA was
isolated and treated with DNA modifying enzymes in order to fill in the gaps and modify
the ends. Interestingly, filling in gaps, blunting the ends, or the addition of random
sequences to the 3’ ends of DNA producing 3’ flaps did not impair the infectivity of
treated DNA following transfection of Vero cells. On the other hand, the formation of 5’
flaps in the DNA following treatment resulted in a dramatic reduction (95-100%) in
infectivity. Virion DNA stimulated DNA-PKcs activity in transfected cells, and DNA
with 5’ flaps stimulated a higher level of DNA-PKcs activity than that observed in cells
transfected with untreated virion DNA. The infectivity of 5’-flapped DNA was restored
in cells that do not express DNA-PKcs and in cells co-transfected with the immediate
early protein, ICP0, which degrades DNA-PKcs. These results are consistent with
previous reports that DNA-PK and the NHEJ repair pathway are intrinsically antiviral
and that ICP0 can counteract this effect. We suggest that HSV-1 DNA with 5’ flaps may
induce an antiviral state due to the induction of a DNA damage response, primarily
mediated by NHEJ, that renders the HSV-1 genome less efficient for lytic infection.

2.2. IMPORTANCE
For productive lytic infection to occur, HSV-1 must counteract a variety of
cellular intrinsic antiviral mechanisms, including the DNA damage response (DDR).
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DDR pathways have been associated with silencing of gene expression, cell cycle arrest
and induction of apoptosis. In addition, the fate of viral genomes is likely to play a role in
whether viral genomes adopt a configuration suitable for lytic DNA replication. This
study demonstrates that virion DNA activates the cellular DDR kinase, DNA-PK, and
that this response is inhibitory to viral infection. Furthermore, we show that HSV-1
ubiquitin ligase, ICP0, plays an important role in counteracting the negative effects of
DNA-PK activation. These findings support the notion that DNA-PK is antiviral and
suggest that the fate of incoming viral DNA has important consequences for the
progression of lytic infection. This study underscores the complex evolutionary
relationships between HSV and its host.

2.3. INTRODUCTION
Herpes Simplex Virus Type 1 has a double stranded linear DNA genome that is
approximately 152 kbp in length. Both the replicating DNA and encapsidated viral
genomes contain nicks and gaps (Kieff, Bachenheimer et al. 1971, Frenkel and Roizman
1972, Gordin, Olshevsky et al. 1973, Sheldrick, Laithier et al. 1973, Wilkie 1973, Biswal,
Murray et al. 1974, Hirsch, Roubal et al. 1976, Jacob and Roizman 1977). In DNA
isolated from virions, gaps have been reported to number 3-13 per genome (Ben-Porat
and Rixon 1979, Sinden, Pettijohn et al. 1982). These gaps are randomly located, and are
present on both strands (Kieff, Bachenheimer et al. 1971, Wilkie 1973, Hyman, Oakes et
al. 1977). Little is known about how nicks and gaps arise, and it is anticipated that the
study of nicks and gaps in the HSV genome may provide insight into host responses to
incoming viral genomes and the mechanism of HSV-1 replication.
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At the earliest stages of HSV infection, the viral genome is released from the
capsid into the nucleus, where it becomes associated with a combination of viral and
cellular proteins. Some of these proteins are factors utilized by the virus to initiate a
robust program of viral gene expression and DNA synthesis, while others are now
recognized for their ability to mount an intrinsic antiviral response. Several intrinsically
antiviral pathways that act to silence viral gene expression have been identified,
including: PML and other components of ND10 (Everett, Parada et al. 2008, Lukashchuk
and Everett 2010), the interferon-inducible DNA sensor, IFI16 (Orzalli, DeLuca et al.
2012, Johnson, Chikoti et al. 2013, Pham, Kwon et al. 2013), and components of the
DNA damage response (Lees-Miller, Long et al. 1996, Parkinson, Lees-Miller et al. 1999,
Lilley, Chaurushiya et al. 2010, Lilley, Chaurushiya et al. 2011). HSV must counteract
these intrinsically antiviral pathways to establish an environment conducive to lytic
infection.
The cellular DNA damage response (DDR) is mediated by three phosphatidyl
inositol 3-kinase-like serine/threonine protein kinases (PIKKs): DNA-PK (DNAdependent protein kinase), ATM (Ataxia-telangiectasia mutated), and ATR (ATM and
Rad3 related) (Abraham 2004, Cimprich and Cortez 2008, Ciccia and Elledge 2010). The
DNA-PK complex, comprised of DNA-PKcs and the Ku70/Ku80 heterodimer, responds
to double strand breaks and stimulates repair via non-homologous end joining (NHEJ)
(Ciccia and Elledge 2010). ATM is activated by double strand breaks and stimulates
repair via homologous recombination (HR) and single strand annealing (SSA). ATR is
activated by stalled replication forks and stretches of ssDNA adjacent to dsDNA (Ciccia
and Elledge 2010). DNA repair proteins play both positive and negative roles during
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HSV infection, and HSV manipulates components of these pathways, activating some
and disabling others (Lees-Miller, Long et al. 1996, Parkinson, Lees-Miller et al. 1999,
Taylor and Knipe 2004, Wilkinson and Weller 2004, Lilley, Carson et al. 2005, Shirata,
Kudoh et al. 2005, Muylaert and Elias 2007, Gregory and Bachenheimer 2008, Mohni,
Livingston et al. 2010, Lilley, Chaurushiya et al. 2011, Mohni, Mastrocola et al. 2011,
Mohni, Dee et al. 2013).
The incoming viral genome with double strand ends, nicks and gaps may be
expected to be recognized by the cellular DDR and activate one or more of the DNA
damage sensing kinases. Activation of a DNA damage response can initiate cell cycle
arrest, gene silencing, and apoptosis, any of which could negatively impact the viral life
cycle by suppressing viral gene expression and virus production. It is also possible that
some DDR pathways may result in “repair” of DNA in a manner that is not consistent
with lytic infection. In HSV-infected cells, several DNA damage-sensing elements are
either degraded or their signaling is blocked. For instance, the immediate early protein
ICP0 is a major player in counteracting cellular antiviral mechanisms by degrading
antiviral proteins such as DNA-PKcs (Lees-Miller, Long et al. 1996, Parkinson, LeesMiller et al. 1999). Interestingly, ICP0 is also a component of the viral tegument and is
thus present at the earliest stages of viral infection even before immediate early protein
synthesis (Yao and Courtney 1992, Loret, Guay et al. 2008, Delboy, Siekavizza-Robles et
al. 2010). ATR-mediated phosphorylation of downstream targets, RPA and Chk1, is also
inhibited by three hours post infection (Shirata, Kudoh et al. 2005, Wilkinson and Weller
2006, Mohni, Livingston et al.). Thus it appears that HSV has evolved to inactivate
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several DDR elements that may recognize the unusual structure of the incoming viral
genome.
In this paper we have explored the role of virion DNA in the activation of DDR
kinases in the absence of the tegument using transfection-based assays. Virion DNA was
treated with enzymes that would be expected to fill in gaps, extend 3’ ends, ligate nicks,
cleave regions of single stranded DNA or result in 5’ flaps. These treatments were used to
confirm the presence of approximately 15 gaps per viral genome. We were also able to
estimate the average gap length to be approximately 30 bases. Virion DNA that had been
enzymatically modified was tested for infectivity by transfection. Although many of the
treatments did not affect infectivity, strand displacement synthesis resulting in 5’ flaps
and endonucleolytic digestion of ssDNA caused significant decreases in infectivity.
Virion DNA containing 5’ flaps activated robust DNA-PKcs activity that also correlated
with the dramatic loss of infectivity. This suppression could be rescued by genetic
deletion of DNA-PKcs or cotransfection with ICP0. These results are consistent with
previous reports that DNA-PKcs represents a cellular antiviral response to infection.

2.4. MATERIALS AND METHODS
2.4.a. Cell lines.
Vero cells and HCT-116 cells were obtained from American Type Culture
Collection (ATCC), and the derivative DNA-PK-/- cell line was generously provided by
Eric A. Hendrickson (University of Minnesota Medical School, Minneapolis, MN), and
has been previously described (Ruis, Fattah et al. 2008). Vero cells were grown in
Dulbecco’s modified minimal essential medium (DMEM) (Gibco) containing 5% fetal
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bovine serum (FBS). HCT-116 cells and DNA-PK-/- cells were grown in McCoy’s 5A
medium (modified) (Gibco) containing 10% FBS.

2.4.b. Viruses and plasmids.
The KOS strain of HSV-1 was used as the wild-type virus. The recombinant virus,
KOS-CMVGFP, contains the GFP gene under the control of the human cytomegalovirus
(HCMV) promoter (2.0kbp insertion) in the intergenic region between UL26 and UL27
genes (Balliet, Kushnir et al. 2007). Wild type ICP0 (pCI-110) and ICP0 ΔRING-Finger
(pCI-FXE) were generously provided by Roger Everett (MRC Virology Unit, Glasgow,
Scotland).

2.4.c. Preparation of viral DNA.
Virion DNA was isolated as previously described (Goldstein and Weller 1988).
Approximately 1 X 108 Vero cells were infected with KOS at a low m.o.i. (0.1-0.5).
When maximum cytopathic effects were observed, infected cells were harvested by
scraping and spun down at 1500rpm for 15 minutes at 4°C. Supernatant was removed and
stored at 4°C for later use. The cell pellet was then resuspended in 3mL of cold 1X RSB,
and incubated on ice for 10 minutes. Cells were then disrupted by dounce
homogenization. Cell debris and nuclei were then removed by centrifugation, 1500 rpm
for 10 minutes at 4°C. The supernatant was combined with the first supernatant and
centrifuged, 9000 rpm for 60 minutes at 4°C. Virions were resuspended in 5 ml of TNE
(10 mM Tris-Cl [pH 7.4], 10 mM NaCl, 30 mM MgCl2,) and frozen at -80°C. Virions
were thawed and SDS and Proteinase K were added to final concentrations of 1% and
	
  

57	
  

100 µg/ml, respectively. The tube was gently inverted and then incubated for 5 hours at
37°C. Then DNA was either dialyzed overnight at 4°C against 1 L TE (10 mM Tris-Cl
[pH 7.5], 1 mM EDTA, or DNA was gently extracted by phenol:chloroform:isoamyl
alcohol (25:24:1), and precipitated by either adding 0.6 volumes of 20% polyethylene
glycol 8000 (PEG 8000)- 2 M NaCl or by ethanol precipitation. DNA was incubated one
hour on ice, and then centrifuged for 15 minutes at 20,000 x g. The pellet was washed
with 70% ethanol, dried briefly, and resuspended in TE. The DNA was aliquoted and
stored at -80°C.

2.4.d. Enzymes.
The Klenow Fragment of E. coli DNA polymerase I was from Boehringer
Mannheim or New England Biolabs (NEB). T4 DNA polymerase, terminal transferase
(TdT), calf intestine alkaline phosphatase (CIP), and mung bean nuclease were from NEB.
T4 DNA ligase was from NEB or Invitrogen.

2.4.e. In vitro modification of virion DNA.
Virion DNA (200 ng, 2 fmol) was incubated with polymerases and other enzymes
in a 25 µl reaction volume for 30 minutes, unless otherwise indicated. For reactions with
Klenow polymerase and T4 DNA ligase, a buffer containing 10 mM Tris-Cl (pH 7.5), 5
mM MgCl2, 7.5 mM dithiothreitol (DTT) was used. The manufacturer-supplied buffer
(NEB) was used for reactions containing T4 polymerase, TdT, mung bean nuclease, and
CIP. ATP was used at 1mM with T4 DNA ligase and CIP, unless otherwise noted, and
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deoxynucleoside triphosphates (dNTPs) were used at 0.5mM where indicated. When
different buffers were used, no-enzyme controls were run using the same buffer.

2.4.f. Measurement of nucleotide incorporation into DNA.
The incorporation of labeled nucleotides was performed using Klenow
polymerase, T4 polymerase, and T4 DNA ligase (reactions described above) with [α32P]
dCTP included in the dNTP mixture. Reactions were incubated at 37°C for the times
indicated in the figures, and stopped by adding 5 µl of 6X gel loading buffer (50%
glycerol, 1 %SDS, 50 mM EDTA, 0.2% bromphenol blue). Half (15 µl) of each sample
was loaded onto a 0.7% agarose TAE (0.04 M Tris-acetate, 0.001M EDTA) gel. The gel
was dried onto DE81 paper (Whatman) and exposed to phosphorimager screens (National
Diagnostics). Dilutions of the dNTP mix were spotted onto paper and exposed to the
phosphorimager screen along with the gel in order to aid in the quantification of the
amount of label incorporated. The ImageQuant version 5.0 software package was used
for quantification of the results. Each time point was repeated independently at least three
times. Adobe Photoshop (v.7.0) and Adobe Illustrator (v. 10) were used in preparation of
the figures.

2.4.g. Calculation of gap number and length.
The incorporation of nucleotides by Klenow/ligase into 1 fmol of HSV genomes
in a 40 minute incubation was compared to the incorporation into the same amount of
DNA by Klenow fragment alone, 500 fmol and 3500 fmol, respectively. The number of
gaps per genome was calculated by dividing the difference in incorporation between
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Klenow alone and T4 pol, by the average length of Klenow strand-displacement (200
nucleotides [nt]):

Gap number = (IncorporationKlenow – IncorporationT4 pol) ÷ 200

(Equation 1)

Average gap length= IncorporationT4 pol ÷ Gap number

(Equation 2)

2.4.h. Infectivity assays.
Reactions were prepared and incubated as described above, without the labeled
nucleotide. All cell types were transfected using Lipofectamine Plus reagent (Invitrogen)
according to the manufacturer’s suggested protocol. Vero cells at 50-70% confluence
were transfected with incorporation products at a concentration of 200ng DNA/60mm
dish. Samples were overlaid with DMEM containing 2% methylcellulose at 17-20 hours
post-transfection. Plaques were fixed and stained with crystal violet four to five days later
and plaques were counted. HCT-116 and DNA-PK-/- cells at 70% confluence were
transfected with purified HSV DNA at a concentration of 0.5µg DNA/35mm dish.
Samples were harvested at 48 hours following transfection and titrated on Vero cells. For
co-transfection experiments, HCT-116 cells were plated on 35mm dishes at 70%
confluence and transfected with 0.5µg of viral DNA and 1µg of plasmid DNA. Virus was
collected at 48 hours following transfection and viral yield was determined by titration on
Vero cells.
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2.4.i. Pulsed-field gel electrophoresis.
Agarose gels were prepared using 1% pulsed-field gel-grade agarose (Bio-Rad) in
0.5X TBE buffer. Samples were diluted in 6X gel loading dye (NEB) and loaded directly
into the wells. Electrophoresis was performed using a CHEF-DR III apparatus (Bio-Rad)
with 0.5X TBE (45 mM Tris, 45 mM borate, 1 mM EDTA, pH 8.3) running buffer.
Samples were separated using 6 V/cm (approximately 200V) for 24 h at 14 °C. Switch
times ramped from 1 to 25 seconds. Lambda Ladder PFG Marker (NEB) and Vero cells
infected with HSV-1 were used as size standards. Gels were stained with ethidium
bromide, photographed, and were transferred by Southern blotting to GeneScreen Plus
membranes (Dupont NEN) according to manufacturer’s protocols. Membranes were
probed with CDP-Star biotin detection reagent (NEB) and imaged using a ChemiDoc MP
Imaging System (Bio-Rad).

2.4.j. Western blot analysis.
Vero cells were transfected with 2.5µg of untreated, Klenow-treated, or
Klenow/ligase-treated infectious DNA (prepared as described above) per dish.
Lipofectamine 2000 Reagent (Invitrogen) was used at a concentration of 10µL per
transfection, as described by the manufacturer. Samples were harvested 24 hours
following transfection and prepared for western blot analysis as previously described
(Mohni, Dee et al. 2013). The primary antibodies used were mouse monoclonal antiRPA32 (9H8) (1:1,000; GeneTex), polyclonal rabbit anti-phospho-RPA S33 (1:3,000;
Bethyl), polyclonal rabbit anti-phospho-RPA S4/S8 (1:3,000; Bethyl), monoclonal mouse
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anti-ICP0 5H7 (1:5,000; EastCoast Bio), monoclonal mouse anti-Ku70 Ab-4 (N3H10)
(1:1,000; Neomarkers). Western blots were quantified using ImageJ software.

2.4.k. Gene expression assay.
Vero cells were transfected with modified KOS-GFP DNA. Samples were fixed
with 4% paraformaldehyde at 24 hours post transfection and resuspended in PBS EDTA
(5 mM). GFP-positive cells were measured using flow cytometry using a BD LSR II and
analyzed using FlowJo software.

2.4.l. Immunofluorescence (IF).
IF analysis was performed as described previously (Livingston, DeLuca et al.
2008, Mohni, Mastrocola et al. 2011). Briefly, cells adhered to glass coverslips were
washed with PBS, fixed with 4% paraformaldehyde, and permeabilized with 1% Triton
X-100. Cells were blocked in 3% normal goat serum and reacted with antibodies as
indicated below. Primary antibodies included monoclonal mouse anti-ICP0 5H7 (1:200;
EastCoast Bio), and polyclonal rabbit anti-phospho-RPA32 S4/S8 (1:200; Bethyl
Laboratories). Alexa Fluor secondary antibodies (1:200; Molecular Probes) were used
with fluorophores excitable at a wavelength of 488, and 594 nm. Images were captured
using a Zeiss LSM 510 confocal nonlinear optical (NLO) microscope equipped with
argon and HeNe lasers and a Zeiss 63X objective lens (numerical aperture, 1.4). Images
were processed and arranged using Adobe Photoshop CS3 and Illustrator CS3.
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2.5. RESULTS
2.5.a. In vitro modification of HSV-1 DNA.
The HSV genome is packaged as a linear, double stranded DNA molecule that
contains nicks and gaps. This unusual structure prompted us to ask how the presence of
nicks and gaps might influence early steps in viral infection particularly with respect to
host factors that respond to incoming DNA. HSV-1 DNA, purified from virions, is
capable of initiating a productive infection in transfected cells. Transfection experiments
thus permit us to explore the infectivity of virion DNA in the absence of tegument
proteins that may act to promote or disable host factors responding to incoming viral
genomes. To better understand how the structural attributes of virion DNA affect
infectivity and host responses, DNA isolated from virions was enzymatically modified in
vitro prior to transfection.
We first sought to confirm the presence of gaps in purified HSV DNA and to
demonstrate that gaps could be repaired in vitro using a gap-filling polymerase. Purified
DNA was treated with the Klenow fragment of E. coli DNA polymerase I, which was
expected to recognize free 3’ termini and incorporate nucleotides thereby filling in gaps.
In a control reaction, virion DNA was denatured and primed with random hexamers.
Figure 1A shows that labeled nucleotides incorporated into the boiled and randomprimed DNA migrated as a smear (left side panels); whereas, nucleotides incorporated
into virion DNA migrated primarily as a single species. The extent of incorporation was
quantified and displayed in the graph shown in Figure 1B. Incorporation of label into
non-denatured virion DNA reached a plateau after 5-10 minutes of incubation, indicating
that the gaps in this DNA substrate had been filled. It is unlikely that the plateau is due to
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inactivation of the enzyme or an exhaustion of the dNTPs, as the incorporation into the
random-primed sample continues to be linear and does not reach a plateau in the same
time frame.

2.5.b. Klenow polymerase strand-displacement activity can be used to measure gap
number and length.
In order to measure the gap number and length of virion DNA, we compared
nucleotide incorporation using DNA polymerases with different biochemical properties.
The Klenow fragment of DNA polymerase I extends 3’ termini at gaps, and is also
capable of strand displacement synthesis. Because Klenow lacks 5’-3’ exonuclease
activity, nucleotides are displaced from the template ahead of the growing chain but are
not cleaved, resulting in a 5’ flap. T4 polymerase, on the other hand, does not possess
strand displacement activity, and dissociates from the DNA template when it reaches the
end of a gap (Panet, van de Sande et al. 1973). In addition, treatment with Klenow and T4
DNA ligase together prevents strand displacement synthesis because under these
conditions, once Klenow has filled in the gap, the 3’ terminus of the newly synthesized
fragment is ligated to the 5’ terminus of the adjacent strand.
Figure 2 shows the incorporation of labeled nucleotides into HSV DNA by
Klenow polymerase alone, Klenow and ligase together, or the T4 DNA polymerase.
While all three reactions reach a plateau, Klenow incorporates approximately 7-fold more
label than the other two reactions. This is consistent with the known ability of Klenow to
carry out strand displacement synthesis. On the other hand the inability of T4 DNA
polymerase and Klenow/ligase to perform strand displacement synthesis is consistent
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with the lower levels of incorporation observed for these conditions.
We took advantage of the known biochemical properties of T4 DNA ligase and
Klenow polymerase to measure the number and length of gaps in HSV-1 DNA using
Equation 1, as described in Materials and Methods. The difference in incorporation
between Klenow treatment versus Klenow/ligase treatment (3000 fmol) represents the
“extra” incorporation by Klenow resulting from strand displacement. Klenow polymerase
is known to displace approximately 200 bases before it dissociates from a DNA template
(Davey and Faust 1990, Kong, Kucera et al. 1993). To estimate the number of invasions,
and consequently, the number of gaps, the value for “extra” incorporation was divided by
200. According to this calculation, the number of gaps in the HSV-1 genome is 15, which
is comparable to previous determinations of 3-13 gaps per genome (Ben-Porat and Rixon
1979, Sinden, Pettijohn et al. 1982). Furthermore, using Equation 2, the average gap size
is calculated to be 33 nucleotides.
The conditions under which the ligation was performed (low DNA concentration,
high concentration of ligase at 37°C for 20 min) support complete sealing of the nicks,
but are unlikely to result in any end-to-end ligation of molecules. In order to verify that
the ends of the HSV-1 DNA were not ligated during the reaction, products were
separated by pulsed-field gel electrophoresis. The untreated HSV-1 DNA migrates as a
linear 152 kb monomer on this gel (Fig. 3, lane marked NT). After treatment with
Klenow or Klenow/ligase together (Fig. 3, lanes marked K and KL, respectively) the
DNA is still monomeric length, and no higher molecular weight species were observed,
indicating that the ligase did not produce concatemers or circles. Species that are shorter
than monomeric length were observed in all lanes, indicating that a portion of the DNA

	
  

65	
  

was sheared. Since fragmentation is more noticeable in the untreated sample, it is likely
that the nicked DNA was more vulnerable to breakage than DNA that had been repaired.

2.5.c. Filling in nicks and gaps does not affect infectivity.
The incorporation studies demonstrated that virion HSV-1 DNA contained gaps
that were readily filled using purified DNA polymerases. We next asked whether the
changes in DNA structure, made in vitro, affected the infectivity of the modified DNA, as
measured by a plaque assay following transfection. Plaque numbers for the control DNA
were in the range of 50-150 per 60 mm dish. Treatment of the DNA with T4 DNA ligase
did not affect infectivity (Fig. 4). Likewise, DNA that was filled in and ligated by
treatment with Klenow/ligase was fully infectious. This indicates that, at least in the
context of transfection, gaps and nicks are not required for infectivity. Filling in nicks and
gaps also did not potentiate the infection, as percent infectivity was similar to that of the
untreated control.

2.5.d. Treatment with mung bean nuclease destroys infectivity, confirming the presence
of gaps.
Infectivity was completely eliminated when HSV-1 DNA was incubated with
mung bean nuclease, an endonuclease that degrades ssDNA (Fig. 4). This result confirms
the presence of gaps in virion DNA, since digestion of the ssDNA at gaps would
fragment the genome and abolish infectivity. On the other hand, virion DNA that had
been treated with Klenow/ligase and then incubated with an excess of mung bean
nuclease retained its infectivity. HSV has been reported to contain complementary single
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3’ nucleotide overhangs at both ends (Mocarski and Roizman 1982, Davison and Rixon
1985). Treatment with mung bean nuclease following repair with Klenow/ligase would
be expected to blunt the ends of the HSV genome by removing overhangs. These
overhangs have been suggested to facilitate end ligation and contribute to circularization
of the genome prior to replication (Strang and Stow 2005). The observation that HSV-1
DNA was still infectious after this treatment confirms that Klenow/ligase can fill in gaps
and that 3’ overhangs are not required for infectivity.

2.5.e. Treatment with calf intestine alkaline phosphatase is tolerated.
End ligation and circularization of DNA would be expected to require the
presence of a 5’ phosphate. In order to determine whether 5’ phosphates on viral DNA
are required for infectivity, HSV-1 DNA was treated with calf intestine phosphatase. This
treatment has no effect on infectivity, suggesting that incoming DNA does not need to be
end-ligated (Fig. 4). We cannot, however, rule out the possibility that cellular kinases
could re-phosphorylate viral DNA.

2.5.f. Virion DNA with 3’ flaps retains infectivity.
To further analyze the effects of in vitro modification on infectivity of virion
DNA, we tested the effect of random 3’ tails added onto the DNA by terminal transferase
(TdT). Treatment with TdT acts in a template-independent manner to catalyze the
addition of deoxynucleotides to an available 3’ terminus. We used terminal transferase to
add tails, which were approximately 100-300 nucleotides in length, onto the HSV-1 DNA
(Roychoudhury, Jay et al. 1976, Tu and Cohen 1980, Chang and Bollum 1986, Boule,
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Rougeon et al. 2001). Despite the fact that the 3’ additions were random, and therefore
non-homologous, these additions had no effect on the infectivity of the DNA (Fig. 4).

2.5.g. Treatment with Klenow polymerase abolishes infectivity.
Interestingly, DNA treated with Klenow alone produced only 0-10% of the
number of plaques seen with untreated DNA (Fig.4). In the absence of nucleotides,
Klenow treatment had no effect on infectivity demonstrating that incorporation of
nucleotides into viral DNA was necessary for the loss of infectivity. In addition, if
Klenow was prevented from generating 5’ flaps by co-incubation with T4 DNA ligase,
infectivity was not impaired. Thus the dramatic decrease in infectivity with Klenowtreated DNA was only seen when strand displacement synthesis was allowed. Since
strand displacement synthesis is believed to result in the formation of 5’ flaps, these
results suggest that 5’ flaps are responsible for the lack of infectivity of Klenow-treated
DNA.
The drastic reduction in infectivity after Klenow treatment was not expected, and
we were interested to determine its cause. To rule out the possibility that Klenowtreatment caused a reduction in transfection efficiency and thus reduced the number of
genomes entering the nucleus, we measured gene expression from DNA that had been
treated with either Klenow or Klenow/ligase. Virion DNA was prepared from cells that
had been infected with a GFP-expressing virus and used to transfect Vero cells in the
presence of PAA to prevent viral replication. Thus, gene expression is expected to
originate only from input genomes, allowing for a direct comparison between treated and
untreated virion DNA. GFP-positive cells were analyzed by fluorescence-activated cell
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sorting (FACS). GFP expression was detected in cells transfected with untreated,
Klenow-treated, or Klenow/ligase-treated KOS-GFP DNA. Figure 5 depicts histograms
showing the distribution of GFP intensity plotted against the number of GFP-positive
cells. These data indicate that transfection efficiencies are similar between treated and
untreated samples, and that the loss of infectivity associated with Klenow treatment is not
caused by differences in transfection efficiency.

2.5.h. Co-transfection of ICP0 with untreated and Klenow-treated HSV-1 DNA
dramatically improves infectivity.
Co-transfection of ICP0 with infectious DNA has previously been shown to
enhance plaque formation in Vero and U20S cells (Yao and Schaffer 1995). We were
interested to see whether ICP0 could boost infectivity in cells transfected with Klenowtreated DNA. HCT-116 cells were co-transfected with wild-type or mutant ICP0, and
purified HSV-1 DNA that was either untreated or treated with Klenow. The ICP0 mutant
lacked the RING-finger domain (ICP0-FXE). Expression of wild-type ICP0 dramatically
increased viral yield from Klenow-treated DNA by more than 3 orders of magnitude
compared to co-transfection of an empty vector with Klenow-treated DNA (Table 1).
Consistent with previous findings (Yao and Schaffer 1995), co-transfection with wildtype ICP0 also improved the infectivity of untreated virion DNA, although to a lesser
extent. There was also a modest effect on the infectivity of both the untreated and
Klenow-treated DNA when co-transfected with ICP0-FXE. This may be due to other
functions of ICP0 that are unrelated to its ubiquitin-ligase activity. Similar results were
also observed in Vero cells (data not shown). These results confirm that ICP0 expression
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improves the infectivity of purified HSV-1 DNA. Interestingly, the presence of ICP0 is
able to overcome the loss-of-infectivity exhibited by Klenow-treated virion DNA
containing 5’ flaps. Although it is unknown whether 5’ flaps arise during HSV infection,
it has been shown that replicating viral DNA adopts complex structures (Severini,
Morgan et al. 1994, Severini, Scraba et al. 1996), and these structures may include 5’
flaps.

2.5.i. HSV-1 DNA stimulates RPA32 phosphorylation in transfected cells, but not
infected cells.
Since HSV virion DNA is linear, it has ends that may be recognized as double
strand breaks by DNA-PK. Furthermore, it is possible that gaps in HSV DNA or other
unusual structures could mimic the substrates that activate ATR (ssDNA adjacent to
dsDNA). Therefore, the structure of the viral genome might be expected to result in
activation of both ATR and DNA-PK. We have, however, previously reported that RPA,
which is a target for phosphorylation by both kinases, is not phosphorylated during HSV
infection (Wilkinson and Weller 2004, Mohni, Dee et al. 2013). HSV inactivates
components of both NHEJ and HR pathways through the action of ICP0. As an
immediate early protein, ICP0 is expressed very early in infection, but it is also present in
the tegument of the incoming virion (Yao and Courtney 1992, Loret, Guay et al. 2008,
Delboy, Siekavizza-Robles et al. 2010), potentially entering the nucleus at the time of
DNA entry. These observations led us to examine whether virion DNA could induce
DNA-PK and ATR kinase activity in transfected cells in which ICP0 and other viral
proteins are not present. The cellular single-strand DNA-binding protein, replication
protein A (RPA), is a well-known downstream target of both DNA-PKcs and ATR in
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response to DNA damage (Anantha, Vassin et al. 2007). The S33 residue of the middle
subunit, RPA32, is specifically phosphorylated by ATR (Vassin, Anantha et al. 2009),
while the S4/S8 residues of RPA32 are phosphorylated by DNA-PK (Zernik-Kobak,
Vasunia et al. 1997, Shao, Cao et al. 1999, Wang, Guan et al. 2001, Anantha, Vassin et al.
2007).
In uninfected Vero cells treated with UV, RPA32 is phosphorylated by DNA-PK
and ATR, as detected using specific antibodies for phospho-RPA32 S4/S8 and phosphoRPA32 S33, respectively (Fig. 6). Consistent with our previous findings, no
phosphorylated RPA was detected in HSV-infected cells (Fig. 6) (Wilkinson and Weller
2004, Wilkinson and Weller 2005, Mohni, Dee et al. 2013). On the other hand, phosphoRPA32 S4/S8 was detected in cells transfected with purified virion DNA demonstrating
that DNA-PK is activated under these conditions (Fig. 6). Interestingly, phospho-RPA32
S33 was not detected, suggesting that incoming virion DNA is not a suitable substrate for
ATR activation (Fig. 6).
The observation that DNA-PK is not activated in infected cells is consistent with
the known ability of ICP0 to degrade DNA-PKcs at least in some cell types (Lees-Miller,
Long et al. 1996, Parkinson, Lees-Miller et al. 1999, Davido, Von Zagorski et al. 2003,
Lin, Noyce et al. 2004). Interestingly however, DNA-PKcs is not degraded in HSVinfected Vero cells (Wilkinson and Weller 2004), raising the possibility that DNA-PK
might be inhibited by a mechanism other than degradation. Vero cells were transfected
with ICP0 or an ICP0 RING-finger mutant (ICP0-FXE), which lacks ubiquitin ligase
activity, UV-irradiated and analyzed by immunofluorescence with antibodies specific for
ICP0 and pRPA-S4S8. Cells expressing ICP0 failed to induce RPA32 S4/S8
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phosphorylation after UV damage, as there was no pRPA32 S4/S8 staining in cells that
were positive for ICP0 expression (Fig. 7, top panel). Conversely, pRPA32 S4/S8 was
observed in cells expressing ICP0-FXE, suggesting that the ubiquitin ligase activity of
ICP0 is required for inhibition of RPA S4/S8 phosphorylation (Fig. 7, bottom panel).
Thus, ICP0 is able to inhibit DNA-PK-dependent signaling, even in cell types in which
DNA-PKcs is not degraded. These observations suggest that either ICP0 degrades
another protein necessary for activation of DNA-PKcs, or that ubiquitination of DNAPKcs is inhibitory even without degradation.

2.5.j. Addition of 5’ flaps to virion DNA increases hyper-phosphorylation of RPA32.
We were intrigued by the dramatic loss of infectivity observed with the Klenowtreated DNA, and by the ability of ICP0 to rescue infectivity (Table 1, above). We
hypothesized that DNA with 5’ flaps may activate a more robust cellular DNA damage
response than wild-type HSV-1 DNA. Given previous reports that DNA-PK is antiviral,
we wanted to test the possibility that loss of infectivity may correlate with a robust DNA
damage response. Therefore, we asked whether modifications to virion DNA could alter
the DDR following transfection. Vero cells were transfected with virion DNA that was
either untreated, Klenow-treated (containing 5’ flaps), or treated with Klenow/ligase
(filled-in and ligated). Untreated transfected DNA stimulated RPA32 S4/S8
phosphorylation, and Klenow/ligase-treated DNA exhibited a similar level of RPA32
S4/S8 phosphorylation as the untreated sample. Interestingly, Klenow-treated DNA
elicited a greater pRPA S4/S8 signal than either the untreated and filled-in sample,
perhaps due to the 5’ flaps produced by Klenow treatment (Fig. 8).
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2.5.k. Infectivity of Klenow-treated DNA is restored in the absence of DNA-PKcs.
As described above, virion DNA treated with Klenow polymerase exhibited a
marked decrease in infectivity and increased levels of pRPA32 S4/S8 phosphorylation.
Since pRPA32 S4/S8 is a substrate of DNA-PKcs, we wanted to determine if DNA-PKcs
itself was responsible for the reduced virus yield seen with Klenow treated DNA. HCT116 (wild-type) and DNA-PKcs-/- cells were transfected with untreated or Klenow-treated
DNA, and infectivity was measured. Infectivity of Klenow-treated DNA in transfected
HCT-116 cells was about 11% of untreated DNA in transfected HCT-116 (Fig. 9). This is
a similar decrease to that observed when Klenow-treated DNA was compared to
untreated DNA in transfected Vero cells (Fig. 4). In DNA-PKcs-/- cells transfected with
Klenow-treated DNA, however, infectivity was 100% compared with untreated DNA in
transfected DNA-PKcs-/- cells (Fig. 9). This suggests that DNA-PKcs plays a role in the
loss of infectivity phenotype observed in wild-type cells.
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2.6. DISCUSSION
2.6.a. Summary.
The results presented in this paper confirm that HSV-1 virion DNA has an
unusual structure, containing multiple nicks and gaps. Virion DNA was treated with
various combinations of enzymes that fill in gaps, ligate nicks, create 3’ and 5’ flaps,
blunt the ends and fragment the genome at sites of ssDNA. Untreated virion DNA was
as infectious as DNA whose nicks and gaps were filled in and ligated, suggesting that
nicks and gaps are not required for virion DNA to be infectious. Other treatments
including blunting of the termini, removal of 5’ phosphates and production of 3’ flaps
are also tolerated. On the other hand, the formation of 5’ flaps in the DNA following
treatment with Klenow alone resulted in a dramatic reduction (95-100%) in infectivity.
Untreated virion DNA was able to activate DNA-PK activity in transfected cells, a
somewhat surprising result considering that DNA-PK is not activated in HSV-infected
cells, even at early times post infection. Interestingly, virion DNA with 5’ flaps
stimulated an even more robust activation of DNA-PK, compared with untreated virion
DNA. Infectivity of Klenow-treated DNA was restored in cells that do not express
DNA-PK, and in cells co-transfected with the immediate early protein ICP0, which is
known to degrade DNA-PKcs. Thus, we suggest that virion DNA with 5’ flaps induces
an antiviral state that is dependent on DNA-PK, and which can be suppressed by ICP0.
In this report we have used DNA with 5’ flaps to explore how the cell responds
to an unusual DNA structure. Although 5’ flaps are unlikely to be present in virion
DNA, the mechanisms of HSV DNA replication are poorly understood. Furthermore, it
is clear that unusual and complex structures containing X and Y junctions arise in
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infected cells, and it is thus possible that 5’ flaps may arise during replication. We have
been particularly interested in whether cells respond to unusual viral DNA
conformations by signaling a damage response that could be antiviral. For instance the
DDR response may silence or degrade viral DNA.
Using a novel assay based on the biochemical properties of the Klenow
polymerase, we were also able to estimate that virion DNA contains on average 15 gaps
per genome, consistent with published observations (Ben-Porat and Rixon 1979, Sinden,
Pettijohn et al. 1982). The presence of gaps in virion DNA might have been expected to
activate the ATR kinase; however, ATR signaling was not activated in cells transfected
with virion DNA. It has been reported that ATR activation requires a stretch of ssDNA
capable of binding at least two consecutive RPA complexes (approximately 65
nucleotides) (Blackwell and Borowiec 1994, Wold 1997). In this paper, we estimated
that the average size of gaps in virion DNA was approximately 33 nucleotides, long
enough bind a single RPA complex, but too short to activate ATR signaling. Thus, the
incoming genome does not appear to be a suitable substrate for ATR activation.
The presence of nicks and gaps in HSV virion DNA has interesting implications
for early stages of viral infection. Only a few other DNA viruses are known to package
nicked and gapped genomes: Pseudorabies virus (PRV) and Marek’s disease virus
(MDV) have nicks and gaps that are randomly distributed (Reznikoff and Thomas 1969,
Lee, Kieff et al. 1971, Ben-Porat, Stehn et al. 1976), while other DNA viruses contain
nicks and gaps located at specific sites. For example, there are five major nicks in T5,
which are thought to occur as a result of a virally encoded nicking enzyme, and may
play a role in the two-step transfer mechanism for ejecting DNA into its host (Rogers
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and Rhoades 1976, Scheible, Rhoades et al. 1977, Wang, Jiang et al. 2005). Like T5,
T7 DNA also has single strand interruptions at specific sites, but these are thought to be
the product of premature terminase activity during packaging (Khan, Hayes et al. 1995).
Little is known, however, about whether the structure of viral genomes plays a role in
infectivity or stimulation of host DDR.

2.6.b. Some cellular DNA damage response pathways are inhibited by HSV-1 infection.
Cells have several different DDR pathways that could be activated during
infection, and it is possible that HSV has evolved to utilize those pathways that are
conducive to productive infection while preventing pathways that inhibit lytic infection.
Using GFP correction assays, we have recently reported that single-strand annealing
(SSA) is increased in HSV-infected cells while NHEJ and HR are inhibited (Schumacher,
Mohni et al. 2012). This “pathway choice” on the part of the virus may be facilitated by
ICP0 consistent with its known ability to degrade components of the NHEJ and HR
pathways. For instance, ICP0 is known to degrade DNA-PKcs, a component of the NHEJ
pathway, as well as RNF8 and RNF168, which function in HR (Lees-Miller, Long et al.
1996, Lilley, Chaurushiya et al. 2010). DNA-PKcs and Ku, which are both essential
components of the NHEJ pathway, are inhibitory to HSV infection: replication is more
efficient in cells lacking DNA-PKcs (Parkinson, Lees-Miller et al. 1999), and viral yields
are increased by almost 50-fold in Ku-deficient murine embryonic fibroblasts (Taylor and
Knipe 2004). In this study, we show that ICP0 is able to inhibit DNA-PKcs-specific
phosphorylation of RPA32 even in a cell type in which DNA-PKcs is not degraded
(Table 1). The observation that HSV may utilize at least two different mechanisms to
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inhibit the activity of DNA-PKcs underscores the apparent necessity for the virus to
inactivate NHEJ.
Although the direct relationship between DNA-PK activation and loss-ofinfectivity is not known, the observation that loss of infectivity of virion DNA with 5’
flaps correlates with the robust activation of DNA-PK (Fig. 8) is consistent with the
notion that DNA-PK is antiviral. Furthermore, infectivity of Klenow-treated DNA was
restored in DNA-PK-/- cells (Fig. 9), suggesting that DNA-PKcs plays a role in the loss of
infectivity phenotype observed in wild type cells. Taken together these results suggest
that the activation of DNA-PK is associated with the drop in infectivity, and we are
intrigued by the mechanism by which this occurs. It is possible that DNA with 5’ flaps
can recruit cellular proteins such as nucleases that are able to process the 5’ flaps
resulting in extreme fragmentation of the viral genome and loss of infectivity. This model,
however, does not explain the observation that the absence of DNA-PK itself can rescue
infectivity. Another model posits that 5’ flaps either directly or indirectly activate DNAPK, and this activation is antiviral. Support for this model comes from reports that DNAPKcs kinase activity is potentiated by dsDNA with ssDNA ends compared to blunt ended
dsDNA (DeFazio, Stansel et al. 2002, Martensson and Hammarsten 2002, Llorca and
Pearl 2004, Rivera-Calzada, Maman et al. 2005). Additionally, DNA with a 5’ overhang
exhibits a greater increase in DNA-PK kinase activity than a 3’ overhang (Pawelczak and
Turchi 2008). The observation that in the absence of DNA-PK the 5’ flap structure is
tolerated supports the notion that the 5’-flapped genome represents a substrate for direct
DNA-PK activation.
DNA-PK plays an important role in a variety of cellular processes, and the
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specific mechanism by which DNA-PK inhibits lytic infection is not understood. It is
possible that DNA-PK, acting as part of the NHEJ pathway, promotes circularization of
the viral genome, which has been correlated with establishment of latent or quiescent
infection (Rock and Fraser 1983, Efstathiou, Minson et al. 1986, Jackson and DeLuca
2003). The report by Jackson and Deluca that the presence of ICP0 can inhibit
circularization (Jackson and DeLuca 2003) may be consistent with this suggestion;
however, further experimentation will be required to elucidate the relationship between
NHEJ and circularization of viral genomes. Regardless of whether circularization is the
mechanism by which NHEJ exerts its antiviral effects, the fate of the viral genome and
the choice of repair/recombination pathway activated during infection appear to have
important consequences for the establishment of lytic infection.
Although the mechanism of recombination in HSV infection is not well
understood, recent experiments from our laboratory suggest that HSV-1 activates the
SSA pathway. During infection, SSA is stimulated in a manner that appears to be
dependent on the viral 5’ to 3’ exonuclease, UL12 (Schumacher, Mohni et al. 2012).
UL12 interacts with ICP8 to form a two-component recombinase capable of strand
exchange (Reuven, Staire et al. 2003, Reuven, Willcox et al. 2004). We are intrigued by
the possibility that UL12/ICP8 work together to promote recombination-dependent
replication by SSA and that this pathway leads to the production of concatemeric DNA
that can be packaged into infectious virus (Weller and Sawitke, manuscript in press). In
addition, we are currently exploring the possible involvement of cellular proteins in the
stimulation of SSA in HSV-infected cells.
Taken together these observations suggest that HSV has evolved mechanisms of
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“pathway choice” that promote lytic replication by inhibiting NHEJ. Our findings
suggest that the presence of nicks and gaps in incoming DNA may result in the
recruitment of a combination of cellular and viral proteins that stimulates a repair
pathway that is beneficial to lytic replication, such as SSA. This process underscores the
complex evolutionary relationships between HSV and its host.
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Health grants awarded to SKW: AI069136 and AI021747.
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TABLE 2.1. Viral yield from cells co-transfected with HSV-1 virion DNA and plasmid
DNA
Viral DNA
Treatment

Plasmid
co-transfected

Viral titer
(pfu/mL)

Std. Error

% Infectivity

Untreated
(wild-type)

Empty vector

2.9 x 103

± 1.7 x 103

100

ICP0

4.1 x 105

± 8.1 x 104

14,000

ICP0 ΔFXE

1.2 x 104

± 3.7 x 103

420

Empty vector

3.0 x 101

± 1.1 x 101

1

ICP0

1.3 x 105

± 4.4 x 104

4,600

ICP0 ΔFXE

1.0 x 103

± 1.9 x 102

35

Klenow-treated
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Figure 2.1. Purified HSV-1 DNA contains gaps than can be filled by DNA
polymerase. (A) The incorporation of labeled nucleotides by the Klenow fragment of E.
coli DNA polymerase I into 200ng HSV-1 DNA was performed as described in Methods.
For lanes 1-6, prior to incubation in the reaction mix, the DNA was boiled 2 min and
quick-cooled, and random primers were added. Samples were analyzed by agarose gel
electrophoresis. (B) Quantification of labeled nucleotides incorporated into the HSV-1
DNA.
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Figure 2. Incorporation of labeled nucleotides into HSV-DNA by Klenow fragment
polymerase alone, Klenow and ligase together or the T4 DNA polymerase. Purified
HSV-1 DNA was incubated with labeled nucleotides and modifying enzymes, as
described in Methods. Treatment with Klenow fragment, Klenow fragment together with
T4
DNA2.2.
ligase
or T4 DNAof
polymerase
and the expected
DNA structures
Figure
Incorporation
labeled nucleotides
into HSV-DNA
by Klenowresulting
fragmentfrom
these treatments are shown.
polymerase alone, Klenow and ligase together or T4 DNA polymerase. Purified HSV-

1 DNA was incubated with labeled nucleotides and the following enzymes, as described
in Methods: Klenow fragment, Klenow fragment together with T4 DNA ligase, T4 DNA
polymerase.

	
  

82	
  

WT K KL

WT K KL

-152kb-

Biotin

Total DNA

Figure 3. Virion DNA before and after treatment with Klenow or Klenow and ligase.
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Figure 5. Transfection efficiency of treated and untreated
KOS-GFP DNA. Vero cells were transfected with untreated
(black), Klenow-treated (red), or Klenow/ligase-treated (blue)
KOS-GFP DNA. The graph depicts overlayed histograms of cells
sorted by FACS and gated for GFP-positive cells.
Figure 2.5. Transfection efficiency of treated and untreated KOS-GFP DNA. Vero
cells were transfected with untreated (black), Klenow-treated (red), or Klenow/ligasetreated (blue) KOS-GFP DNA. The graph depicts overlayed histograms of cells sorted by
FACS and gated for GFP-positive cells.
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Figure 7. ICP0 prevents pRPA32 S4/S8 in Vero cells. Vero cells were transfected
with ICP0 wt or the FXE mutant and then irradiated with 100 J/m2 UV. Cells were
allowed to recover for 2 hours and then fixed and stained as indicated. Cells transfected
with 2.7.
ICP0
areprevents
designated
with
arrows.
Figure
ICP0
pRPA32
S4/S8
in Vero cells. Vero cells were transfected
with wild-type ICP0 or the ICP0 ΔFXE mutant and then irradiated with 100 J/m2 UV.
Cells were allowed to recover for 2 hours and then fixed and stained as indicated. Arrows
highlight cells transfected with ICP0.
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Figure 8. Addition of 5’ flaps to virion DNA increases hyperphosphorylation of RPA32. (A)Vero cells were transfected with purified
KOS DNA that was either not treated (NT), Klenow-treated (K), or
Figure 2.8. Addition of 5’ flaps to virion DNA increases hyper-phosphorylation of
Klenow & ligase-treated (KL). Samples were harvested at 3h following
serum addition. As a positive control for pRPA S4/S8, Vero cells were
RPA32. (A) Vero cells were transfected with purified KOS DNA that was either not
treated with 50 J/m2 and allowed to recover for 1h at 37°C (“UV”). (B)
Densitometry analysis of western blot in panel B. Relative density was
treated (NT), Klenow-treated
(K), or Klenow & ligase-treated (KL). Samples were
calculated by the ratio of the densities of pRPA S4/S8 and Ku70. **Indi-

harvested at 3h following serum addition. As a positive control for pRPA S4/S8, Vero
cells were treated with 50 J/m2 and allowed to recover for 1h at 37°C (“UV”). (B)
Densitometry analysis of western blot. Relative density was calculated by the ratio of the
densities of pRPA S4/S8 and Ku70. **Indicates p=0.001.
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Figure 2.9. Infectivity of Klenow-treated DNA is rescued in the absence of DNA-PK.
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DNA control. Viral titers were normalized to untreated DNA control set at 100%.
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CHAPTER 3.

Genomes produced by the HSV-1 alkaline nuclease-null virus, AN-1, are
structurally aberrant and result in loss-of-infectivity.

Samantha Smith, Smaranda Wilcox, Renata Szczepaniak, Jack Griffith and Sandra K.
Weller

Author contributions: S.W. performed the EM analysis and gp32 binding experiments
shown in Figure 3.6 and Figure 3.7. R.S. performed the sucrose gradients for Figure 3.5.
All other experiments and reagent preparations were done by S.S.

3.1. ABSTRACT
Herpes simplex virus type I (HSV-1) encodes an alkaline nuclease, UL12, which
is required for efficient viral replication. UL12 has been shown to stimulate DNA repair
by single strand annealing (SSA) in cells (Schumacher, Mohni et al. 2012), and
participate in DNA strand exchange in vitro (Reuven, Willcox et al. 2004). The UL12null virus, AN-1, produces aberrant DNA and exhibits defects in both virus yield and
DNA packaging (Shao, Rapp et al. 1993, Martinez, Sarisky et al. 1996). Thus, it has been
proposed that UL12 plays a role in facilitating the correct DNA repair pathway choice
during infection in order to produce viral DNA that is infectious and suitable for
packaging (Martinez, Sarisky et al. 1996, Goldstein and Weller 1998). This chapter
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examines the phenotype of the AN-1 virus with respect to the infectivity and structure of
DNA produced during infection. Purified AN-1 DNA was not infectious on Vero or
complementing cells (6-5), and we determined that this is due to restriction of immediate
early gene expression. Using pulsed field gel electrophoresis (PFGE), we found a species
of aberrant viral DNA produced during AN-1 infection that was previously unreported.
Interestingly, this species of DNA was not present during infection with the ANF-1
mutant virus, which does not express full-length UL12, but encodes the amino-terminally
truncated UL12.5 protein that does not localize to the nucleus. It has previously been
reported that AN-1 produces fewer C capsids and more A capsids than wild type virus
(Shao, Rapp et al. 1993). We now show that this defect is partially relieved on
complementing (6-5) cells. We tested the stability of purified C capsids and found that
encapsidated AN-1 DNA appears to be as stable as encapsidated wild type DNA. EM
analysis also suggested that AN-1 virion DNA may contain more ssDNA regions than
wild type virion DNA. Taken together, these results suggest that UL12 is required to
efficiently produce DNA that is infectious and suitable for packaging.

3.2. INTRODUCTION
Herpes simplex virus 1 (HSV-1) is a large double-stranded linear DNA virus that
infects humans. The HSV-1 genome is approximately 152kb in length and is replicated in
the nucleus of the host cell. The virus encodes seven essential replication proteins: the
heterotrimeric helicase/primase (UL5/8/52), DNA polymerase (UL30), the polymerase
processivity factor (UL42), the origin binding protein (UL9), and the single strand DNA
binding protein (ICP8). These seven proteins together with an origin of replication (Ori)
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sequence are considered to be the minimum requirements for viral DNA synthesis.
Replication is thought to occur in a biphasic manner, beginning with origin-dependent, or
theta, replication, and later switching to a mechanism capable of producing concatemeric
DNA (Schildgen, Graper et al. 2005, Weller and Coen 2012)}. The production of
concatemeric DNA is an essential step for the generation of progeny virus, as the
packaging machinery must recognize longer-than-unit-length concatemers. The second
phase of DNA replication, which is thought to be origin-independent, is poorly
understood; however, several lines of evidence suggest that this phase may involve
recombination-dependent DNA replication.
Despite the identification of cis- and trans-acting elements needed for HSV-1
DNA replication, the mechanism of replication is still poorly understood. It has been
proposed that the viral genome circularizes and rolling circle replication leads to the
formation of concatemers (Roizman, Jacob et al. 1979, Garber, Beverley et al. 1993);
however, it is becoming increasingly apparent that the mechanism of HSV-1 utilizes a
more complex and unusual mechanism for DNA replication. Simple rolling circle
replication does not explain the observation that genomic inversions occur as soon as
viral DNA synthesis can be detected (Zhang, Efstathiou et al. 1994, Lamberti and Weller
1996, Severini, Scraba et al. 1996). Furthermore, replicating HSV-1 DNA does not
assume a linear concatemeric structure; instead, the products of HSV-1 DNA replication
are large branched structures that contain X and Y shaped DNA elements that may
represent recombination intermediates and replication forks, respectively (Jacob and
Roizman 1977, Severini, Scraba et al. 1996, Bataille and Epstein 1997). The HSV-1
replication machinery can also produce complex structures when replicating SV40 DNA,
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which when replicated using SV40 machinery produces concatenated DNA (Blumel,
Graper et al. 2000). Generation of these complex structures by HSV-1 appears to be an
inherent property of the replication machinery and does not require a specific sequence.
As alluded to earlier, we believe that HSV-1 utilizes a recombination-dependent
mechanism to produce concatemeric DNA suitable for packaging. In support of this
notion, the virus encodes a two-subunit recombinase, consisting of the alkaline nuclease,
UL12, and ICP8. By analogy to the redα/β system of Lambda phage, UL12 is thought to
resect 5’ DNA ends to expose regions of homology, and ICP8 acts as a single strand
annealing protein (SSAP) (Weller and Sawitzke 2014). We have previously shown that
UL12 and ICP8 can catalyze a strand exchange reaction in vitro (Reuven, Willcox et al.
2004). More recently, we have utilized a cell-based GFP report assay to monitor DNA
double strand break (DSB) repair during infection. Using this method, we have found that
UL12 is sufficient to stimulate single strand annealing (SSA) (Schumacher, Mohni et al.
2012), and we believe that the viral recombinase may influence DNA repair pathway
choice during infection in order to produce infectious viral DNA that is suitable for
packaging.
The phenotype of the UL12-null virus (AN-1) is complex, affecting several stages
of the virus life cycle. When AN-1 is propagated in Vero, HEK293, and BHK cells, viral
yields are decreased by 2-3 logs, compared to growth on a complementing Vero cell line
(6-5) (Weller, Seghatoleslami et al. 1990, Shao, Rapp et al. 1993, Balasubramanian, Bai
et al. 2010). Viral DNA synthesis is not severely compromised in AN-1-infected Vero
cells (50-90% of wild type levels) and terminal DNA ends can be detected by southern
blot, suggesting that concatemers are cleaved; however, a more severe defect in
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encapsidation and capsid egress was observed (Shao, Rapp et al. 1993). These results
suggest that although DNA synthesis occurs and concatemers are cleaved for packaging,
the DNA synthesized by AN-1 in Vero cells cannot be encapsidated efficiently into stable
DNA-containing capsids that are competent for nuclear egress. We suggest that this could
be the result of unresolved DNA recombination intermediates or other anomalies in DNA
structure that diminish the efficiency of encapsidation. The observation that AN-1 DNA
is more fragile and prone to fragmentation upon isolation than wild type DNA indicates
that the structure of AN-1 DNA is abnormal compared to wild type (Goldstein and
Weller 1998). The observation that the structure of AN-1 DNA is abnormal is consistent
with the encapsidation defect. In this chapter we report that DNA isolated from virions
that were produced in the absence of UL12 (AN-1 and ambUL12 infections) is not
infectious on transfected Vero cells (Shao, Rapp et al. 1993, Porter and Stow 2004).
Replicating DNA also appears to be aberrant in AN-1 infection: unlike wild-type
replicating DNA, which can enter a pulsed-field gel after being digested by a restriction
enzyme that cuts once per genome, similar treatment of replicating DNA from the AN-1
virus releases no discrete bands, which may suggest a more complex structure (Martinez,
Sarisky et al. 1996).
Replicating DNA is complex, but packaged virion DNA is linear. Encapsidation
requires that replicating DNA “mature” from a complex structure into an acceptable
substrate for cleavage and packaging. The phenotype of the UL12-null virus (AN-1)
supports the notion that UL12 is involved in some aspect of recombination-dependent
replication- either through pathway choice, resolution of recombination intermediates or
some combination of the two. This chapter examines the defects in viral infection with
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the UL12-null virus, AN-1 in order to better understand the role of UL12 in these
processes.

3.3. MATERIALS AND METHODS
3.3.a. Cell lines and viruses.
Vero, NHF, and HeLa cells were obtained from American Type Culture
Collection (ATCC). Vero cells were grown in Dulbecco’s modified minimal essential
medium (DMEM) (Gibco) containing 5% fetal bovine serum (FBS). The UL12expressing Vero cell line, 6-5, was previously described (Shao, Rapp et al. 1993). Vero
and 6-5 cells were grown in Dulbecco’s modified minimal essential medium (DMEM)
(Gibco) containing 5% fetal bovine serum (FBS). 6-5 cells were supplemented with G418
to maintain selection for the UL12 cassette. HeLa cells were maintained in DMEM
containing 10% FBS. The KOS strain of HSV-1 was used as the wild-type virus. The
UL12-null virus, AN-1, was derived from KOS and lacks 917bp of the UL12 gene due to
replacement with a LacZ insertion under the ICP6 promoter (Weller, Seghatoleslami et al.
1990).

3.3.b. Purification of viral DNA
Virion DNA was isolated as previously described (Goldstein and Weller 1988).
Approximately 1 X 108 Vero cells were infected with KOS at a relatively low MOI (0.1
to 0.5 PFU/cell). When maximum cytopathic effects were observed, infected cells were
harvested by centrifugation at 1500rpm for 15 minutes at 4°C. Supernatant was removed
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and stored at 4°C for later use. The cell pellet was resuspended in 3mL of cold 1X RSB
and incubated on ice for 10 minutes. Cells were disrupted by dounce homogenization and
cell debris and nuclei were removed by centrifugation at 1500 rpm for 10 minutes at 4°C.
The supernatant was combined with the first supernatant and centrifuged, 9000 rpm for
60 minutes at 4°C resulting in a suspension of intra and extracellular capsids, which were
resuspended in 5 ml of TNE (10 mM Tris-Cl pH 7.4, 10 mM NaCl, 30 mM MgCl2,) and
frozen at -80°C. Virions were thawed, and SDS and Proteinase K were added to final
concentrations of 1% and 100 µg/ml, respectively. The tube was gently inverted and
incubated for 5 hours at 37°C to release virion DNA, which was gently extracted by
phenol:chloroform:isoamyl alcohol (25:24:1) and precipitated with ice cold ethanol
(100%). DNA was incubated one hour on ice, and then centrifuged for 15 minutes at
20,000 x g. The pellet was washed with 70% ethanol, dried briefly, and resuspended in
TE buffer. Virion DNA was aliquoted and stored at -80°C for further use.

3.3c. Plaque assay.
Vero and 6-5 cells were seeded onto 60mm dishes at 50-70% confluence. Cells
were transfected with either the specified virion DNA, or no DNA for the mock sample,
at a concentration of 200ng DNA/dish using Lipofectamine Plus reagent (Invitrogen)
according to the manufacturer’s suggested protocol. Samples were overlaid with DMEM
containing 2% methylcellulose at 17-20 hours post-transfection. When plaques were
visible (approximately 4 to 5 days following transfection), samples were fixed with 8%
formaldehyde in 1X PBS and stained with crystal violet and plaques were photographed
and counted.
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3.3.d. Pulsed-field gel electrophoresis (PFGE)
Infected cell plugs were prepared as follows: Cells were seeded in 60 mm dishes
and infected at an MOI of 5 PFU/cell. At 20-24 h post infection, cells were harvested and
centrifuged at 2,000 rpm for 5 min in a Beckman model TJ-6 tabletop centrifuge. The
supernatant was then removed and cells were resuspended in approximately 600 µl of
55°C 1% low-melting-point agarose (BioRad LMP) in 0.5X TBE Buffer. Blocks were
stored at 4°C in 50 mM EDTA (pH 8.0). Lysis of the cells in plugs was performed by
incubation in 1% laurylsarcosine–0.4 M EDTA (pH 9.0) with proteinase K at 1 mg/ml for
24 h at 50°C. Blocks were then rinsed in 1X TE at 50°C, three times for 1 hour each, to
remove the detergent and the proteinase K and stored at 4°C in TE. PFGE was performed
as previously described (Smith, Reuven et al. 2014). Briefly, agarose gel was prepared
using 1% Pulsed Field Gel-Grade agarose (Bio-Rad) gel in 0.5X TBE buffer. Samples
were diluted in 6X Gel Loading Dye (NEB) and loaded directly into the wells.
Electrophoresis was performed using a CHEF-DR III apparatus (Bio-Rad) with 0.5X
TBE (45 mM Tris, 45 mM borate, 1 mM EDTA, pH 8.3) running buffer. Samples were
separated using 6 V/cm (approximately 200V) for 24 h at 14 °C. Switch times ramped
from 1-25 seconds. Lambda Ladder PFG Marker (NEB), MidRange II Marker (NEB),
and Vero cells infected with HSV-1 were used as size standards. Gels were stained with
ethidium bromide and imaged using a ChemiDoc MP imaging system (BioRad).
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3.3.e. Southern blot analysis
Gels were transferred by vacuum blotting to GeneScreen Plus membranes
(Dupont NEN) according to manufacturer’s protocols. The BamHI K fragment probe was
labeled by incorporation of dCTP [α-32P] using the Random Primer DNA Labeling Kit
(Life Technologies). The biotinylated BamHI S fragment probe was generated by PCR
incorporation of Biotin-14-dATP (Forward primer, 5’ CTCTCCGCATCACCACAGAA;
Reverse primer, 5’ AAAGGGGCCATGTGTAGGTG). Following PCR, probes were
cleaned up using Qiaquick PCR Cleanup Kit (Qiagen). Membranes were, developed
using the CDP-Star biotin detection reagent (NEB) and imaged using a ChemiDoc MP
imaging system (Bio-Rad).

3.3.f. Western blot analysis
Samples were harvested 24 hours following transfection and prepared for western
blot analysis as previously described (Mohni, Dee et al. 2013). The primary antibodies
used were anti-UL12 antibody (BWpUL12), which detects UL12 was a gift from Joel
Bronstein and Peter Weber (Parke-Davis Pharmaceutical Research), and monoclonal
mouse anti-β-actin (1:15,000; Sigma). Western blots were imaged using a ChemiDoc MP
imaging system (BioRad).

3.3.g. Preparation of capsids
To isolate capsids from infected cells, Vero cells were infected with either KOS
or AN-1 virus, and 6-5 cells were infected with AN-1 virus at a multiplicity of infection
of 3 pfu/cell. At 24 h post infection, samples were harvested and C capsids were
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separated by analytical ultracentrifugation on a sucrose density gradient (50-20%).
Purified C capsids were divided into 50µL aliquots and stored in a buffer containing
500mM MaCl and 35% sucrose at -20°C until further analysis.

3.3.h. Electron microscopy
To image virion DNA from purified C capsids, samples were stained using 1.7µL
of cytochrome C in a total volume of 50µL, and allowed to develop for 90 seconds so that
particles surface in a cytochrome film and picked up by the grid. For drop spreading,
samples were diluted 1:10 in 10mM Tris and 250mM ammonium acetate and then
immediately spread onto the grid by drop spreading. For the gp32 binding experiment,
samples were digested in Proteinase K and then incubated with the T4 ssb, gp32 prior to
analysis.

3.4. RESULTS
3.4.a. Purified AN-1 DNA is not infectious, even in cells expressing UL12.
Purified wild-type HSV-1 DNA is infectious when delivered by transfection into
cells. On the other hand, it has previously been reported that virion DNA from the UL12null virus, ambUL12, was not infectious (Porter and Stow 2004). In order to determine
whether the AN-1 mutant virion DNA also exhibited a noninfectious phenotype, viral
DNA was purified from AN-1-infected Vero cells and infectivity was measured.
Transfection of Vero cells with 200µg of wild-type KOS DNA resulted in the formation
of numerous plaques (Figure 3.1.A). In contrast, Figure 3.1.B. shows that no plaques

	
  

99	
  

were observed in Vero cells transfected with 200µg of AN-1 DNA, and in a duplicate
experiment, two plaques were observed. Similar results were observed in another
experiment in which cells were transfected with 1-2 µg of AN-1 or KOS DNA (data not
shown). The cell line, 6-5, expresses UL12 and has been shown to complement the
growth of AN-1, albeit not quite to wild type levels. To determine whether infectivity
could be restored by UL12 expression, 6-5 cells were transfected with AN-1 virion DNA.
Again, the AN-1 DNA did not produce any plaques (Figure 3.1.B), suggesting that the
loss of infectivity phenotype of purified AN-1 DNA cannot be rescued in the presence of
UL12. We suggest that UL12 must be present at the time of DNA synthesis and that once
aberrant DNA has been packaged it cannot be rescued by the presence of UL12 in
transfected cells. As a control, transfection of 6-5 cells with KOS DNA resulted in
numerous plaques (Figure 3.1.C), although there were fewer than seen on Vero cells. The
KOS DNA produced numerous plaques on 6-5 cells; however, there appeared to be fewer
plaques on 6-5 cells than on Vero cells (Figures 3.1C and 3.1.A, respectively). This is
consistent with previous reports that KOS infection is not as efficient on 6-5 cells as on
wild type Vero cells (Shao, Rapp et al. 1993).

3.4.b. Viral gene expression is not detectable in cells transfected with purified AN-1
DNA.
Next, we wanted to determine the stage of the HSV lifecycle at which the
infectivity of AN-1 DNA was being restricted. We next examined whether viral gene
expression could be detected in cells transfected with AN-1 DNA. To do this, Vero cells
were transfected with 0.5µg of KOS or AN-1 virion DNA. Cell lysates were harvested at
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24 h post transfection and analyzed by western blot for expression of the immediate-early
protein, ICP4. Figure 3.2 shows that cells transfected with KOS virion DNA exhibit
robust ICP4 expression at 24 h; whereas, no ICP4 expression is detected in the AN-1
sample. These results indicate that gene expression is markedly decreased in cells
transfected with AN-1 DNA.

3.4.c. High molecular weight viral DNA is produced during AN-1 infection of noncomplementing cell lines.
The lack of infectivity and viral gene expression of AN-1 DNA suggests that
there may be an inherent flaw in the DNA itself. It has previously been reported that the
DNA produced during AN-1 infection is extremely fragile, and replicating AN-1 DNA is
aberrant and has a more complex structure than KOS DNA (Martinez, Sarisky et al. 1996,
Goldstein and Weller 1998). With this in mind, we next wanted to compare AN-1 DNA
produced in complementing and non-complementing cells. To do this, Vero, HeLa and 65 cells were infected with AN-1 or KOS. At 18 to 20 hours post infection, the samples
were harvested, suspended in low melting point agarose, and subjected to pulsed field gel
electrophoresis (PFGE) (Figure 3.3). At this time point, we expect to see replicating DNA,
which remains in the well, and unit length (152kb) viral genomes, which have been
cleaved and packaged (Figure 3.3.A). Figure 3.3.B shows a southern blot of the PFGE
using a BamHI K fragment probe, which detects the junction region of the HSV-1
genome. The portion of the gel containing “well DNA” was removed from Figure 3.3.B
to allow for longer exposure of DNA that has entered the gel. In lanes 1,2 and 3, samples
from KOS- infected Vero, HeLa, and 6-5 cells are displayed.. All three of the KOS
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samples exhibit sharp bands corresponding to unit-length packaged DNA (152kb). In
contrast, all three of the AN-1 samples (Figure 3.3.B, lanes 4, 5, and 6) exhibit greatly
diminished amounts of unit-length DNA, consistent with previous reports that AN-1
infection produces less DNase-protected (encapsidated) DNA (Shao, Rapp et al. 1993,
Martinez, Sarisky et al. 1996). Furthermore, the 152kb bands seen in the AN-1 infected
Vero and HeLa cell samples are more diffuse than the sharp bands of unit-length KOS
DNA. The diffuse nature of this band may indicate heterogeneity in the size or structure
of the packaged DNA. In contrast to the AN-1 DNA produced on Vero and HeLa cells,
the 152kb DNA produced in AN-1 infected 6-5 cells appears to be more discrete,
suggesting that the diffuse bands correlate with a non-productive infection.
Figure 3.3 also shows an additional slow-migrating species of viral DNA
produced in AN-1 infected Vero and HeLa cells that is not present in wild-type samples
or in AN-1 DNA from 6-5 cells. This species represents DNA that has migrated out of
the well but is outside the linear range of separation by PFGE in what is termed the
compression zone (CZ). The molecular weight of linear DNA migrating in the CZ ranges
from > 300kbp to < 2Mbp; however, it is also possible that some branched molecules and
very large, supercoiled circular DNA could also migrate at this position. If the CZ DNA
has an unusual structure, its migration pattern would not be expected to reflect its
molecular weight.
To determine whether viral CZ DNA was unique to the AN-1 virus PFGE was
used to examine the DNA produced by another UL12 mutant virus, ANF-1. The ANF-1
virus is mutated in such a way that it does not express the full length UL12 gene, but still
expresses an N-terminally truncated protein, UL12.5, expressed from a distinct mRNA
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(Costa, Draper et al. 1983, Martinez, Shao et al. 1996 1983, Martinez, Goldstein et al.
2002, Corcoran, Saffran et al. 2009). CZ DNA was not observed in cells infected with
ANF-1. (Figure 3.4.B). Thus, CZ DNA was only produced in non-permissive cells
infected with a nuclease deficient virus.

3.4.d. Fewer C capsids are produced during AN-1 infection than during wild-type
infection.
As mentioned in the introduction, we previously reported that cells in infected
with AN-1, nearly wild type levels of viral DNA was produced and terminal fragments
were detected, indicating cleavage of concatemeric products of viral DNA replication;
however, a defect in stable encapsidation and egress from the nucleus was observed
(Shao, Rapp et al. 1993). We therefore wanted to examine the capsids generated in AN-1
infection to determine whether a defect could be detected.
When infected cell lysates are subjected to centrifugation in a sucrose gradient,
capsids band at three separate densities, labeled A, B, and C from least dense to greatest
density, respectively (Figure 3.8, far left). Capsids assembled in HSV-1 infected cells
(procapsids) are spherical and contain an internal scaffold that is cleaved prior to or
concomitantly with DNA packaging. Scaffold containing procapsids are unstable
angularize into scaffold containing capsids, which are designated as B-capsids following
sucrose gradient sedimentation. Capsids that have successfully completed cleavage and
packaging of virion DNA are C-capsids, which have replaced their scaffold with virion
DNA. A-capsids are thought to represent capsids in which the packaging process has
been initiated, and the scaffold has left the capsid; however, the DNA that enters the
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capsid is not retained (Addison, Rixon et al. 1990). Thus, A capsids are devoid of
scaffold and DNA and exhibit the least density of any capsid types.
We previously reported that, compared to wild type infection, a high proportion of
A-capsids are produced in cells infected with AN-1, indicating that packaging may have
been initiated but was subsequently aborted. Few, if any, DNA-containing C-capsids
could be detected (Shao, Rapp et al. 1993). We have confirmed a defect in the production
of stable C-capsids (Figure 3.5.A).

Although C-capsids could be observed in cells

infected with AN-1, they were much less numerous than those produced during KOS
infection of Vero cells (Figure 3.5.A). We have also analyzed capsids from AN-1
infected NHFs and observe the same phenotype (Figure 3.5.B.). In addition, the Ccapsids that are produced in AN-1 infected Vero and NHF cells appear to be more diffuse
than those produced in KOS infection. We have also analyzed capsids produced in 6-5
cells infected with AN-1 infection and observed that fewer A-capsids and more C-capsids
than in AN-1 infected Vero or NHF cells non-complementing cells infected. However,
the phenotype does not appear to be completely rescued by the resident copy of UL12 in
6-5 cells, as capsids from AN-1 infected 6-5 cells contain more A-capsids and fewer Ccapsids than the KOS sample (Figure 3.5). This result may be consistent with previous
observations that the defects in AN-1 can only be partially complemented in 6-5 cells,
since AN-1 yields are is improved on 6-5 cells compared to Vero and NHF but are still
significantly less than the virus yield of KOS (Shao, Rapp et al. 1993).
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3.4.e. Encapsidated AN-1 DNA appears to have more single strand regions, compared
with that of wild type.
We hypothesized that encapsidated AN-1 DNA is less stable and thus more likely
to be ejected from C-capsids, producing an abundance of A-capsids we observed by
sucrose gradient sedimentation. To assess C-capsid stability, we treated C capsids
isolated from KOS and AN-1 infections under various conditions to determine if the AN1 capsids were more likely to disgorge or lose virion DNA than wild type C-capsids.
Purified C-capsids were spread on EM grids and analyzed by rotary shadow EM. KOS
and AN-1 C-capsids were first spread with cytochrome C in the high salt buffer in which
they were stored (250mM NaCl). Neither the KOS nor the AN-1 capsids lost their DNA
under these conditions (data not shown). We next diluted the salt to 125mM and again
spread the capsids for EM analysis. Surprisingly, the KOS capsids ejected their DNA, but
the AN-1 capsids appeared to maintain encapsidated DNA (data not shown). This
indicates that wild type capsids may be more sensitive to changes in salt concentration,
although we cannot rule out the possibility that some AN-1 capsids had already lost their
DNA prior to the spreading and thus appeared to be undisrupted.
We also wanted to determine whether the encapsidated DNA from AN-1 Ccapsids could be distinguished from those from KOS-infected cells. Capsids were diluted
1 to 10 in 10mM Tris buffer and drop spread for EM analysis. For both the KOS and AN1 samples, the genomic DNA appeared as coils surrounding capsids. Because of the
conformation of the genomic DNA, we were unable to determine the length or structure
of the DNA with any accuracy. Thus, there were no observable differences between the
DNA from AN-1 capsids and KOS capsids by this method (Figure 3.6).
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One possible reason for the diffuse bands observed in unit-length AN-1 DNA by
PFGE would be heterogeneity due to structural difference such as more single stranded
DNA than in wild type genomes. This could also explain the diffuse nature of the Ccapsids seen in AN-1-infected cells by sucrose gradient sedimentation. In Chapter 2, we
demonstrated that, on average, wild type virion DNA contains approximately 15 gaps per
genome, each with an average length of 33nt (Smith, Reuven et al. 2014). With this in
mind, we wanted to compare the amount of ssDNA in AN-1 virion DNA to that of wild
type. However, because purified AN-1 DNA is extremely fragile, we could not use the
incorporation method for measurement of ssDNA, as we had done for wild type. Instead,
we performed a binding experiment using an ssDNA binding protein (ssb) to qualitatively
analyze ssDNA content by EM. To do this, we selected T4 phage gp32 protein as the ssb
because it has a DNA footprint small enough to bind the gaps in the wild type genome.
Figure 3.7 shows binding of the gp32 ssb protein to KOS (A) and AN-1 (B) from Vero
cells and AN-1 from 6-5 cells (C). In each image, the arrows point to representative
regions of viral DNA on which gp32 has bound. There appears to be more gp32 binding
to the AN-1 DNA from infected Vero cells (Figure 3.7.B) than to KOS DNA from Vero
cells. In addition, gp32-binding of AN-1 DNA from 6-5 cells appears to be similar in
quantity to the KOS DNA. This result suggests that AN-1 grown on Vero cells has more
ssDNA than KOS grown on Vero cells or AN-1 grown on 6-5 cells.
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3.5. DISCUSSION
3.5.a. AN-1 DNA: quantity vs. quality.
The phenotype of the UL12-null virus is quite complex. Wild-type levels of DNA
are observed in AN-1-infected cells; however, this DNA is not infectious. Furthermore,
at least some AN-1 DNA is cleaved into approximately unit length molecules and
terminal fragments are observed, indicating that encapsidation has been initiated;
however, the production of stable C-capsids and the number of C capsids in the
cytoplasm are greatly reduced compared to wild type infections. This complex phenotype
may indicate that UL12 is needed for two distinct steps, DNA processing and production
of stable capsids. However, the defects displayed by AN-1 may all be attributed to a
single event, the production of aberrant DNA. Previously published findings are
consistent with this notion. For example, although AN-1 synthesizes 60 to 90% of wild
type DNA levels, viral yields of AN-1 are only 0.1 to 1% of wild type yields (Weller,
Seghatoleslami et al. 1990, Shao, Rapp et al. 1993, Martinez, Shao et al. 1996).
Furthermore, replicating DNA (“well DNA” in PFGE) has been shown to be more
complex than in AN-1 infection than wild type infection, and virion DNA appears as a
smear by PFGE (Martinez, Sarisky et al. 1996). Taken together, these results suggest that,
although DNA is produced in AN-1 infection, it is unusual. We were intrigued by the
possibility that the defect in AN-1 growth was due to the aberrant structure of DNA
produced during AN-1 infection.
In this chapter, we demonstrated that purified viral DNA produced by the AN-1
mutant virus is not infectious because it cannot support immediate early gene expression
in transfected cells. AN-1 DNA was also not infectious in cells that express the UL12
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gene (6-5 cells). This may indicate that the loss of infectivity phenotype of purified AN-1
DNA cannot be rescued in the presence of UL12. It should be noted, however, that the
UL12 gene in 6-5 cells is controlled by the ICP6 promoter (Shao, Rapp et al. 1993), and
therefore requires immediate early gene expression to be activated. Since immediate early
gene expression does not occur in cells transfected with AN-1 DNA, UL12 would not be
present. Another consideration is that viral genes that are stably integrated into cellular
genomes generally remain silent unless infected with virus, thus UL12 expression is not
likely to occur in transfected cells. Wild type KOS DNA also appeared to produce fewer
plaques on 6-5 cells than on Vero cells (Figure 3.1). There is currently no clear
explanation for this observation; however, it may be due to variation in expression levels
and kinetics between the UL12 gene in the viral genome versus the UL12 gene in 6-5
cells. UL12 is a potent exonuclease, and it is likely that its function must be regulated
during infection, possibly by phosphorylation or other post-translational modifications.
Further experiments will be required to confirm this hypothesis, but it is possible that
overexpression of UL12 is not tolerated by wild type KOS because it cannot regulate
excess amounts of UL12.

3.5.b. What is the nature of compression zone (CZ) DNA?
We are particularly intrigued by the notion that DNA produced in the absence of
UL12 is aberrant, and we have begun characterization of the DNA produced in AN-1infected cells. As shown in Figures 3.3 and 3.4, we identified a species of DNA that
migrated in the “compression zone” (CZ DNA). CZ DNA was seen when AN-1 was
grown in non-complementing cells but not detectable in partially permissive cells. By
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definition, the CZ is beyond the linear range of separation in PFGE. Therefore, the
species of AN-1 DNA migrating within the CZ could represent a large range of sizes and
possibly structures. Further experiments will be required to better characterize this
species of DNA. Better resolution of CZ DNA during PFGE may be achieved by altering
the manner in which voltage is applied to the gel. The PFGE experiments presented in
this chapter utilized a ramped switch time from 2 seconds to 70 seconds and a pulse angle
120°. Increasing the final switch time and decreasing the pulse angle from 120° to 94°
may result in better resolution. It may be possible to determine whether CZ DNA
contains unusual structures through treatment with structure specific endonucleases, such
as T7 endonuclease I, which cleaves X and Y structures to produce linear DNA. Infected
cell plugs could be treated with the enzyme and then PFGE could be employed to
determine whether the treatment successfully resolved the CZ DNA. Although we would
like to excise and purify CZ DNA from gels for EM analysis, this would likely be
troublesome for two reasons. First, the CZ contains not only viral DNA but also cellular
DNA, which would be present in all samples. Second, the amount of viral CZ DNA that
can be separated in one PFGE well is very small. Because the CZ contains both cellular
and viral DNA, the individual species within the CZ cannot be accurately quantified.
The observation that CZ DNA was not present in ANF-1 infected cells was
surprising. ANF-1 only expresses the UL12.5 gene product, which cannot complement
for UL12 for viral growth (Martinez, Goldstein et al. 2002). UL12.5 is lacks a nuclear
localization signal (NLS), and is known to localize predominantly to the cytoplasm,
specifically to the mitochondria (Corcoran, Saffran et al. 2009). Thus it has been assumed
that it would not influence viral DNA replication, which takes place in the nucleus, There
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are several interesting possibilities to explain why AN-F1 is defective for viral growth
but does not produce the CZ DNA produce. First, although UL12.5 does not contain an
NLS, it is possible that some UL12.5, which is active for nuclease, may still be getting to
the nucleus and processing or eliminating CZ DNA; however, it is not a great enough
quantity to affect viral titer. A more speculative possibility pertains to the fact that
UL12.5 is required for the elimination of mitochondrial DNA that takes place during
HSV-1 infection (Latchman 1988, Saffran, Pare et al. 2007). We know that HSV-1
infection results in an increased oxidation state (Palamara, Perno et al. 1995, Mathew,
Bryant et al. 2010). What causes the increase in oxidation state is currently unknown;
however, mitochondrial dysfunction is often associated with aberrant oxidation, and it is
possible that elimination of mitochondrial DNA could contribute to the increased
oxidation observed during HSV-1 infection. Oxidation and production of reactive oxygen
species could result in extensive DNA damage, which in turn could stimulate DDR
proteins that participate in recombination. Although UL12.5 is not required for efficient
viral replication (Martinez, Goldstein et al. 2002), perhaps in the absence of full length
UL12, UL12.5 provides an alternative mechanism to stimulate recombination dependent
replication during HSV-1 infection. To further explore the contributions of UL12 and
UL12.5 to the outcome of viral DNA replication, it would be valuable to examine the
DNA produced during infection with the UL12 M127 mutant virus, which expresses
UL12 but not UL12.5 (Martinez, Goldstein et al. 2002).
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3.5.c. Does aberrant DNA account for the defects in C capsid formation during AN-1
infection?
AN-1 infection produces an abundance of A capsids, which are thought to be
produced as a result of abortive packaging (Addison, Rixon et al. 1990, Shao, Rapp et al.
1993). This observation and the diffuse nature of AN-1 C capsids, led us to hypothesize
that AN-1 C capsids were in some way more fragile than wild type C capsids. Thus, we
were surprised to find that the C capsids produced during AN-1 infection were as stable
as, if not more stable than, wild type C capsids. However, using an ssb-DNA binding
experiment, we showed that encapsidated AN-1 DNA has more single strand regions than
wild type DNA (Figure 3.7). It is unclear at this time whether the nature of the virion
DNA contributes to the diffuse appearance of C capsids produced during AN-1 infection
in non-complementing cells, which we observed by sucrose gradient sedimentation
(Figure 3.5). In addition, it is tempting to speculate that these observations may correlate
to the smeared appearance of unit-length AN-1 DNA by PFGE, because ssDNA may
contribute to the fragility of DNA and result in breakage.

3.5.d. UL12, AN-1 DNA, and the cellular DNA damage response.
In this chapter, we have proposed that AN-1 DNA is not infectious because it
contains structural abnormalities. We have previously shown (Chapter 2) that altering the
structure of viral DNA can greatly affect DDR pathway choice and lead to loss of
infectivity. In Chapter 2, we manipulated the structure of wild type DNA in order to
determine the requirements for infectivity. We demonstrated that, although the virus
tolerates some unusual DNA structures, introducing 5’ flaps into virion DNA eliminates
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the infectivity of KOS DNA (Smith, Reuven et al. 2014). In this situation, infectivity is
lost because 5’ flaps induce robust DNA-PKcs activity. DNA-PKcs has many antiviral
properties, including its role as an activator of the classic non-homologous end joining
(C-NHEJ) DNA repair pathway (Lees-Miller, Long et al. 1996, Taylor and Knipe 2004,
Smith, Reuven et al. 2014). We have proposed that DNA-PKcs exerts its antiviral effects
during HSV-1 infection by promoting incorrect pathway choice. One interesting
explanation for the lack of infectivity of AN-1 DNA may be that this DNA is the result of
incorrect pathway choice.
The production of aberrant DNA during AN-1 infection may illustrate the
important role that UL12 plays in DNA repair pathway choice during HSV-1 infection.
Because HSV-1 DNA replication remains poorly understood it is difficult to fully
understand the function of UL12 in the HSV-1 virus life cycle. HSV-1 replication
produces complex DNA structures, but the mechanism for this remains unknown. We
have proposed that HSV-1 utilizes SSA to produce concatemers (Schumacher, Mohni et
al. 2012), but how this is initiated and how the process plays out in the context of
infection is also unclear. It is possible that UL12 is required to direct repair toward the
correct pathway, either by resecting DNA at DSBs or recruiting DDR proteins. The role
of UL12 in DNA repair pathway choice will be explored in more detail in Chapter 4.
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Figure 3.1. Plaque assay for cells transfected with purified virion DNA. A. Vero cells
transfected with KOS DNA. B. Vero cells transfected with AN-1 DNA. C. 6-5 cells
transfected with KOS DNA. D. 6-5 cells transfected with AN-1 DNA. E. Mock
transfected Vero cells. Each sample has two replicates.
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Figure 3.2. ICP4 is expressed in Vero cells transfected with purified KOS DNA, but
not in Vero cells transfected with purified AN-1 DNA. Using Lipofectamine Plus
Reagent (Invitrogen), Vero cells were transfected with 0.5µg of DNase resistant DNA
was purifed from either KOS or AN-1 infection. Cells were harvested at ~24 hours
following serum addition and analyzed by western blot with mAb α ICP4 (U.S.
Biological) [1:1000], and mAb α ß-actin (Sigma) [1:5,000].
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Figure 3.3. Pulsed field gel electrophoresis of KOS and AN-1 DNA. KOS and AN-1 infected cells were embedded in agarose and treated with Proteinase K. Samples were
then separated by PFGE. A. Ethidium bromide stain of total DNA B. Southern blot was
performed with BamHI K probe (SQ fragment). Arrow for “cz” points to bands in
compression zone (present in AN-1/Vero and AN-1/HeLa samples only). Numbers
indicate lane numbers referred to in the text.
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Figure 3.4. Pulsed field gel electrophoresis of KOS, AN-1, and ANF-1 infected Vero
and 6-5 cell plugs. A. SYBR Gold staining of total DNA. “λ” indicates lambda ladder
(NEB) and “M” indicates Midrange II marker (NEB). This image correlates to the blot on
the left side of panel B. B. Replicate southern blots with biotinylated BamHI S-fragment
probe. Arrow points to bands in compression zone “cz” (present in AN-1/Vero samples
only).
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Figure 3.5. Sucrose gradient sedimentation of capsids isolated from KOS and AN-1
infected cells. Capsids were separated by analytical ultracentrifugation on a sucrose
density gradient (50-20%). A. KOS and AN-1 infection on Vero cells and AN-1 infection
on 6-5 cells. For AN-1/Vero samples, #1 and #2 represent replicate samples. B. KOS and
AN-1 capsids from infected Vero and NHF cells.
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A.
KOS from infected Vero cells

B.
AN-1 from infected Vero cells
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Figure 3.6. Genomes isolated from KOS and AN-1 C-capsids appear to be similar by
electron microscopy (EM) analysis. C-capsids were isolated from KOS (A) and AN-1
(B) infected Vero cells using sucrose gradient ultracentifugation. Samples were diluted
1:10 in 10mM Tris & 250mM ammonium acetate. Samples were incubated in
cytochrome C and then immediately spread onto an EM grid and imaged.
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A.
KOS DNA from infected Vero cells

	
  
B.
AN-1 DNA from infected Vero cells
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C.
AN-1 DNA from infected 6-5 cells

	
  

Figure 3.7. AN-1 DNA from C-capsids isolated from infection of non-complementing
cells (Vero) contains more ssDNA than KOS. EM analysis of gp32-binding to KOS
and AN-1 DNA from Proteinase K-treated C capsids. Arrows indicate examples of ssb
bound to DNA.
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CHAPTER 4.

The HSV-1 alkaline nuclease, UL12, inhibits Ligase IV-mediated NHEJ during
infection.

Samantha Smith, Kareem N. Mohni, and Sandra K. Weller

Author contributions: KNM performed the experiments in Figure 4.4.B. All other
experiments performed by S.S.

4.1. ABSTRACT
Replication of herpes simplex virus 1 (HSV-1) is associated with a high degree of
recombination, and cellular DNA damage response (DDR) pathways have been shown to
exert both positive and negative effects on this process. HSV-1 has evolved mechanisms
to influence DDR pathway choice in order to establish productive infection. We have
previously shown that HSV-1 stimulates the single strand annealing (SSA) pathway,
while inhibiting homologous recombination (HR), classic non-homologous end joining
(C-NHEJ), and microhomology-mediated end joining (MMEJ). We have now shown that
knockout of the core C-NHEJ proteins, LIG IV and XRCC4, improves growth of wild
type virus 2- to 3-fold, suggesting that these proteins are antiviral. The viral proteins,
UL12 and ICP0, have both been implicated DDR pathway choice during infection.
Therefore, in this chapter, we have set out to examine the roles of UL12 and ICP0 in the
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suppression of C-NHEJ and MMEJ. Using knockout cell lines for core C-NHEJ proteins,
we demonstrated that growth of the UL12-null virus (AN-1) was more robust on C-NHEJ
deficient cells; whereas, ICP0-null (0β) growth was unchanged on these cells. In addition,
using a reporter substrate that measures relative MMEJ and C-NHEJ activities, we found
that C-NHEJ was more active in the absence of UL12, and MMEJ was more active in the
absence of ICP0 compared to wild type. Taken together, these findings suggest that UL12
may play a role in suppressing C-NHEJ, and ICP0 may help to suppress the MMEJ
pathway during infection.

4.2. INTRODUCTION
4.2.a. The cellular DNA damage response (DDR).
In order to maintain genetic integrity, cells encode a variety of mechanisms for
the repair of DNA damage. The two main pathways for double strand break repair
(DSBR) are homologous recombination (HR) and non-homologous end joining (NHEJ)
(Figure 4.1). Although lower organisms rely on HR for most DSBR, vertebrates
predominantly utilize NHEJ. HR requires extensive amounts of homology in order to
facilitate repair; whereas, NHEJ requires little or no sequence homology at the dsDNA
ends. HR encompasses at least two homology-dependent recombination mechanisms,
including strand invasion (SI) and single strand annealing (SSA). NHEJ encompasses at
least two discrete pathways that facilitate repair of DSBs through direct fusion of dsDNA
ends, classic non-homologous end joining (C-NHEJ) and microhomology mediated end
joining (MMEJ). These pathways differ in the proteins and mechanisms used to facilitate
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end joining. The most well defined NHEJ pathway is classic (or canonical) nonhomologous end joining (C-NHEJ).
C-NHEJ is initiated when the Ku70/86 heterodimer senses DSBs and binds
dsDNA ends (Figure 4.2). This is a crucial step, as it not only promotes C-NHEJ, but also
prevents end resection and thus inhibits other DNA repair pathways, such as HR, SSA,
and some types of MMEJ. The DNA-dependent protein kinase catalytic subunit (DNAPKcs) is recruited to dsDNA ends by Ku and phosphorylates other DNA-modifying
enzymes. For example, DNA-PKcs binds and phosphorylates Artemis, the endonuclease
activity of which is involved in end-trimming or other processing if the ends are not
easily ligatable (Figure 4.2, right panel). The end ligation reaction is performed by DNA
ligase IV (LIGIV), which forms a trimeric complex with its accessory factors, XRCC4
and XLF (Figure 4.2, left panel)(Lieber 2010).
The “core” components of the C-NHEJ pathway are thought to include the
Ku70/86 heterodimer (hereafter Ku), DNA-dependent protein kinase catalytic subunit
(DNA-PKcs), Artemis, DNA ligase IV (LIGIV), X-ray-cross- complementation gene 4
(XRCC4), and Cernunnos/XRCC4-like factor (XLF); however, some of these proteins
may be dispensable for C-NHEJ (Figure 4.2). Genetic studies in conditional knockout
cell lines using reporter plasmids biased for NHEJ have revealed that C-NHEJ can occur
in the absence of Ku, ostensibly using only the LIGIV/XRCC4/XLF complex to facilitate
repair (Oh, Harvey et al. 2014). Even though it is not absolutely required for C-NHEJ, Ku
is an important factor in DSBR pathway choice, as its presence can inhibit other DDR
pathways, such as LIGIII (DNA Ligase III)–mediated MMEJ (described below) (Oh,
Harvey et al. 2014). XLF may also be dispensable, as it may functionally overlap DNA-
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PKcs and ATM (Kumar, Alt et al. 2014). In addition, C-NHEJ that does not require end
processing may proceed in the absence of DNA-PKcs and Artemis (Ma, Pannicke et al.
2002, Kumar, Alt et al. 2014). DNA-PKcs is an evolutionarily new protein, which does
not exist in lower eukaryotes and prokaryotes. Because of this, C-NHEJ in higher
organisms is sometimes referred to as D-NHEJ (DNA-PKcs-dependent C-NHEJ) (Dueva
and Iliakis 2013). This is an important distinction, given that NHEJ is flexible with
respect to the substrates it acts on and the components required.
Microhomology-mediated end joining (MMEJ) is another form of NHEJ present
in higher organisms; however, it is only activated when C-NHEJ is inhibited. Thus,
plasmid rejoining assays in cells that are genetically deficient for C-NHEJ have
demonstrated that MMEJ can be “unleashed” and its activity stimulated (Fattah, Lee et al.
2010). Because of this, MMEJ is sometimes referred to as alternative-NHEJ (A-NHEJ) or
backup-NHEJ (B-NHEJ), indicating that is activated only when C-NHEJ is prevented.
Figure 4.1 shows a hierarchical schematic of how cells may rely on MMEJ for repair
when other mechanisms fail. MMEJ is thought to be similar in mechanism to SSA,
although MMEJ requires only 5 to 25 nt of homology; whereas, SSA requires >30 nt to
occur. Both SSA and MMEJ result in deletions and can cause genomic translocations.
The role of this pathway is still poorly understood, but there is evidence that MMEJ
functions as more than just a backup mechanism for C-NHEJ in humans. MMEJ is
believed to be an important mechanism for repair of collapsed replication forks, and
microhomology has been detected at breakpoint junctions of chromosomal translocations
in human cancer cells, implicating MMEJ in their repair (Bentley, Diggle et al. 2004,
Mattarucchi, Guerini et al. 2008, Tsai, Lu et al. 2008, Truong, Li et al. 2013).
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4.2.b. DDR during HSV-1 infection.
Herpes simplex virus 1 (HSV-1) is a dsDNA virus that replicates its linear 152kb
genome in the nucleus of host cells. Replication of HSV-1 DNA is associated with a high
degree of recombination, and cellular DNA damage response (DDR) pathways have been
shown to exert both positive and negative effects on this process (Lilley, Chaurushiya et
al. 2010, Lilley, Chaurushiya et al. 2011, Weitzman and Weller 2011, Smith and Weller
2015). HSV-1 has evolved mechanisms to influence DDR pathway choice in order to
establish productive infection. Using cell-based GFP correction assays, Schumacher et al.,
demonstrated that HSV-1 infection potently stimulates SSA activity, and inhibits HR and
NHEJ (Schumacher, Mohni et al. 2012). We believe that HSV-1 mediates DDR pathway
choice by inactivating components of the C-NHEJ and HR pathways, which may be
antiviral, while recruiting DDR elements that are favorable for productive infection.
In Chapter 2, we proposed that the viral ubiquitin ligase, ICP0, may be a key
mediator of DDR pathway choice during infection. ICP0 degrades numerous proteins
involved in the cellular antiviral and DNA damage responses, such as PML, IFI16, DNAPKcs, RNF8, RNF168, and PARG (Lees-Miller, Long et al. 1996, Everett, Freemont et al.
1998, Lilley, Chaurushiya et al. 2010, Grady, Hwang et al. 2012, Johnson, Chikoti et al.
2013). In fact, several components of the C-NHEJ pathway have been shown to be
antiviral. HSV-1 viral yields are 30 to 50-fold greater in Ku70-deficient MEFs, compared
to growth on wild type MEFs (Taylor and Knipe 2004), and Parkinson, et al., have
reported that HSV-1 virus yields were greater in human glioma cells that are deficient for
DNA-PKcs (Parkinson, Lees-Miller et al. 1999). We and others have shown that DNA-
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PKcs is degraded or inhibited in many cell types during infection (Lees-Miller, Long et al.
1996, Parkinson, Lees-Miller et al. 1999, Lin, Noyce et al. 2004, Taylor and Knipe 2004,
Lilley, Carson et al. 2005, Smith, Reuven et al. 2014). Therefore, DNA-PKcs appears to
be antiviral, and the ability of ICP0 to degrade DNA-PKcs provides one mechanism by
which HSV-1 counteracts its activity. Furthermore, we have shown that even in cells in
which DNA-PKcs is not degraded, ICP0 can directly inhibit its activity (Smith, Reuven et
al. 2014).
It has been assumed that the inhibition of DNA-PKcs by ICP0 results in the
inhibition of C-NHEJ; however, the recognition that DNA-PKcs-independent pathways
of C-NHEJ exist in mammalian cells complicates this analysis (Figure 4.2). It is therefore
important to look at how HSV-1 interacts with core components of the C-NHEJ pathway,
such as LIGIV and XRCC4, in order to determine the mechanism by which C-NHEJ is
inhibited during infection. It is clear that ICP0 plays a role in counteracting antiviral
mechanisms, but there may be additional viral factors required to effect pro-viral pathway
choice and inhibit C-NHEJ. In other words, other factors are likely to influence the fate
of the viral genome and how it is replicated.
In this chapter, we will investigate whether the viral alkaline nuclease, UL12, also
influences cellular DDR pathway choice during infection. Using GFP repair assays, we
have shown that UL12 exonuclease activity potently stimulates SSA (Schumacher,
Mohni et al. 2012). In addition, UL12 interacts with DDR proteins, such as Ku70 and the
MRN

(MRE11/RAD50/NBS1)

complex

(Balasubramanian,

Bai

et

al.

2010,

Balasubramanian 2011). Recently, UL12 was also shown to interact with FANCD2,
which is a key mediator of DDR in uninfected cells and may contribute to inhibition of
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C-NHEJ during infection (Karttunen, Savas et al. 2014). Although its precise function of
UL12 in viral replication remains unclear, we have proposed that UL12 stimulates SSA
in order to produce DNA concatemers that can be packaged into progeny virus. This
notion is supported by the phenotype of two UL12-null viruses, AN-1 and ambUL12,
which have been reported to produce structurally aberrant DNA that is inefficiently
packaged into capsids (Shao, Rapp et al. 1993, Martinez, Sarisky et al. 1996, Porter and
Stow 2004).
The picture that is emerging is that the DDR pathway chosen by HSV-1 during
infection impacts the course of the infection in at least two ways. As mentioned above,
some DDR pathways are antiviral and HSV has evolved mechanisms to counteract these.
In addition it is important for HSV to generate concatemeric DNA suitable for
encapsidation in order to produce infectious virus. HSV must walk a fine line, balancing
these requirements. In this chapter, we will focus on the roles of UL12 and ICP0 in
directing DNA repair pathway choice during infection. Because NHEJ has been shown to
be antiviral, we will focus on the effects of both UL12 and ICP0 on the two types of
NHEJ repair, classic non-homologous end joining (C-NHEJ) and microhomologymediated end joining (MMEJ).
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4.3. MATERIALS AND METHODS
4.3.a. Cell lines.
Vero, U2OS, and HCT-116 cells were obtained from American Type Culture
Collection (ATCC), and the derivative cells lines: DNA-PK-/- (Ruis, Fattah et al. 2008),
LIG IV-/- (Oh, Wang et al. 2013), XRCC4-/- (B. Ruis and E. A. Hendrickson, manuscript
in preparation), and XLF-/- (Fattah, Kweon et al. 2014) were generously provided by Eric
A. Hendrickson (University of Minnesota Medical School, Minneapolis, MN). The
UL12-expressing Vero cell line, 6-5, was previously described (Shao, Rapp et al. 1993).
Vero and 6-5 cells were grown in Dulbecco’s modified minimal essential medium
(DMEM) (Gibco) containing 5% fetal bovine serum (FBS). 6-5 cells were also
supplemented with G418 to maintain selection for the UL12 cassette. HCT-116 and
derivative cell lines were grown in McCoy’s 5A medium (modified) (Gibco) containing
10% FBS. U2OS cells were grown in DMEM with 10% FBS.

4.3.b. Viruses.
The HSV-1 strain, KOS, was used as the wild-type virus in all experiments,
unless otherwise noted. The UL12-null virus, AN-1, is derived from KOS and has been
previously described (Weller, Seghatoleslami et al. 1990). The ICP0-null virus, 0β, was
derived from KOS and contains lacZ insertions in both copies of the ICP0 gene. 0β was
generously provided by Neal Deluca (University of Pittsburgh School of Medicine,
Pittsburgh, PA). The HSV-1 strain 17+ viruses, in1863 (wt) and dl1403/CMVlacZ
(ΔICP0) were obtained from Chris Preston (MRC Virology Unit, Glasgow, Scotland).
These viruses contain the lacZ gene under the control of the human cytomegalovirus
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(HCMV) promoter/enhancer inserted into the tk gene (Strang and Stow 2007, Everett,
Parada et al. 2008). KOS and in1863 were grown and titrated on Vero cells. AN-1 was
grown and titrated on 6-5 cells. 0β and dl1403/CMVlacZ were grown and titrated on
U20S cells.

4.3.c. Western blot analysis.
Samples were harvested 24 hours following transfection and prepared for western
blot analysis as previously described (Mohni, Dee et al. 2013). The primary antibodies
used were polyclonal rabbit anti-Human DNA Ligase IV (1:1000; Abcam), monoclonal
mouse anti-DNA-PKcs Ab-4 (Cocktail) (1:1,000; Neomarkers), and monoclonal mouse
anti-b-actin (1:15,000; Sigma).

4.3.d. Pulsed-field gel electrophoresis (PFGE) and Southern blot analysis.
Cells were seeded in 60mm dishes and infected at an MOI of 5 for 24 h. Infected
cells were then spun down and resuspended in 1200µL 1% low melting point agarose in
0.5X TBE buffer, except HCT-116* which was resuspened in 600 µL. Plugs were
Proteinase K (Roche) digested overnight at 50ºC. Approximately 1/2 plug was loaded per
well of 1% PFG grade agarose gel (BioRad) in 0.5X TBE buffer (45 mM Tris, 45 mM
borate, 1 mM EDTA, pH 8.3). Electrophoresis was performed using a CHEF-DR III
apparatus (Bio-Rad) with 0.5X TBE running buffer. Samples were separated at 6 V,
switch times ramped from 2 to 70 s for 18 h at 14ºC. Following electrophoresis, gels were
vacuum-transferred to GeneScreen Plus membranes (Dupont NEN), according to the
manufacturer’s protocols. Southern blot was performed using a biotinylated probe
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specific for the BamHI S fragment of HSV-1. Detection was performed with CDP-Star
reagent (NEB) on the BioRad Chemi-Doc MP imaging system.

4.3.e. Viral growth curves and yields.
Cells were seeded in 35mm dishes and infected at an MOI of 0.1 PFU/cell unless
otherwise stated and harvested at the times described (0, 6, 12, 24, and 48 h post infection.
KOS was titrated on Vero cells, AN-1 and D340E were titrated on 6-5 cells, and 0β was
titrated on U2OS cells. When plaques were visible, the cells were fixed with 8%
paraformaldehyde in 1X PBS (approximately 2 to 4 days post infection). Cells were
stained using 0.1% crystal violet and plaques were counted.

4.3.f. Probability of plaque formation assay.
The probability of plaque formation assay was performed as previously described
(Mohni, Livingston et al. 2010). Briefly, HCT-116, DNA-PK-/-, and LIG IV-/- cells were
infected with identical dilutions of in1863 and dl1403/CMVlacZ. Cells were fixed at 24 h
postinfection with 2% paraformaldehyde for 1 h, and stained for β-galactosidase activity
(5 mM potassium ferricyanide, 5 mM potassium ferricyanide, 2 mM MgCl2, and 1 mg/ml
X-Gal [5-bromo-4-chloro-3- indolyl-β-D-galactopyranoside]). β-galactosidase-positive
plaques were counted.
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4.3.g. Microhomology assay.
The microhomology assay was performed as previously described (Verkaik,
Esveldt-van Lange et al. 2002) with the following modifications. Briefly, cells were
infected with wild type (KOS), UL12-null (AN-1), a recombinant virus expressing the
nuclease-dead UL12 mutant (D340E), or ICP0-null (0β) virus at an MOI of 3. Cells were
transfected with 1.5 µg of EcoRV/AfeI-linearized pDVG94 plasmid per well using
Lipofectamine 2000 (Invitrogen) according to manufacturer’s instructions. Cells were
harvested at 48 h post transfection, and the repaired substrate was isolated using a
modified Qiagen minipreparation protocol. Repaired products were PCR amplified using
primer FM30 and DAR5 (Verkaik, Esveldt-van Lange et al. 2002). One half of the PCR
product was digested with BstXI and one half was used as the undigested control.
Samples were separated by polyacrylamide gel electrophoresis with using a 6%
acrylamide gel and 1X TBE buffer. Gels were stained using SYBR Safe DNA stain
(Invitrogen) and imaged using a ChemiDoc MP Imaging System (Bio-Rad). The 180bp
and 120bp bands were quantified using ImageJ software.
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4.4. RESULTS
4.4.a. DNA-PKcs inhibits probability of plaque formation, but not viral production in
human epithelial cells.
As described in the introduction, various components of the C-NHEJ pathway
have been shown to be antiviral. For instance, Parkinson et al., reported that virus
production of wild type HSV-1 (syn17+ strain) DNA-PKcs deficient human glioma cells
is 6 to 200-fold higher than on DNA-PKcs proficient cells (Parkinson, Lees-Miller et al.
1999). In order to further understand how and why C-NHEJ components are antiviral, we
have explored the growth of wild type and mutant HSV-1 on cell lines deficient for
DNA-PKcs and other components of the C-NHEJ pathway including LIGIV and XRCC4.
If a cellular component such as DNA-PKcs is inhibitory to viral growth, viral replication
is predicted to be more efficient on DNA-PKcs deficient cells. Furthermore, if the role of
ICP0 is to inhibit an antiviral restriction factor, an ICP0 deficient mutant is predicted to
grow better in cells deficient for that factor. We have used assays that either measure
either virus production or the probability of plaque formation assay. The plaque
formation assay reflects the probability that an incoming genome will commit the
infected cell to lytic infection. This assay has proven a useful indication of whether a
virus can overcome intrinsic antiviral mechanisms to establish a productive infection. The
virus production assay measures total viral production and is not as sensitive for detecting
early blocks to infection.
In order to confirm that DNA-PKcs is antiviral, we compared DNA-PKcs
deficient and proficient versions of the human epithelial cell line (HCT-116) (Ruis,
Fattah et al. 2008) in a plaque formation assay using in1863, a wild type 17syn+ strain
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virus that contains a lac Z insertion. Figure 4.3.A shows that the in1863 exhibited no
change in probability of plaque formation between wild type HCT-116 cells and DNAPKcs-/- cells, a result that contrasts with that of Parkinson et al. (Parkinson, Lees-Miller et
al. 1999). On the other hand, we were able to confirm the observation reported by
Parkinson, et al. that virus production on DNA-PKcs-/- human glioma cells infected with
an ICP0 deletion mutant (ΔICP0, dl1403) was up to 7-fold higher than on wild type cells
(Parkinson, Lees-Miller et al. 1999). We were able to repeat this result using a probability
of plaque formation assay. Figure 4.3.A shows that indeed, the probability of plaque
formation by ΔICP0 is more than 5-fold greater on DNA-PKcs-/- cells than on wild type
HCT-116 cells. Thus, in the absence of ICP0, DNA-PKcs inhibits viral growth
confirming previous observations.
The observation that DNA-PKcs is antiviral may indicate that the C-NHEJ
pathway itself is antiviral. However, in addition to its role in C-NHEJ, DNA-PKcs plays
other roles in the cell including inhibition of transcription by RNAP II and DNA sensing
as part of the IRF-3 immune response (Kuhn, Gottlieb et al. 1995, Ferguson, Mansur et al.
2012, Pankotai, Bonhomme et al. 2012). Thus, it is possible that DNA-PKcs is antiviral
due to one of its additional functions apart from its role in C-NHEJ. If DNA-PKcs were
antiviral due to its role in the C-NHEJ pathway, we would expect to see a greater
probability of plaque formation on cells deficient for the essential C-NHEJ ligase, LIGIV,
compared to wild type cells. Thus, to determine whether DNA-PKcs-independent CNHEJ was antiviral, we measured the probability of plaque formation of wild type and
ΔICP0 on an HCT-116 derivative cell line that was deficient for LIGIV (Oh, Wang et al.
2013). Again, we observed no change in probability of plaque formation on LIGIV-/- cells
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infected with wild type virus (Figure 4.3.A). Interestingly, we also found that ΔICP0 did
not exhibit increased probability of plaque formation in LIGIV-/- cells with ΔICP0infected wild type cells. This suggests that the antiviral properties of DNA-PKcs may be
related to a function other than C-NHEJ.
ICP0 is required to degrade or inhibit cellular factors that would otherwise restrict
viral replication. The growth defects exhibited by ICP0-null viruses are much more
pronounced at low multiplicities of infection presumably because the presence of
restriction factors lowers the probability that the incoming viral genome will lead to lytic
infection (Boutell and Everett 2013). Therefore, we wanted to determine whether virus
production of the ICP0-null virus, 0β, would be inhibited by DNA-PKcs at very low
multiplicities of infection (MOIs). We measured virus yields of 0β at very low MOIs on
DNA-PKcs-/-, and HCT-116 cells. We also tested virus yields for 0β on LIGIV-/- cells to
determine whether a functional C-NHEJ mechanism would inhibit growth. Figure 4.4
shows that viral yields between the three cell types were not significantly different at any
of the MOIs tested (MOI= 0.1, 0.05, 0.01, 0.005, and 0.001 PFU/cell). This was
consistent with the findings in Parkinson et al. that ΔICP0 (dl14030 was not significantly
inhibited by DNA-PKcs at very low MOIs (Parkinson, Lees-Miller et al. 1999).
Taken together, these results suggest that in the absence of DNA-PKcs plaque
formation by an ICP0 mutant is enhanced, but virus production was not increased even at
low multiplicities of infection. One explanation for this is that ICP0 degrades many
proteins, some of which are antiviral, and depletion of DNA-PKcs alone may not be
sufficient to overcome the defect caused by the absence of ICP0. Another interpretation is
that that C-NHEJ is inhibited by a mechanism that does not involve ICP0 or
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degradation/inhibition of DNA-PKcs. If C-NHEJ is inhibited even in the absence of ICP0,
for example by another viral protein, then ΔICP0 viral yields would be unaffected by CNHEJ deficiency. Since we know that C-NHEJ is inhibited during HSV-1 infection
(Schumacher, Mohni et al. 2012), the results presented thus far suggest that an additional
viral factor is required to inhibit C-NHEJ.

4.4.b. LIGIV and XRCC4 are antiviral.
HSV-1 may need to inhibit C-NHEJ in order to promote a DDR pathway that is
beneficial for viral replication, and we were intrigued by the possibility that C-NHEJ may
be inhibited by a mechanism other than degradation of DNA-PKcs. Therefore, we wanted
to determine whether another viral factor was required to inhibit C-NHEJ during
infection. We thought that UL12 may be implicated in DNA repair pathway choice and
participate in inhibition of C-NHEJ, since UL12 has been shown to stimulate SSA repair
(Schumacher, Mohni et al. 2012). In addition, UL12 has been shown to interact with
cellular DDR proteins (Balasubramanian, Bai et al. 2010, Karttunen, Savas et al. 2014),
although the biological significance of these interactions is not clear. Furthermore, we
have shown that AN-1 (UL12-null) exhibits severe growth defects and produces aberrant
DNA on non-complementing cells (Shao, Rapp et al. 1993, Martinez, Sarisky et al. 1996).
We speculated that these defects were caused by the inability of AN-1 to induce a DDR
pathway that would be conducive to productive infection. To assess whether UL12 plays
a role in the manipulation of the cellular DDR, we asked whether AN-1 infection would
be more efficient in cells defective for C-NHEJ. We also compared these results to KOS
growth on the same cell lines. If our hypothesis is correct, we would expect that AN-1
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yields would be greater on C-NHEJ deficient cells, and that the increase may be even
more significant than the increase in KOS on LIG IV-/- and XRCC4-/-.
In order to compare virus production from KOS and AN-1 infected C-NHEJdeficient cells, we measured viral growth over time in wild type HCT-116 cells and the
derivative cell lines DNA-PK-/-, LIGIV-/-, and XRCC4-/-. Cells were infected at an MOI
of 0.1 (PFU/mL). Samples were harvested at 0, 6, 12, 24, and 48 h post infection and
titrated (as described in the Materials and Methods section). Figure 4.5.A shows the virus
production over time in KOS-infected cells. Between 0 h and 24 h post infection, KOS
viral yields were similar among the cell lines tested; however at 48 h post infection,
growth yields of KOS on LIG IV-/- and XRCC4-/- cells were about 3 and 5 fold greater,
respectively, than growth yields on either HCT-116 (wt) cells or DNA-PKcs-/- cells
(Figures 4.5.A and 4.6). This result suggests that C-NHEJ is antiviral, since knocking out
the core components of C-NHEJ, LIGIV and XRCC4, showed a small but reproducible
improvement in viral growth. Furthermore, the observation that this effect was not seen
on DNA-PKcs-/- cells supports the notion that the antiviral effect of C-NHEJ may be
independent of DNA-PKcs.
We next wanted to determine whether C-NHEJ proteins inhibited AN-1 infection
more efficiently than KOS infection. Figure 4.5.B shows viral growth curves for AN-1
on HCT-116, DNA-PKcs-/-, LIGIV-/-, and XRCC4-/- cells. As early as 12 h post infection,
growth of AN-1 appears to be about 2-fold greater on all three knock out cell lines
compared to growth HCT-116. By 48 h post infection, AN-1 growth is more than one log
greater on XRCC4-/- cells than HCT-116 cells (Figures 4.5.B and 4.6.B). This increase is
much more pronounced that than seen in KOS-infected LIGIV-/- and XRCC4-/- cells.
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Thus, the core C-NHEJ proteins, LIGIV and XRCC4, are even more antiviral in the
absence of UL12, suggesting that UL12 may play a role in inhibiting C-NHEJ during
infection.

4.4.c. XLF may be dispensable for C-NHEJ.
We next asked whether XLF, another core C-NHEJ factor, was antiviral. During
C-NHEJ, XLF interacts with DNA and forms filaments with XRCC4 and LIGIV to
stabilize dsDNA ends and promote ligation (Gu, Lu et al. 2007, Ropars, Drevet et al.
2011, Mahaney, Hammel et al. 2013). We tested growth of KOS and AN-1 on HCT-116
and an XLF-/- derivative cell lines were infected at an MOI of 0.1, and viral yields were
measured at 24 h and 48 h post infection. At these time points, KOS replication was
approximately 2 to 3.5-fold less efficient on XLF-/- cells than on HCT-116 cells (Figure
4.6). The fact that virus production is decreased on XLF deficient cells suggests that XLF
may have a beneficial role during KOS infection. In contrast, AN-1 grows approximately
2 to 3-fold more efficiently on XLF-/- cells than on HCT-116 cells. This result suggests
that XLF may be antiviral but only in the absence of UL12. AN-1 growth on XLF-/- cells
was considerably less efficient than on either LIGIV-/- or XRCC4-/- cells, suggesting that,
like DNA-PKcs, XLF may be dispensable for C-NHEJ-mediated inhibition of HSV-1. In
support of this notion, genetic studies have shown that XLF has overlapping roles with
DNA-PKcs, 53BP1, and ATM, all of which have been implicated in DSBR pathway
choice (Zha, Guo et al. 2011, Liu, Jiang et al. 2012, Oksenych, Kumar et al. 2013, Kumar,
Alt et al. 2014). Furthermore, it has been suggested that these proteins may compensate
for one and other in C-NHEJ. Thus, the fact that only a modest increase in virus
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production was observed from AN-1 infection of XLF-/- cells may be due to
compensatory roles of other proteins. Alternatively, given that XLF deficiency had
opposite effects on wild type and AN-1 infections, it is possible that XLF exerts both
positive and negative effects on infection. This may indicate that XLF plays more than
one role during infection. Nevertheless, these results demonstrate that, in the absence of
UL12, XLF is antiviral.

4.4.d. Aberrant DNA is produced in in cells that are non-permissive for AN-1 infection
but not in semi-permissive DNA-PK-/- and LIG IV-/- cells.
We were intrigued by the possibility that UL12 is involved in pathway choice and
contributes to the inhibition of C-NHEJ. Pulsed-field gel electrophoresis of viral DNA
from AN-1-infected Vero or HeLa cells, which are non-permissive, revealed the presence
of high molecular weight bands that do not resolve beyond the compression zone of the
gel (CZ DNA) as well as a diffuse band of DNA at around 152 kb (see Chapter 3). On the
other hand, KOS DNA and AN-1 DNA from complementing cells appears a discrete
genome-length band at 152kb. We wanted to determine whether the unusual, aberrant
structure of DNA produced when AN-1 is grown under non-permissive conditions was a
result of an inappropriate DDR pathway choice. Because AN-1 replication was more
efficient in cells deficient for C-NHEJ, we asked whether AN-1 DNA would appear less
aberrant in cells deficient for C-NHEJ.
DNA from KOS and AN-1 infected cells was separated by PFGE and probed by
southern blot for viral DNA (Figure 4.7). As shown on the left side of Figure 4.7, DNA
from KOS-infected cells separated into two populations by PFGE. This is consistent with
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previous reports that, when separated by PFGE, replicating HSV-1 DNA does not enter
the gel and thus appears as “well” DNA, and genome-length HSV-1 DNA migrates at
approximately 152kb (Martinez, Sarisky et al. 1996, Goldstein and Weller 1998). In
addition, we observed that KOS infection produced significantly more genome-length
DNA than AN-1 infection at the same MOI (consistent with the results presented in
Chapter 3). AN-1 infection on HCT-116, HCT-116+3 (which express MLH1), and
RAD52-/- all produce an aberrant, slow migrating band of viral DNA that appears in the
compression zone (Figure 4.7, marked “cz”); however, AN-1 infected-DNA-PK-/- and
LIG IV-/- cells do not. This result suggests that C-NHEJ may play a role in generating this
aberrant phenotype.
Since the compression zone is beyond the limit of resolution in the PFGE, the
exact size and structure of CZ DNA is not known. It is possible that the compression
zone may contain genomes that are not linear; however, it seems likely that CZ DNA
does not consist of simple circular genomes, since it does not migrate at the same position
as the circular, bacmid-derived KOS genome (Figure 4.7, far right). Thus, CZ DNA is
unlikely to be the result of simple end-to-end ligation of the genome, and may represent a
more complex structure. Further experiments will be required to determine the precise
structure(s) of DNA species within the CZ and the kinetics of CZ DNA formation during
AN-1 infection.

4.4.e. UL12 may not require its nuclease activity to inhibit C-NHEJ.
Since UL12 is a potent exonuclease, and this activity is required for stimulation of
SSA (Goldstein and Weller 1998, Schumacher, Mohni et al. 2012), we hypothesized that
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UL12 nuclease activity might be needed to direct DDR pathway choice during infection.
Specifically, we wanted to know whether UL12 nuclease activity was required to
overcome viral inhibition by C-NHEJ. One possible mechanism by which UL12 could
inhibit C-NHEJ could involve extensive resection of dsDNA ends. This resection could
render dsDNA ends unsuitable for ligation by LIGIV. The D340E mutation in UL12
eliminates its exonuclease activity and is unable to stimulate SSA (Goldstein and Weller
1998, Schumacher, Mohni et al. 2012). If UL12 nuclease activity is required to inhibit CNHEJ, then we would expect that growth of the UL12 D340E mutant would be greater on
cells deficient for C-NHEJ proteins. Figure 4.8 shows virus yields for AN-1 and
recombinant UL12 D340E virus at 24 and 48 h. Viral titers were measured following
infection of HCT-116 cells and cells deficient for C-NHEJ proteins (DNA-PK-/-, LIG IV/-

, and XRCC4-/-cell lines) at an MOI of 0.1. As shown in Figure 4.6, AN-1 grew better on

cells that were deficient for core C-NHEJ proteins. In contrast, C-NHEJ proteins did not
appear to be antiviral in the context of D340E infection, as viral growth was similar on all
cell lines tested. In addition, D340E infection produced similar virus yields to AN-1
infection on LIG IV-/- and XRCC4-/- cells. This result suggests that UL12 does not require
its nuclease activity in order to relieve the antiviral activity of C-NHEJ. Thus, UL12 may
be inhibiting C-NHEJ by a mechanism that does not involve DNA end resection.
Alternatively, UL12 may recruit another nuclease to perform end resection.

4.4.f. Measurement of MMEJ on C-NHEJ deficient HCT-116 cell lines.
Since UL12 appeared to inhibit the antiviral effects caused by C-NHEJ, we
hypothesized that C-NHEJ may be more robust during AN-1 infection. To examine this
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possibility, we measured the relative efficiency of MMEJ versus C-NHEJ during
infection using the pDVG94 reporter substrate (Verkaik, Esveldt-van Lange et al. 2002,
Lou, Chen et al. 2004). The pDVG94 plasmid is linearized by digestion with AfeI and
EcoRV to produce a blunt-ended, dsDNA substrate that contains 6bp direct repeats at
each end (Figure 4.9). End joining produces a circularized plasmid, which can then be
recovered from transfected cells and PCR amplified. Repair of the substrate by MMEJ
requires end resection, which removes one of the direct repeats, and thus creates a
sequence that is sensitive to digestion by BstXI and appears as a 120bp band by
polyacrylamide gel electrophoresis (PAGE). On the other hand, C-NHEJ generally
preserves both direct repeats, and does not result in a BstXI-sensitive repair product, thus
producing a 180bp uncut band by PAGE.
As mentioned earlier, C-NHEJ is the predominant mechanism of repair in
vertebrates, and it has been proposed that MMEJ acts as a backup mechanism for repair if
C-NHEJ fails (Dueva and Iliakis 2013, Oh, Harvey et al. 2014). This is supported by the
observation that only about 1% of the total repaired pDVG94 plasmid recovered from
wild type HCT-116 cells is BstXI-sensitive, which is to say that only about 1% of repair
is facilitated by MMEJ ((Oh, Harvey et al. 2014) and Figure 4.10). On the other hand,
almost all of the plasmid DNA recovered from C-NHEJ-deficient cells could be digested
by BstXI, producing a 120 bp product ((Oh, Harvey et al. 2014) and Figure 4.10). Thus,
MMEJ is the predominant form of repair in cells deficient for C-NHEJ proteins.
We used this assay to measure the relative frequency of repair by C-NHEJ versus
MMEJ during wild type infection or infection with mutant viruses on the HCT-116
derivative cell lines. Cells were first infected with virus and transfected with the blunt-
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ended linear pDVG94 substrate. At 48 h post infection, the repaired substrate was
recovered, PCR amplified, subjected to BstXI digestion, and analyzed by PAGE. Figure
4.9 shows a representative experiment testing the effect of mock, KOS, AN-1, D340E,
and 0β infections on MMEJ activity in the HCT-116 derivative cell lines. Table 4.2
shows the averages and statistics for replicate experiments and the average calculated
relative frequency of MMEJ for each sample normalized to mock infection on HCT-116
cells.
In general, infection with the various viruses did not alter the predominant form of
repair utilized in each of the cells lines. For example, C-NHEJ was the predominant
repair mechanism in wild type HCT-116 cells (Figure 4.10, panel A), and the cell lines
lacking components of the C-NEHJ predominantly utilized MMEJ for repair (Figure 4.10,
panels B-E). We have previously shown that, using an HEK293 cell line with a
chromosomally integrated reporter, MMEJ (A-NHEJ) is suppressed during infection
(Schumacher, Mohni et al. 2012). This observation would seem to suggest that MMEJ is
antiviral; however, the results shown in Figures 4.6 and 4.10 collectively suggest that
KOS grows the same, if not a little better, on cells lines for which MMEJ is the
predominant mechanism for end joining (i.e. DNA-PK-/-, LIGIV-/-, and XRCC4-/- cells).
Thus, MMEJ activity may not be antiviral, even though it is suppressed in some cell
types.
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4.4.g. MMEJ is stimulated in 0β infected cells.
Because ICP0 degrades or inhibits DNA-PKcs in a variety of cell types (LeesMiller, Long et al. 1996, Parkinson, Lees-Miller et al. 1999, Taylor and Knipe 2004,
Smith, Reuven et al. 2014), we had initially thought that ICP0 was responsible for the
inhibition of C-NHEJ during HSV-1 infection (Schumacher, Mohni et al. 2012). If this
hypothesis were correct, we would have expected 0β to grow better on C-NHEJ deficient
cells; however, this was not the case, since 0β did not grow better on LIGIV-/- cells
(Figure 4.4). We therefore hypothesized that ICP0 may not be responsible for inhibition
of C-NHEJ. To test this hypothesis, we used the pDVG94 reporter substrate, to measure
repair by end joining during HSV-1 infection in the presence and absence of ICP0. If our
hypothesis was correct, and ICP0 did not inhibit C-NHEJ, then we would expect the ratio
of MMEJ to C-NHEJ to be similar in wild type and ICP0-null (0β) infected cells. For this
assay we measured the proportion of end joining that was facilitated by microhomology
(MMEJ) in HCT-116 and Vero cells during mock, KOS, AN-1 D340E, and 0β infections.
The results were then normalized to the percent MMEJ for mock. Figure 4.11 represents
the average of at least three individual experiments. We were surprised to find that in
cells infected with 0β, the relative frequency of MMEJ was 2.5-fold (Vero) to 3-fold
(HCT-116) greater than mock, meaning that C-NHEJ is more efficiently inhibited in the
absence of ICP0. This suggests that rather than inhibiting C-NHEJ, ICP0 may play a role
in inhibiting or at least regulating factors involved in MMEJ.
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4.4.h. MMEJ is significantly reduced in AN-1 infected cells.
Figures 4.5 and 4.6 showed that AN-1 grew substantially better on LIGIV-/- and
XRCC4-/- cells. Because of this, we thought that UL12 may play a role in inhibiting the
C-NHEJ pathway during infection. Therefore, in the same assay described above, we also
examined the effect of AN-1 infection on the relative frequency of MMEJ in HCT-116
and Vero cells. AN-1-infected HCT-116 cells exhibited 44% (about 2-fold) less MMEJ
activity than mock-infected cells (Figure 4.11). MMEJ activity was further decreased in
AN-1-infected Vero cells, about 33% (about 3-fold) less than mock-infected Vero cells.
This suggests that MMEJ is significantly less active during AN-1 infection than it is in
mock infection or in wild type KOS infection, and C-NHEJ is more robust in the absence
of UL12 during infection. Thus, UL12 appears to play a role in the suppression of CNHEJ during infection.

4.4.i. D340E infection stimulates MMEJ in HCT-116 cells, but inhibits MMEJ in Vero
cells.
As mentioned earlier, C-NHEJ can occur in the absence of DNA-PKcs and Ku if
the substrate being repaired has ends that are easily ligatable, and therefore do not require
additional processing. Initially, we speculated that UL12 nuclease activity was required
to resect DNA ends, rendering them unsuitable for ligation by LIGIV, and thereby
inhibiting C-NHEJ. Thus, using the pDVG94 assay described above, we also tested
whether the nuclease activity of UL12 was required to suppress C-NHEJ activity by
measuring MMEJ activity during D340E infection of HCT-116 and Vero cells (Figure
4.11). An interesting discrepancy in the effect of D340E infection on MMEJ activity
appeared between HCT-116 cells and Vero cells. MMEJ activity in HCT-116 cells
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infected with D340E was significantly greater, about 4-fold, than in mock infected HCT116 cells (Figure 4.11), suggesting that C-NHEJ is being inhibited. This finding is
consistent with the observation that C-NHEJ does not appear to have an antiviral effect
on D340E infection and supports our hypothesis that UL12 does not require nuclease
activity to inhibit C-NHEJ during infection.
This observation, however, may be cell-type specific. In contrast to HCT-116
cells, Vero cells infected with the D340E exhibit significantly less MMEJ activity (nearly
2-fold less) compared to mock infected Vero cells (Figure 4.11, light green bars). This
suggests that C-NHEJ may not be inhibited by D340E in this cell type. Thus, UL12
nuclease activity may affect MMEJ activity, perhaps by inhibiting C-NHEJ, in a cell-type
specific manner. Another interesting explanation for this cell type dependence may be the
presence of DNA-PKcs. We know that ICP0 degrades DNA-PKcs in HCT-116 cells, but
not Vero cells [Mohni, unpublished data, (Wilkinson and Weller 2004)]. Furthermore, in
Chapter 2, we demonstrated that DNA-PKcs signaling is inhibited in Vero cells, even
though the protein is not degraded (Figure 2.7). Thus, in HSV-infected Vero cells, DNAPKcs is present, but not catalytically active. Several studies have suggested that the
presence of catalytically inactive DNA-PKcs is more deleterious to the cell than the
absence of DNA-PKcs altogether because DNA-PKcs may still be able to inhibit other
repair pathways, even in a catalytically inactive state (Calsou, Frit et al. 1999, Wang,
Perrault et al. 2003, Perrault, Wang et al. 2004, Convery, Shin et al. 2005, Cui, Yu et al.
2005). It may be that, in cell types in which DNA-PKcs is not degraded, UL12 is required
to overcome inhibition by DNA-PKcs and to stimulate more productive forms of repair.
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Further experiments will be required to determine whether this is the case, and what
affect inactive DNA-PKcs has on DDR pathway choice in the context of infection.

4.5. DISCUSSION
4.5.a. Summary
Cellular DNA damage response (DDR) pathways have been shown to exert both
positive and negative effects on HSV-1 infection. Accordingly, HSV-1 has evolved
mechanisms to influence DDR pathway choice in order to establish productive infection.
Several lines of evidence suggest that C-NHEJ is antiviral, and that HSV-1 inhibits this
pathway during infection. First, we have previously shown that NHEJ is inhibited during
HSV-1 infection (Schumacher, Mohni et al. 2012). Furthermore, DNA-PKcs has been
shown to moderately inhibit viral replication in infected human glioma cells (Parkinson,
Lees-Miller et al. 1999). We have now shown that the knockout of the core C-NHEJ
proteins, LIGIV and XRCC4, improves growth of wild type virus 2 to 3-fold, suggesting
that these proteins are antiviral. The viral proteins, UL12 and ICP0, have both been
shown to influence DDR pathway choice during infection, and we therefore sought to
examine the roles of UL12 and ICP0 in the suppression of C-NHEJ and MMEJ activity.
Using knockout cell lines for core C-NHEJ proteins, we demonstrated that growth
of the UL12-null virus (AN-1) was more robust on C-NHEJ deficient cells. Although
growth of the ICP0-null virus (0β) was unchanged on C-NHEJ deficient cells, we found
that viral gene expression was more robust on DNA-PKcs -/- cells (Figure 4.4). This result
may suggest that DNA-PKcs has an auxiliary antiviral activity, which is separate from its
role in C-NHEJ (discussed below). Finally, using a reporter substrate that measures

149	
  

relative MMEJ and C-NHEJ activities, we found that C-NHEJ was more active in AN-1
infected cells, and MMEJ was more active in 0β infected cells, compared to mock
infected cells (Figure 4.11). Taken together, these findings suggest that UL12 may play a
role in suppressing C-NHEJ, and ICP0 may help to suppress the MMEJ pathway during
infection; however, further studies will be required to determine the mechanisms
underlying these observations.
The results described in this chapter demonstrate that both ICP0 and UL12 have
essential and distinct roles in directing DDR pathway choice during HSV-1 infection. It
has previously been shown that ICP0 acts as a “first line” of defense during HSV-1
infection by degrading or inhibiting components of ND10 and the DDR pathways in
order to prevent silencing of the viral genome (Parkinson, Lees-Miller et al. 1999,
Parkinson and Everett 2000, Lilley, Chaurushiya et al. 2011, Smith, Reuven et al. 2014).
In addition, infection with an ICP0-null virus results in silencing of viral genomes in nonpermissive cells (Jackson and DeLuca 2003). If ICP0 is unable to prevent genome
silencing at early times, then the infection proceeds to latency. The phenotype of the
UL12-null virus (AN-1), on the other hand, displays defects associated with later times
during the HSV lifecycle, resulting in aberrant DNA structures and the accumulation of
empty (“A”) capsids (Shao, Rapp et al. 1993, Porter and Stow 2004). In this study we
showed that C-NHEJ proteins, DNA-PKcs and LIGIV, may contribute to the production
of aberrant, slow-migrating viral DNA during AN-1 infection, which has previously been
observed in other non-complementing cell types (Figure 4.7 and Chapter 3). Thus, UL12
may influence viral replication at later times than ICP0 during infection.
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4.5.b. UL12 may modulate cellular factors that influence DDR pathway choice, such as
FANCD2, Ku70, and MRE11.
The mechanism by which a cell commits to a specific DNA repair pathway
involves a variety of factors, including cell cycle, the nature of the damage, the structural
complexity of DNA ends, and the repair proteins that initially respond to the DSB. Many
of the details underpinning DDR pathway choice are still being disputed or remain
unknown; however, it is clear that the inhibition or stimulation of DNA resection is a
major determinant. HR, SSA, and MMEJ all require an initial end resection step; whereas,
C-NHEJ does not (Lieber 2010, Truong, Li et al. 2013). In uninfected mammalian cells,
the Ku70/86 heterodimer is thought to rapidly bind dsDNA ends in order to promote CNHEJ (Fukushima, Takata et al. 2001, Zhang, Zhu et al. 2001, Beucher, Birraux et al.
2009, Shibata, Conrad et al. 2011) and inhibit HR, SSA, and MMEJ (Pierce, Hu et al.
2001, Stark, Pierce et al. 2004, Oh, Harvey et al. 2014). On the other hand, dsDNA end
resection by MRE11 and CtIP is thought to disrupt Ku binding to DNA, and promote
homology-mediated repair pathways (Shibata, Conrad et al. 2011, Truong, Li et al. 2013,
Shibata, Moiani et al. 2014). In addition, the FA effector protein, FANCD2, has been
shown to inhibit Ku70-binding to dsDNA ends by a similar mechanism, and thus inhibit
C-NHEJ (Pace, Mosedale et al. 2010).
It is likely that end resection is also at the heart of DDR pathway choice during
HSV-1 infection, and UL12 is strongly implicated in this process. We have previously
shown that UL12 stimulates SSA in a nuclease-dependent fashion, perhaps by extensive
resection at dsDNA ends (Schumacher, Mohni et al. 2012). We now also believe that
UL12 plays a role in the inhibition of the C-NHEJ pathway during HSV-1 infection,
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since the UL12-null virus (AN-1) grows significantly better on cells that are deficient for
core C-NHEJ proteins. Interestingly, UL12 does not require its nuclease activity to inhibit
C-NHEJ in HCT-116 cells (Figure 4.11). UL12 has been shown to interact with MRE11
(Balasubramanian, Bai et al. 2010) and FANCD2 (Karttunen, Savas et al. 2014), and
perhaps recruits these factors in order to promote end resection and inhibit C-NHEJ.
Ku70 has also been shown to interact with UL12 during HSV-1 infection
(Balasubramanian, Bai et al. 2010); however, it is currently unclear whether UL12 exerts
a positive or negative effect on Ku activity. In any case, UL12, by itself or with the help
of interacting partners, may disrupt Ku binding at dsDNA ends (Figure 4.12). Future
studies will be required to determine whether UL12 mediates DDR pathway choice, at
least in part, through its interactions with cellular DDR factors, such as FANCD2, Ku70,
and MRE11 (Balasubramanian, Bai et al. 2010, Balasubramanian 2011, Karttunen, Savas
et al. 2014).

4.5.c. ICP0 and its complicated relationship with C-NHEJ
ICP0 acts as the special ops of HSV-1 infection; it eliminates cellular defenses
that would otherwise silence the viral genome and inhibit infection. It is a fascinating
protein because it inhibits and degrades numerous cellular factors during HSV-1
infection; however, the pleiotropic nature of ICP0 also makes it difficult to determine
why it is beneficial for the virus to inhibit any individual target of ICP0. For instance,
ICP0 degrades or inhibits DNA-PKcs signaling in numerous cell types, thus it is
generally believed that ICP0 plays an important role in inhibiting C-NHEJ (Lees-Miller,
Long et al. 1996, Parkinson and Everett , Smith, Reuven et al. 2014). Yet, DNA-PKcs is
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not absolutely required for C-NHEJ, and the results presented in this paper suggest that
ICP0 may inhibit DNA-PKcs in order to promote viral gene expression or evade other
antiviral mechanisms.
ICP0 also degrades the cellular E3 ubiquitin ligase, RNF8 (Lilley, Chaurushiya et
al. 2010). RNF8 is a DDR factor that is commonly associated with HR; however, it has
also been shown to play an important role in facilitating resolution of C-NHEJ, by
removing Ku86 from DSBs (Feng and Chen 2012). Thus, ICP0 may also help to inhibit
C-NHEJ through degradation of RNF8. In order to determine whether this is the case,
further experiments would be required to examine whether Ku86 is retained at DSBs in
ICP0-null infected cells, and if so, what effect Ku86-retention may have on repair
pathway choice during infection. In addition, it is possible that ICP0 affects DDR
pathway choice through degradation of one of its other targets as well (discussed below).

4.5.d. ICP0-mediated degradation of PARG may inhibit MMEJ.
MMEJ remains poorly understood, in part because the factors required for this
process are not completely defined. Nevertheless, several factors have been implicated in
MMEJ. PARP-1 (poly (ADP-ribose) polymerase 1) is a molecular sensor of DNA breaks,
and is thought to compete with Ku for binding of DNA ends (Wang, Wu et al. 2006).
MRE11 has been shown to interact with PARP-1 and is recruited to DSBs to perform the
initial end resection step required in order to expose regions of microhomology (Haince,
McDonald et al. 2008, Bryant, Petermann et al. 2009, Pines, Mullenders et al. 2013).
DNA ligase III (LIGIII) is thought to be the primary ligase involved in MMEJ, although
DNA ligase I (LIGI) may compensate for LIGIII (Wang, Rosidi et al. 2005, Liang, Deng
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et al. 2008). Other accessory factors implicated in MMEJ include XRCC1, CtIP, and
DNA pol β (Ottaviani, LeCain et al. 2014), and additional proteins may yet be identified.
In this study, we have reported that MMEJ is stimulated in cells infected with the
ICP0-null (0β) virus (Figure 4.11), suggesting that ICP0 may inhibit MMEJ during HSV1 infection. Given that the components of MMEJ are not fully characterized, it is difficult
to conjecture as to the mechanism by which ICP0 inhibits MMEJ; however, among the
known degradation targets of ICP0, there may be at least one candidate. ICP0 has
recently been shown to degrade the poly (ADP-ribose) (PAR) glycosylase (PARG)
(Grady, Hwang et al. 2012). PARG plays an important role in the resolution of DNA
damage foci by cleaving PAR polymers that are attached to DNA and proteins by PARP1 in response to DNA damage. PARG promotes attachment of XRCC1 and LIG III at
sites of DNA damage, which are factors associated with MMEJ. Thus, PARG may
promote repair by MMEJ (Wei, Nakajima et al. 2013). With this in mind, it is tempting to
speculate that ICP0 inhibits MMEJ during wild type (KOS) infection through degradation
of PARG; however, additional experiments will be required to determine the exact
mechanism by which ICP0 affects pathway choice.

4.5.e. The role of C-NHEJ proteins in HSV-1 infection.
Parkinson et al. reported that HSV-1 infection produced 6 to 200-fold more virus
on DNA-PKcs deficient human glioma cells (M059J) compared with wild type cells
(M059K)(Parkinson, Lees-Miller et al. 1999). On the other hand, we observed that DNAPKcs deficiency did not have a significant effect on wild type HSV-1 growth in the HCT116 cell line (Figure 4.6). We believe that the discrepancy between these findings may be
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due to several differences between the M059J and HCT-116 DNA-PKcs-/- cell lines. First,
the panel of HCT-116 cell lines used in our study are isogenic, meaning that they are
genetically matched. Thus, the wild type HCT-116 cells and the DNA-PKcs-/- cells only
differ in expression of DNA-PKcs (Ruis, Fattah et al. 2008). In contrast, the M059J cell
line was isolated from a patient (Allalunis-Turner, Barron et al. 1993), and the DNAPKcs deficiency was the result of a spontaneous mutation. Thus, M059J cells are not
isogenically matched with the wild type (M059K) cell line. In fact, M059J cells are
highly aneuploid (Anderson, Dunn et al. 2001) and contain mutations in numerous genes,
including: ATM (Tsuchida, Yamada et al. 2002), p53 (Anderson and Allalunis-Turner
2000), FANCA (Halling-Brown, Bulusu et al. 2012). Therefore, although these cell lines
have been extensively used to study DNA repair, it is unclear whether the observations
reported by Parkinson et al., are directly due to DNA-PKcs deficiency (Parkinson, LeesMiller et al. 1999). Although we do believe that DNA-PKcs is antiviral, it is possible that
it is not as inhibitory to viral growth as previously reported and other components of the
C-NHEJ pathway may restrict the virus more efficiently.
Although we have shown that NHEJ is inhibited during infection, there is
conflicting evidence as to whether the core components of the C-NHEJ pathway, namely
LIGIV and XRCC4, are antiviral. Muylaert et al., reported that RNAi knockdown of
LIGIV and XRCC4 decreased viral yield at 20 h post infection by 8-fold and 19-fold,
respectively, and (Muylaert and Elias 2007). This result is similar to our findings at
earlier times post infection, where LIGIV-/- and XRCC4-/- cells appear to replicate HSV-1
less efficiently than wild type HCT-116 cells (Figure 4.5, Table 4.1). However, at 48 h
post infection, we show that viral yields are about 3 fold greater on LIGIV-/- and XRCC4-
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cells compared to wild type HCT-116 cells (Figures 4.5 and 4.6, Table 4.1). Thus,

although it was previously reported that LIGIV and XRCC4 are required for efficient
viral replication, we now show that LIGIV and XRCC4 are antiviral.
Determining whether C-NHEJ plays a positive or negative role during HSV-1
infection is part of a bigger question regarding the mechanism of HSV-1 replication,
which remains poorly understood. It has been proposed that the HSV-1 genome
circularizes upon infection and undergoes rolling circle replication (Jacob, Morse et al.
1979, Mocarski and Roizman 1982, Poffenberger and Roizman 1985, Garber, Beverley et
al. 1993). Muylaert and Elias reported that the LIGIV/XRCC4 complex was required for
the formation of endless genomes (Muylaert and Elias 2007). From this observation, they
proposed that the LIGIV/XRCC4 complex is required for circularization of the HSV-1
genome prior to rolling circle replication, suggesting that C-NHEJ plays a positive role
during infection. The notion that HSV-1 undergoes rolling circle replication, however,
has not been proven. In fact, there is evidence that circularization of the genome is
associated with establishment of latent infection, rather than lytic infection (Rock and
Fraser 1983, Efstathiou, Minson et al. 1986, Jackson and DeLuca 2003). Thus, the
observation that LIGIV/XRCC4 are required for the formation of endless genomes may
indicate that these proteins are antiviral and promote latent infection. Whether or not CNHEJ activity causes circularization, the fate of the viral genome and the choice of
repair/recombination pathway activated during infection appear to have important
consequences for the establishment of lytic infection.
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Figure 4.1. Schematic of the hierarchical model for DSBR pathway choice. In this
model, homology directed repair (HR) and classic non-homologous end joining (CNHEJ) are the predominant mechanisms for the repair of DNA double strand breaks
(DSBs). In the event that repair by HR fails (left), the break can either be repaired by
single strand annealing (SSA) or by microhomology mediated end joining (MMEJ). In
the event that C-NHEJ fails, the break can be repaired by MMEJ (right).
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Figure 4.2. Diagram of the relationship between the classic non-homologous end
joining (C-NHEJ) and DNA-PKcs-dependent (D-NHEJ) pathways. DNA double
strand breaks (DSBs) are sensed and bound by the Ku70/86 heterodimer. C-NHEJ of
DSBs that are easily ligatable (left panel) requires LIGIV/XRCC4/XLF. D-NHEJ occurs
if DSB ends are not easily ligatable (right panel). For D-NHEJ, DNA-PKcs is required to
activate end-processing enzymes, such as Artemis, to produce suitable DNA ends for CNHEJ.
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HCT-116 wt p<0.001
DNA-PK -/-

Figure 4.3. 0β has a greater probability of plaque formation on DNA-PK-/- cells.
(A) HCT-116 (wt), DNA-PK-/-, and LIG IV

-/-

cells were plated and infected with

identical dilutions of either wt (in1863) or ΔICP0 (dl1403/CMVlacZ). The relative
probability of plaque formation was determined at each dilution. The values represent the
averages of 5 independent experiments and the error represents the standard error.
Representative plaque plates are shown for 1 dilution of ICP0 on each cell line. (B)
Western blot for DNA-PKcs expression on wild type and DNA-PKcs-/- cell lines (top
panel) and LIGIV expression on wild type and LIGIV-/- cell lines (bottom panel). (C)
Representative experiment showing LacZ staining of ΔICP0 (dl1403)-infected HCT-116,
DNA-PKcs-/-, and LIGIV-/- cells **Experimental data and figure produced by Kareem N.
Mohni.

160	
  

8

Virus Titer (log10 PFU/mL)

7
6
5

HCT-116
DNA-PK-/LIG IV-/-

4
3
2
1
0.1

0.05

0.01

0.005

0.001

Multiplicity of infection (MOI)

Figure 4.4. Neither DNA-PKcs nor LIGIV affect virus production from ΔICP0
infection at very low MOIs. HCT-116, DNA-PK-/-, and LIG IV-/- cells were infected
with the ICP0-null virus, 0β, at very low MOIs (0.1, 0.05, 0.01, 0.005, 0.001) for 48
hours. Infected cell lysates were harvested and viral yields were titrated on U2OS cells.
Error bars represent standard error of the mean for three individual experiments.
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LIG IV and XRCC4 are required for efficient replication of HSV-1 ΔUL12 (AN-1). HCT-116
and derivative cell lines: DNA-PKcs-/-, LIG IV-/- and XRCC4-/- were infected at an MOI of
0.1 pfu/cell. Progeny virus was collected at the indicated times post infection and titrated
on the indicated cell lines. (A) Growth curves for KOS, titrated on Vero cells. (B) Growth
curves for AN-1, titrated on UL12-complementing (6-5) cells. Values represent the averages of at least three independent experiments. Error bars represent standard error of
the mean for each data point.
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Figure 4.5. Time course of KOS and AN-1 growth on C-NHEJ-deficient cell lines.
HCT-116, DNA-PKcs-/-, LIG IV-/-, and XRCC4-/- cells were infected at an MOI of 0.1
pfu/cell. Samples were harvested at either 24 h post infection (A), or 48 h post infection
(B), and titrated on their respective complementing cell lines (see Materials and Methods
section). Values represent the average of at least three independent experiments. Error
bars represent standard error of the mean for each data point.
*p≤0.01; **p≤0.001; ***p≤0.0001
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Figure 4.6. Fold change in KOS and AN-1 virus yield on DNA-PK-/-, LIG IV-/-,
XRCC4-/-, and XLF-/- cells relative to growth on HCT-116 cells. Fold change in virus
yield was calculated relative to virus on HCT-116 for each virus. Values represent the
average of at least three independent experiments. Error bars represent standard error of
the mean for each data point. P values were calculated using the two-tailed student t-test
with equal variance. *p≤0.01; **p≤0.001; ***p≤0.0001; ****p≤0.00001
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Figure 4.7. Southern blot of HSV-1 replicating and virion DNA separated by pulsedfield gel electrophoresis (PFGE). Pulsed field gel electrophoresis of KOS and AN-1
infected cells (cell lines indicated above). The label, “cz”, indicates the compression zone
of the gel. “O” indicates circular genome derived from HSV-1 BAC grown in E. coli. The
152kb mark indicates the size of HSV-1 monomeric genomes. Preparation of plugs is
described in the Materials and Methods section. HCT-116* was prepared with 2X the
amount of infected cells as the HCT-116 sample.
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Figure 4.8. AN-1, and D340E virus growth yields on C-NHEJ-deficient cell lines.
HCT-116 (wt) cells and cells deficient for components of the C-NHEJ pathway (DNAPK-/-, LIG IV-/-, and XRCC4-/-) were infected with AN-1 or D340E at an MOI of 0.1.
Samples were harvested at either 24 h post infection (A), or 48 h post infection (B), and
titrated on their respective complementing cell lines (see Materials and Methods section).
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Figure 4.9. Schematic of the pDVG94 plasmid-based microhomology assay. (A)
Diagram of the plasmid-based reporter substrate, pDVG94, which is biased for repair via
microhomology-directed NHEJ (MMEJ). The plasmid is digested with Afe I and EcoRV
to produce a blunt-ended linear substrate with 6-bp direct repeats regions (boxes) at both
ends. DSB Repair by C-NHEJ will preserve a portion of both repeats. MMEJ results in
the deletion of one repeat, leaving a single intact repeat, which is a substrate for BstXI.
This panel is excerpted from Verkaik et al., 2002, Eur. J. Immunol., 32∶701. (B) The
experimental scheme for analysis of the plasmids recovered from transfected cells.
Recovered plasmids were PCR amplified, products were digested BstXI restriction
enzyme, and then analyzed via PAGE.

Panels A and B of this figure were taken from:
Fattah F, Lee EH, Weisensel N, Wang Y, et al. (2010) Ku Regulates the NonHomologous End Joining Pathway Choice of DNA Double-Strand Break Repair in
Human Somatic Cells. PLoS Genet 6(2): e1000855. doi:10.1371/journal.pgen.1000855
http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1000855
© 2010 Fattah et al. This is an open-access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use, distribution, and
reproduction in any medium, provided the original author and source are credited.
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Figure 4.10. Representative experiments measuring the effect of infection on MMEJ
in wild type and C-NHEJ-deficient cell lines. Representative microhomology
experiments were performed in HCT-116, DNA-PK-/-, LIG IV-/-, XRCC4-/-, and XLF-/cells infected with KOS, AN-1, D340E, and 0β. Left Panels: SYBR staining of
undigested (control) and BstXI-digested PCR products separated by PAGE. The 180bp
band (uncut) is substrate that had been repaired by C-NHEJ; whereas, the 120bp (cut)
band is MMEJ-repaired substrate. Right Panels: The representative experiments shown
on the left were quantitated using Image J software. Repair mediated by C-NHEJ or
MMEJ are represented as percent of the total repaired substrate.
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Figure 4.11. The effect of infection on the relative frequency of MMEJ in HCT-116
cells and Vero cells. HCT-116 cells and Vero cells were either mock infected, or
infected with KOS, AN-1, D340E, or 0β at an MOI of 3. At 1 h post infection cells were
transfected with the linearized pDVG94 reporter. The substrate was recovered at 48 h,
PCR amplified, and digested with BstXI. Total repaired substrate was quantified using
Image J software. Values are normalized to percent MMEJ in mock-infected cells. Values
represent the average of three experiments. Error is calculated by standard error of the
mean. P values were calculated using the two-tailed student t-test with equal variance.
* p ≤ 0.05; ** p ≤ 0.01
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Figure 4.12. A model for the mechanisms by which ICP0 and UL12 may direct DNA
repair pathway choice. (A) Diagram demonstrating how ICP0 and UL12 may work at
different stages to inhibit C-NHEJ and promote SSA/MMEJ. At early stages, ICP0
degrades or inhibits DNA-PKcs (Lees-Miller, Long et al. 1996, Parkinson, Lees-Miller et
al. 1999), perhaps to inhibit processing of DSBs for C-NHEJ. Inhibition of DNA-PKcs
may also play a positive role in early viral gene expression. Once expressed (~2h post
infection), UL12 interacts with Ku70, perhaps to prevent binding of Ku heterodimers to
dsDNA ends (Balasubramanian 2011). The UL12-FANCD2 interaction may play a role
in inhibiting Ku (Karttunen, Savas et al. 2014). UL12 has also been shown to interact
with the MRN complex (Balasubramanian, Bai et al. 2010). This interaction may help
recruit MRE11 to DSBs to perform limited end resection, either for MMEJ or as the first
stage of resection for SSA. Finally, ICP0 may suppress MMEJ so that repair by SSA is
favored. (B) ICP0 and UL12 may exert opposing forces on MMEJ.
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CHAPTER 5.

Summary and Perspectives

Portions of the text from this chapter were submitted as a review manuscript by
Samantha Smith and Sandra K. Weller, for publication in Future Virology.

5.1. SUMMARY
The overall goal of this thesis was to examine the factors that mediate DDR
during HSV-1 infection, and the consequences of incorrect pathway choice. Specifically,
we sought to determine whether UL12 acts as a mediator of DDR pathway choice in
order to produce DNA that is infectious and that can be packaged for productive infection.
The DNA produced in the absence of UL12 was found to be aberrant and non-infectious.
We have provided evidence that the production of aberrant DNA may be the result of
incorrect pathway choice. We showed that both ICP0 and UL12 inhibit aspects of the CNHEJ pathway in order to promote productive infection. This work demonstrates that CNHEJ is antiviral and that correct DDR pathway choice is essential for productive HSV-1
infection.
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5.2. SPECIFIC AIMS*
Aim 1. Test the hypothesis that the molecular architecture of HSV-1 DNA affects its
infectivity and the cellular DNA damage response.
This aim was addressed in Chapter 2, in which we enzymatically manipulated
purified DNA to determine whether structural elements in viral DNA could alter
infectivity. First, using a novel method, we calculated the number and length of gaps in
the HSV-1 genome. This method measured incorporation of labeled nucleotides into the
HSV-1 genome by Klenow polymerase. Confirming previous reports, we found HSV-1
genomes to contain about 15 gaps and that the gaps, on average, were about 33
nucleotides in length. We found that purified virion DNA activates DNA-PKcs in
transfected cells. This was in contrast to infection, in which DNA-PKcs was not activated.
DNA-PKcs is a component of the C-NHEJ pathway, which has been shown to be
antiviral. ICP0 is known to degrade DNA-PKcs in some cell types (Lees-Miller, Long et
al. 1996, Parkinson, Lees-Miller et al. 1999), and in Chapter 2 we showed that ICP0 is
sufficient to inhibit DNA-PKcs activity even in cells in which DNA-PKcs is not degraded.
In that study we also found that virion DNA with nicks and gaps was infectious but that
some enzymatic treatments had a profound effect on infectivity. For instance, it is known
that Klenow polymerase is capable of strand displacement synthesis, and when gaps were
filled in with Klenow alone, the polymerase was able to displace the 5’ ends of the next
fragment, creating 5’ flaps. Interestingly, Klenow-treated DNA lost infectivity. On the
other hand, other alterations to the DNA structure, such as filling-in gaps with a
polymerase that is not capable of strand displacement synthesis or addition of 3’ flaps,
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did not affect infectivity. The infectivity of virion DNA with 5’ flaps could be restored by
overexpression of ICP0 or by transfection of DNA-PKcs-/- cells. The observation that
infectivity can be restored by ICP0 and in the absence of DNA-PKcs along suggests that
ICP0 inhibits DNA-PKcs activation in order to promote productive infection.

Aim 2. Test the hypothesis that the growth defect observed in UL12-null (AN-1)
infection is due to the production of aberrant DNA.
Experimental data supporting this hypothesis was presented in Chapter 3 and
Chapter 4. First, we demonstrated that, although AN-1 growth is extremely defective in
most cell types, the growth defects are much less pronounced in complementing cells and
in DNA-PK -/- and LIG IV-/-cells. In Chapter 3, we also showed that purified AN-1 DNA
is not infectious when it is used to transfect Vero cells. Under these conditions, no viral
gene expression could be observed. AN-1 DNA was also not infectious in UL12expressing (6-5) cells. These observations are consistent with the hypothesis that the
DNA produced during AN-1 infection is aberrant and contributes to the overall growth
defect observed during AN-1 infection. Why AN-1 DNA does not support gene
expression is not yet known; however, it is likely related to the fragile nature of purified
AN-1 DNA and may be due to fragmentation. Further experiments will be required to
determine whether the AN-1 genome is silenced because it elicits a robust DDR response
than wild type DNA. For example, AN-1 DNA may induce a greater pRPA32 S4/S8
signal, as was observed with Klenow-treated DNA in Chapter 2 (Smith, Reuven et al.
2014). Another possibility is that, because AN-1 DNA is very fragile, pipetting the DNA
for transfection may render the genome too fragmented to be infectious. In support of this
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notion, in Chapter 2 we showed that fragmenting the wild type genome with mung bean
nuclease rendered it noninfectious (Smith, Reuven et al. 2014). Finally, transfection
efficiency should also be evaluated to rule out the possibility that uptake of AN-1 DNA is
less efficient than uptake of wild type DNA.
We also analyzed AN-1 DNA by PFGE and showed that AN-1 DNA from noncomplementing cells is different from AN-1 DNA from 6-5 cells in two important ways.
First, the AN-1 DNA from non-complementing cells appears as a smear at the 152kb
(genome length) mark. Second, there is an additional slower-migrating species present in
the compression zone of the gel. In Chapter 3, we show that compression zone (CZ)
DNA is present in AN-1-infected Vero and HeLa cells, neither of which complement
UL12; however, the CZ DNA species is not present AN-1-infected 6-5 cells. In Chapter
4, we demonstrated that CZ DNA is also not present in AN-1-infected cells that are
deficient for core C-NHEJ proteins (DNA-PK and LIG IV). This suggests that if C-NHEJ
is active, the viral DNA that is produced is aberrant in some way. In Chapter 4 we
demonstrated that AN-1 infection is more robust on C-NHEJ-deficient cell lines. Thus,
the appearance of aberrant CZ DNA correlates with conditions in which AN-1 growth is
most severely diminished. One explanation for these results is that C-NHEJ is antiviral,
perhaps leading to a DDR pathway choice that is not conducive to productive infection,
and the production of aberrant forms of viral DNA. It is possible that in cells infected
with wild type virus, UL12 plays a role in inhibiting C-NHEJ and that in the absence of
UL12, AN-1 is very sensitive to this pathway.
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Aim 3. Test the hypothesis that UL12 plays a role in the inhibition of DNA-PKcsindependent C-NHEJ.
Previously, we showed that HSV-1 infection stimulates SSA while inhibiting HR
and NHEJ (Schumacher, Mohni et al. 2012). It has previously been shown that HSV-1
viral growth is better on cells that do not express DNA-PKcs, a component of the CNHEJ pathway (Parkinson, Lees-Miller et al. 1999). These results suggest that DNAPKcs is antiviral and that ICP0 may play a role in counteracting antiviral effects. In fact,
it was previously recognized that DNA-PKcs, is degraded by ICP0 in many cell types
(Lees-Miller, Long et al. 1996, Parkinson, Lees-Miller et al. 1999, Davido, Von Zagorski
et al. 2003, Lin, Noyce et al. 2004, Lilley, Carson et al. 2005, Gregory and Bachenheimer
2008); however, we and others have shown that DNA-PKcs is not degraded during
infection in Vero cells. In Chapter 2, we demonstrated that ICP0 is sufficient to inhibit
DNA-PKcs activity in Vero cells. Thus, ICP0 inhibits DNA-PKcs even in cells in which
DNA-PKcs is not degraded. These results are consistent with the notion that DNA-PKcs
is antiviral and that HSV has evolved at least two ICP0-dependent mechanisms to inhibit
it. The observation that DNA-PKcs is not absolutely required for all C-NHEJ activity
(Riballo, Kuhne et al. 2004, van Heemst, Brugmans et al. 2004, Mari, Florea et al. 2006)
raised the question of whether other components of the C-NHEJ pathway are also
antiviral. We asked whether two core components of this pathway, LIG IV and XRCC4,
were also antiviral. In Chapter 4 we reported that the knockout of the core C-NHEJ
proteins, LIG IV and XRCC4, improves growth of wild type virus 2- to 3-fold,
suggesting that these proteins are antiviral. Interestingly, knockout of these proteins
improves growth of the UL12-null 8-fold and 11-fold, respectively. These results suggest
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that core C-NHEJ proteins are antiviral, and that in the presence of UL12, HSV-1 can
overcome this antiviral mechanism; however, in the absence of UL12, infection is
compromised. Unlike the null virus, the UL12 nuclease-dead mutant (D340E) grows
equally well on wild type HCT-116 cells as it does on the C-NHEJ knockout cells lines,
and D340E viral yields on these cell lines are equivalent to UL12-null on permissive cells
(ie. XRCC4-/- and LIG IV-/-). Thus the UL12-nuclease activity is not required for UL12mediated suppression of C-NHEJ.
In addition, we performed experiments using a reporter substrate that measures
relative MMEJ and C-NHEJ activities. It is now thought that MMEJ is “backup” pathway
that is activated when C-NHEJ is inactive (Bennardo, Cheng et al. 2008, Fattah, Lee et al.
2010). We have used a transfection-based assay that can distinguish between MMEJ and
C-NHEJ. In this assay if MMEJ activity is high, it indicates that C-NHEJ activity has
been suppressed, and vice-versa. We have previously shown that HSV infection inhibits
both pathways, and we now want to know which viral proteins are responsible. We have
already shown that ICP0 is at least in part responsible for inhibition of DNA-PK (and
presumably C-NHEJ), and we are now interested in how HSV inhibits MMEJ. In cells
infected with AN-1, MMEJ is decreased by more than two fold. In this assay, low MMEJ
indicates active C-NHEJ, suggesting that UL12 plays a role in suppression of C-NHEJ.
The nuclease dead mutant (D340E) is still able to inhibit C-NHEJ, raising the interesting
possibility that UL12 suppresses C-NHEJ through its interactions with DDR proteins
such as FANCD2, MRE11, or Ku70 rather than through its own nuclease activity.
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Figure 5.1. Diagram of the outcomes of DDR pathway choice, with and without
UL12, during HSV-1 infection. Left panel: In the presence of UL12, SSA is stimulated
and thus concatemer formation and successful cleavage and packaging of viral DNA is
promoted. Right panel: In the absence of UL12, C-NHEJ is inefficiently inhibited and
thus aberrant viral DNA is formed resulting in failed cleavage and packaging of viral
DNA.
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Figure 5.2. Model of the mechanism by which ICP0 and UL12 prevent the antiviral
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activity. UL12 inhibits C-NHEJ activity and prevents the formation of aberrant DNA
caused by incorrect DDR pathway choice.
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5.3. Models and future directions.
As described above, we have now shown that both ICP0 and UL12 inhibit aspects
of the C-NHEJ pathway in order to promote productive infection. In addition, we have
demonstrated that the structure of the viral genome itself may also influence the outcome
of DDR pathway choice at early stages during infection. Although the precise
mechanisms by which UL12, ICP0, and the viral genome regulate repair pathway usage
are not yet known, we have proposed several models:

5.3.a. UL12 may recruit cellular proteins to influence DDR pathway choice.
We have proposed that AN-1 DNA is not infectious because it contains structural
abnormalities and that aberrant DNA is the result of incorrect pathway choice. The
production of aberrant DNA during AN-1 infection may illustrate the important role that
UL12 plays in DNA repair pathway choice during HSV-1 infection. Because HSV-1
DNA replication remains poorly understood it is difficult to fully understand the function
of UL12 in the HSV-1 virus life cycle. HSV-1 replication produces complex DNA
structures, but the mechanism for this remains unknown. We have proposed that HSV-1
utilizes SSA to produce concatemers (Schumacher, Mohni et al. 2012, Weller and
Sawitzke 2014), but how this is initiated and how the process plays out in the context of
infection is also unclear. It is possible that UL12 is required to direct repair toward the
correct pathway, either by resecting DNA at DSBs or recruiting DDR proteins.
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It is likely that end resection is also at the heart of DDR pathway choice during
HSV-1 infection, and UL12 is strongly implicated in this process. We have previously
shown that UL12 stimulates SSA in a nuclease-dependent fashion, perhaps by extensive
resection at dsDNA ends (Schumacher, Mohni et al. 2012). We now also believe that
UL12 plays a role in the inhibition of the C-NHEJ pathway during HSV-1 infection,
since the UL12-null virus (AN-1) grows significantly better on cells that are deficient for
core C-NHEJ proteins. In Chapter 4 we demonstrated that UL12 does not require its
nuclease activity to inhibit C-NHEJ in HCT-116 cells (Figure 4.11). UL12 has been
shown to interact with MRE11 (Balasubramanian, Bai et al. 2010) and FANCD2
(Karttunen, Savas et al. 2014), and perhaps recruits these factors in order to promote end
resection and inhibit C-NHEJ. Ku70 has also been shown to interact with UL12 during
HSV-1 infection (Balasubramanian, Bai et al. 2010); however, it is currently unclear
whether UL12 exerts a positive or negative effect on Ku activity. In any case, UL12, by
itself or with the help of interacting partners, may disrupt Ku binding at dsDNA ends
(Figure 4.12). Future studies will be required to determine whether UL12 mediates DDR
pathway choice, at least in part, through its interactions with cellular DDR factors, such
as FANCD2, Ku70, and MRE11 (Balasubramanian, Bai et al. 2010, Balasubramanian
2011, Karttunen, Savas et al. 2014). In Chapter 4, we proposed that UL12 might recruit
MRE11 to DSBs, and MRE11 may perform the initial end resection step required for
either SSA or MMEJ (Figure 4.12). To test this, virus production, stimulation of SSA,
and inhibition of NHEJ could be measured on the MRE11-H129N nuclease mutant cell
line (Truong, Li et al. 2013), and compared to measurements of these properties on wild
type cells.
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5.3.b. ICP0 may inhibit C-NHEJ and MMEJ through degradation of antiviral factors.
The IE protein, ICP0, is an E3 ubiquitin ligase that promotes productive infection
by targeting antiviral factors for proteasomal degradation. ICP0 degrades or inhibits
DNA-PKcs signaling in numerous cell types, thus it is generally believed that ICP0 plays
an important role in inhibiting C-NHEJ (Lees-Miller, Long et al. 1996, Parkinson and
Everett , Smith, Reuven et al. 2014). The results presented in Chapter 4 suggest that ICP0
may also be required to inhibit MMEJ during infection. The mechanism by which ICP0
inhibits MMEJ is not yet known, but two previously characterized targets of ICP0 may be
implicated in this process: RNF8 and PARG (Lilley, Chaurushiya et al. 2010, Grady,
Hwang et al. 2012).
The E3 ubiquitin ligase, RNF8, functions in the cellular double strand break
response (DSBR), is a target of ICP0, and is degraded during HSV-1 infection (Lilley,
Chaurushiya et al. 2010). RNF8 recruits HR and C-NHEJ proteins to sites of damage,
and aiding in the resolution of DNA damage foci (Huen, Grant et al. 2007, Kolas,
Chapman et al. 2007, Mailand, Bekker-Jensen et al. 2007). More recently, Ku86 has been
identified as a target of RNF8 for ubiquitin ligase-mediated degradation (Feng and Chen
2012). RNF8 degrades Ku86 after the Ku70/86 heterodimer binds dsDNA ends. This is
an essential step in the resolution of C-NHEJ. In the absence of RNF8, Ku would be
expected to remain bound at dsDNA ends. Thus, completion of C-NHEJ would be
inhibited. Additionally, DNA bound by Ku would be protected from end resection, and
therefore other homology-mediated repair mechanisms may also be inhibited. Thus, ICP0
may also help to inhibit C-NHEJ and MMEJ through degradation of RNF8. If this were
the case, we would expect to see Ku retained at DSBs during HSV-1 infection. In support
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of this notion, it has been previously reported that Ku86 is present in replication
compartments (Taylor and Knipe 2004). Further experiments would be required to
examine whether Ku86 is retained at DSBs in replication compartments, and if so, what
effect Ku86-retention may have on repair pathway choice during infection. It was also be
important to determine whether ICP0 is sufficient to induce retention of Ku at sites of
DNA damage. To do this, the persistence of Ku at sites of DNA damage could be
monitored using immunofluorescence microscopy of cells transfected with ICP0. The
same type of experiment could also be done with infected cells by comparing persistence
of Ku in wild type-infected cells versus ICP0-null infected cells.
It is also possible that ICP0 affects DDR pathway choice through degradation of
one of its other targets as well. The DDR protein, PARG †, is also a target of ICP0mediated degradation during HSV-1 infection (Grady, Hwang et al. 2012). PARG plays
an important role in the resolution of DNA damage foci by cleaving PAR polymers that
are attached to DNA and DDR proteins in response to DNA damage. In addition, PARG
promotes attachment of XRCC1 and LIG III at sites of DNA damage, which are factors
associated with MMEJ (Wei, Nakajima et al. 2013). Thus, PARG may promote repair by
MMEJ. In Chapter 4, we demonstrated that ICP0 plays a role in the inhibition of MMEJ
during HSV-1 infection. One possible model for the inhibition of MMEJ by ICP0 during
wild type (KOS) infection is through the degradation of PARG. Additional experiments
will be required to determine whether ICP0-mediated degradation of PARG contributes
to inhibition of MMEJ during infection; however, this may be difficult, since ICP0
targets so many cellular proteins.
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Determining whether C-NHEJ plays a positive or negative role during HSV-1
infection is part of a bigger question regarding the mechanism of HSV-1 replication,
which remains poorly understood. It has been proposed that the HSV-1 genome
circularizes upon infection and undergoes rolling circle replication (Jacob, Morse et al.
1979, Mocarski and Roizman 1982, Poffenberger and Roizman 1985, Garber, Beverley et
al. 1993). On the other hand, it is possible that DNA-PKcs and the C-NHEJ pathway
promote circularization of the viral genome, as an antiviral mechanism to establish latent
or quiescent infection (Rock and Fraser 1983, Efstathiou, Minson et al. 1986, Jackson
and DeLuca 2003). This notion is supported by that observation made by Jackson and
Deluca, that ICP0 can inhibit circularization, and that circular viral genomes are more
prevalent during infection in the absence of ICP0 (Jackson and DeLuca 2003). In any
case, further experimentation will be required to fully understand how C-NHEJ and
circularization of viral genomes are antiviral. Regardless of whether circularization is the
mechanism by which C-NHEJ exerts its antiviral effects, the fate of the viral genome and
the choice of repair/recombination pathway activated during infection appear to have
important consequences for the establishment of lytic infection.
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5.4.Perspectives: Virus-host interactions and the evolutionary arms race.
Peter Wildy first observed genetic recombination between strains of HSV in 1955
(Wildy 1955). At the time, knowledge of DNA repair mechanisms was limited, and it has
only been in the last decade that particular DNA damage response (DDR) pathways have
been examined in the context of viral infections. One of the first reports addressing the
interaction between a cellular DDR protein and HSV-1 was that DNA-PKcs levels were
depleted in an ICP0-dependent manner during HSV-1 infection (Lees-Miller, Long et al.
1996). Since then, there have been numerous reports describing the interactions between
HSV infection and cellular DDR pathways (Wilkinson and Weller 2003, Everett 2006,
Lilley, Schwartz et al. 2007, Weitzman, Lilley et al. 2010, Weller 2010). The interaction
between HSV-1 and the cell reflects an evolutionary tug of war in which cells have
evolved antiviral mechanisms that are, in turn, counteracted by viral strategies that
promote lytic infection. Because viruses rely on host cellular machinery during infection,
they have evolved to usurp cellular processes. On the other hand, cells have intracellular
antiviral defenses designed to fight viral infections. An important feature of the antiviral
response is the cellular ability to sense viral DNA as “foreign”, and components of the
cellular DNA damage response (DDR) have been shown to function in this capacity.
Thus, although HSV-1 may utilize some components of the DNA damage response
machinery to replicate its genome, other components are antiviral, and HSV-1 has
developed mechanisms to silence some DDR factors in order to avoid antiviral restriction.
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The work presented in this thesis examines how the cellular NHEJ pathways are
manipulated by HSV-1 infection. It is likely that researchers have only scratched the
surface regarding the identification of cellular proteins that can trigger antiviral responses.
We predict that additional cellular factors that exert antiviral effects by sensing foreign
DNA will be identified. Cellular DDR pathways have no doubt influenced how HSV-1
has evolved an unusual mechanism by which to replicate its genome. If filling in nicks
and gaps and circularization are antiviral as we have suggested, it is possible that
recombination-dependent replication pathways using SSA and SDSA provide a
mechanism that evades these antiviral mechanisms and produces DNA concatemers that
can be packaged into infectious virus. We are struck by the fact that linear DNA viruses
from bacteria, protozoa, yeast, mammals and insects that replicate through concatemeric
DNA all encode two subunit recombinases similar to UL12 and ICP8. The evolutionary
conservation between the recombinases from these different DNA viruses suggests that
they have evolved replication strategies that are distinct from cellular replication
mechanisms and utilize an unusual form of recombination-dependent DNA replication. In
the case of HSV-1, which has co-evolved with its mammalian host, there has also been
evolutionary pressure to evade intrinsic and innate antiviral mechanisms.
A relevant example of a protein that may have evolved to avert viral infection is
the DNA sensing kinase, DNA-PKcs. This protein is absent in prokaryotes and lower
eukaryotes, and thus, is evolutionarily speaking, a relatively new protein. It has been
speculated that the emergence of DNA-PKcs as a component of the C-NHEJ may be part
of the reason that this pathway is the predominant mechanism for repair in vertebrates
and other higher eukaryotes (Mladenov and Iliakis 2011). In addition to its role in C-
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NHEJ, DNA-PKcs functions as part of the host innate response to foreign DNA. In this
role, DNA-PKcs acts as a DNA sensor, along with IFI16, to induce the IRF-3 dependent
innate response (Ferguson, Mansur et al. 2012). It would be interesting to examine how
viral proteins that interact with the C-NHEJ pathway have evolved to accommodate and
counteract the advent of DNA-PKcs, and whether DNA-PKcs arose from a need to
combat viral pathogens, such as HSV-1.
It is often discussed that viruses and their hosts are involved in an evolutionary
arms race, and indeed, herpesviruses are a prehistoric family that has existed before the
first mammal. The subfamily of Alphaherpesviruses is estimated to have arisen 400
million years ago, and coevolved with our first synapsid relatives (Grose 2012). As we
gain a better understanding of virus-host interactions, we also gain insight into the
evolutionary genealogy of the individual organisms. When a virus infects a new species
of host, it is often extremely virulent, and it is believed that virulence is attenuated as the
virus coevolves with its new host species. Since herpes is an ancient virus, it is tempting
to speculate that our very existence- the fact that we have brains and spines and fingers to
type on all sorts of technology- the fact that we are humans, we may at least, in part, have
herpes to thank. Maybe we evolved to avoid infection, and became more complex in
order to outwit the virus. At the very beginning of our evolution, the results could have
been dramatic.
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